The Beachbody Company, Inc. (BODI) 10-K 11 Mar 24 2023 FY Annual report Financial data

Cover Page

Cover Page - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Mar. 03, 2024	Jun. 30, 2023
Document Information [Line Items]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2023
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	FY
Entity Registrant Name	The Beachbody Company, Inc.
Entity Central Index Key	0001826889
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Document Financial Statement Error Correction [Flag]	false
Entity Shell Company	false
Entity Public Float				$ 57,754,248
Entity Interactive Data Current	Yes
Entity File Number	001-39735
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	85-3222090
Entity Address, Address Line One	400 Continental Blvd
Entity Address, Address Line Two	Suite 400
Entity Address, City or Town	El Segundo
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	90245
City Area Code	310
Local Phone Number	883-9000
Document Annual Report	true
Document Transition Report	false
Title of 12(b) Security	Class A Common Stock, par value $0.0001 per share
Trading Symbol	BODI
Security Exchange Name	NYSE
Documents Incorporated by Reference	Parts of the registrant ’ s definitive proxy statement for the 2024 Annual Meeting of Stockholders to be filed pursuant to Regulation 14A under the Securities Exchange Act of 1934 are incorporated by reference in Part III of this Annual Report on Form 10-K.
Auditor Name	Deloitte & Touche LLP	Ernst & Young LLP
Auditor Location	Los Angeles, California	Los Angeles, California
Auditor Firm ID	34	42
Common Class A [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding			4,101,895
Class X Common Stock [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding			2,729,003

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents (restricted cash of $0.1 million and $0.0 million at December 31, 2023 and 2022, respectively)	$ 33,409	$ 80,091
Restricted short-term investments	4,250
Inventory	24,976	54,060
Prepaid expenses	10,715	13,055
Other current assets	45,923	39,248
Total current assets	119,273	186,454
Property and equipment, net	45,055	74,147
Content assets, net	21,359	34,888
Goodwill and intangible assets, net	85,166	133,370
Right-of-use assets, net	3,063	5,030
Other assets	2,923	9,506
Total assets	276,839	443,395
Current liabilities:
Accounts payable	10,659	17,940
Accrued expenses	42,147	64,430
Deferred revenue	97,169	95,587
Current portion of lease liabilities	1,835	2,150
Current portion of Term Loan	8,068	1,250
Other current liabilities	5,325	3,283
Total current liabilities	165,203	184,640
Term Loan	21,491	39,735
Long-term lease liabilities, net	1,425	3,318
Deferred tax liabilities, net	10	181
Other liabilities	5,950	3,979
Total liabilities	194,079	231,853
Stockholders' equity:
Preferred stock, $0.0001 par value; 100,000,000 shares authorized, none issued and outstanding as of December 31, 2023 and 2022
Additional paid-in capital	654,657	630,738
Accumulated deficit	(571,876)	(419,235)
Accumulated other comprehensive income (loss)	(23)	37
Total stockholders’ equity	82,760	211,542
Total liabilities and stockholders' equity	276,839	443,395
Class A Common Stock [Member]
Stockholders' equity:
Common stock value	1	1
Class X Common Stock [Member]
Stockholders' equity:
Common stock value	1	1
Class C Common Stock [Member]
Stockholders' equity:
Common stock value

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Restricted cash	$ 0.1	$ 0
Preferred stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	100,000,000	100,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	1,900,000,000	1,900,000,000
Class A Common Stock [Member]
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	1,600,000,000	1,600,000,000
Common stock, shares issued	3,978,356	3,418,237
Common stock, shares outstanding	3,978,356	3,418,237
Class X Common Stock [Member]
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	2,729,003	2,825,006
Common stock, shares outstanding	2,729,003	2,825,006
Class C Common Stock [Member]
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	0	0
Common stock, shares outstanding	0	0

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Revenue:
Revenue	$ 527,109	$ 692,199
Cost of revenue:
Cost of revenue	204,022	322,626
Gross profit	323,087	369,573
Operating expenses:
Selling and marketing	282,147	359,987
Enterprise technology and development	74,407	104,363
General and administrative	57,932	78,426
Restructuring	6,497	10,047
Impairment of goodwill	40,000	0
Impairment of intangible assets	3,092	19,907
Total operating expenses	464,075	572,730
Operating loss	(140,988)	(203,157)
Other income (expense)
Loss on partial debt extinguishment	(3,168)
Impairment of other investment	(4,000)
Change in fair value of warrant liabilities	2,679	8,322
Interest expense	(8,874)	(3,368)
Other income, net	1,747	958
Loss before income taxes	(152,604)	(197,245)
Income tax (provision) benefit	(37)	3,053
Net loss	$ (152,641)	$ (194,192)
Net loss per common share, basic	$ (24.47)	$ (31.58)
Net loss per common share, diluted	$ (24.47)	$ (31.58)
Weighted-average common shares outstanding, basic	6,238,777	6,149,784
Weighted-average common share outstanding, diluted	6,238,777	6,149,784
Digital [Member]
Revenue:
Revenue	$ 258,370	$ 300,673
Cost of revenue:
Cost of revenue	64,942	66,419
Nutrition And Other [Member]
Revenue:
Revenue	249,510	353,331
Cost of revenue:
Cost of revenue	109,170	164,753
Connected Fitness [Member]
Revenue:
Revenue	19,229	38,195
Cost of revenue:
Cost of revenue	$ 29,910	$ 91,454

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Statement of Comprehensive Income [Abstract]
Net loss	$ (152,641)	$ (194,192)
Other comprehensive (loss) income:
Change in fair value of derivative financial instruments, net of tax	(360)	55
Reclassification of losses on derivative financial instruments included in net loss	222	108
Foreign currency translation adjustment	78	(105)
Total other comprehensive (loss) income	(60)	58
Total comprehensive loss	$ (152,701)	$ (194,134)

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock [Member] Common Class A and Class X [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Income (Loss) [Member]
Beginning balance at Dec. 31, 2021	$ 385,385	$ 2	$ 610,447	$ (225,043)	$ 21
Beginning balance, Shares at Dec. 31, 2021		6,192
Net loss	(194,192)			(194,192)
Other comprehensive income (loss), net of tax	58				58
Equity-based compensation	17,620		17,620
Equity-based compensation, Shares		17
Options exercised, net of tax withholdings	2,854		2,854
Options exercised, net of tax withholdings, Shares		37
Shares withheld for tax withholdings on vesting of restricted stock	(183)		(183)
Shares withheld for tax withholdings on vesting of restricted stock, Shares		(3)
Ending balance at Dec. 31, 2022	211,542	$ 2	630,738	(419,235)	(37)
Ending balance, Shares at Dec. 31, 2022		6,243
Net loss	(152,641)			(152,641)
Other comprehensive income (loss), net of tax	(60)				(60)
Equity-based compensation	23,891		23,891
Equity-based compensation, Shares		230
Forfeiture of shares per the Forfeiture Agreement , Shares		(160)
Issuance of shares due to Employee Stock Purchase Plan	553		553
Issuance of shares due to Employee Stock Purchase Plan , Shares		47
Issuance of Equity Offering, net of issuance costs	1,653		1,653
Issuance and sale of shares		421
Shares withheld for tax withholdings on vesting of restricted stock	(2,178)		(2,178)
Shares withheld for tax withholdings on vesting of restricted stock, Shares		(74)
Ending balance at Dec. 31, 2023	$ 82,760	$ 2	$ 654,657	$ (571,876)	$ (23)
Ending balance, Shares at Dec. 31, 2023		6,707

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net loss	$ (152,641)	$ (194,192)
Adjustments to reconcile net loss to net cash used in operating activities:
Impairment of goodwill	40,000	0
Impairment of intangible assets	3,092	19,907
Impairment of other investments	4,000
Depreciation and amortization expense	39,573	74,848
Amortization of content assets	23,755	24,276
Provision for inventory and inventory purchase commitments	10,561	39,757
Realized losses on hedging derivative financial instruments	222	108
Change in fair value of warrant liabilities	(2,679)	(8,322)
Equity-based compensation	23,891	17,620
Deferred income taxes	(191)	(2,961)
Amortization of debt issuance costs	1,899	733
Paid-in-kind interest	1,310	598
Loss on partial debt extinguishment	3,168
Change in lease assets	1,967
Other non-cash items		1,219
Changes in operating assets and liabilities:
Inventory	17,508	41,510
Content assets	(10,226)	(19,787)
Prepaid expenses	2,340	2,806
Other assets	(4,438)	4,241
Accounts payable	(7,103)	(26,705)
Accrued expenses	(20,293)	(8,673)
Deferred revenue	2,163	(9,563)
Other liabilities	(415)	(4,593)
Net cash used in operating activities	(22,537)	(47,173)
Cash flows from investing activities:
Purchase of property and equipment	(6,576)	(26,493)
Investment in restricted short-term investments	(4,250)
Net cash used in investing activities	(10,826)	(26,493)
Cash flows from financing activities:
Proceeds from exercise of stock options		3,162
Remittance of taxes withheld from employee stock awards		(308)
Debt Borrowings		50,000
Debt repayments	(17,000)	(625)
Proceeds from issuance of common shares in the Employee Stock Purchase Plan	553
Tax withholdings payments for vesting of restricted stock	(2,178)	(183)
Payment of debt issuance costs		(4,485)
Proceeds from issuance of Equity Offering, net of issuance costs	4,908
Net cash (used in) provided by financing activities	(13,717)	47,561
Effect of exchange rates on cash	398	(858)
Net decrease in cash, cash equivalents and restricted cash	(46,682)	(26,963)
Cash, cash equivalents and restricted cash, beginning of year	80,091	107,054
Cash, cash equivalents and restricted cash, end of year	33,409	80,091
Supplemental disclosure of cash flow information:
Cash paid during the year for interest	5,389	2,082
Cash paid during the year for income taxes, net	11	389
Supplemental disclosure of noncash investing activities:
Property and equipment acquired but not yet paid for	817	2,025
Supplemental disclosure of noncash financing activities:
Warrants issued in relation to Term Loan		$ 5,236
Change in fair value of term loan warrants due to amended exercise price	802
Paid-in-kind fee recorded as incremental debt issuance cost	$ 488

Description of Business and Sum

Description of Business and Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business and Summary of Significant Accounting Policies	Note 1 . Description of Business and Summary of Significant Accounting Policies Organization The Beachbody Company, Inc. (“BODi” or the “Company”) is a leading subscription health and wellness company and the creator of some of the world’s most popular fitness programs. The Company’s fitness programs are available for streaming through subscription to Beachbody On Demand (“BOD”) and, together with the Company’s live fitness and comprehensive nutrition programs, through subscription to Beachbody On Demand Interactive (“BODi”). During the three months ended March 31, 2023, the Company launched an improved BODi experience and began migrating all BOD-only members to BODi on their renewal dates. BODi offers nutritional products such as Shakeology nutrition shakes, Beachbody Performance supplements and BEACHBAR snack bars, which have been designed and clinically tested to help customers achieve their goals. BODi also offers a commercial-grade stationary cycle which can include a 360-degree touch screen tablet and connected fitness software. The Company’s revenue has historically been generated primarily through a network of micro-influencers (“Partners”), social media marketing channels, and direct response advertising. Basis of Presentation and Principles of Consolidation The Company prepares its consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) as determined by the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) and pursuant to the regulations of the U.S. Securities and Exchange Commission ("SEC"). The consolidated financial statements include the accounts of the Company and its controlled subsidiaries. All intercompany transactions and balances with or among our consolidated subsidiaries have been eliminated in consolidation. Use of Estimates The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that may impact the amounts reported in the consolidated financial statements and accompanying notes. Significant estimates in our consolidated financial statements include, but are not limited to, the useful life and recoverability of long-lived assets, the valuation of warrant liabilities, the recognition and measurement of income tax assets and liabilities, the valuation of intangible assets, impairment of goodwill and intangible assets, and the net realizable value of inventory. The Company bases these estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying amounts of assets and liabilities. Our actual results could differ from our estimates. We periodically review estimates and assumptions and we reflect the effects of changes, if any, in the consolidated financial statements in the period that they are determined. Segments The Company has one operating and reporting segment. In reaching this conclusion, management considered the definition of the Chief Operating Decision Maker (“CODM”); how the business is defined by the CODM; the nature of the information provided to the CODM and how that information is used to make operating decisions; and how resources and performance are accessed. The Company's CODM is the chief executive officer ("CEO"). The results of the operations are provided to and analyzed by the CODM at the Company level and accordingly, key resource decisions and assessment of performance are performed at the Company level based on the Company’s consolidated net revenues and operating income. Prior to the third quarter of 2022, the Company concluded it had two operating segments, Beachbody and Other, and one reportable segment, Beachbody. During the third quarter of 2022, in connection with the consolidation of its Openfit streaming fitness offering onto a single Beachbody digital platform, the Company determined that it had one operating and reportable segment and changed its segment reporting accordingly. Summary of Significant Accounting Policies Reverse Stock Split On November 21, 2023, we effected a 1-for-50 reverse stock split of our issued and outstanding common stock. Each stockholder's percentage ownership and proportional voting power generally remained unchanged as a result of the reverse stock split. All applicable share data, per share amounts and related information in the consolidated financial statements and notes thereto have been adjusted retroactively to give effect to the 1-for-50 reverse stock split. See Note 15 Stockholders' Equity for additional information regarding the reverse stock split. Recurring Fair Value Measurements For assets and liabilities that are measured using quoted prices (unadjusted) in active markets for identical assets or liabilities, the total fair value is the published market price per unit multiplied by the number of units held without consideration of transaction costs (Level 1). Assets and liabilities that are measured using significant other observable inputs are valued by reference to similar assets or liabilities, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data (Level 2). For all remaining assets and liabilities for which there are no significant observable inputs, fair value is derived using an assessment of various discount rates, default risk, credit quality, and the overall capital market liquidity (Level 3). These valuations require significant judgment. Non-Recurring Fair Value Measurements Certain assets are measured at fair value on a non-recurring basis. These assets are not measured at fair value on an ongoing basis but are subject to fair value adjustments only in certain circumstances. These assets can include long-lived assets that have been reduced to fair value when they are held for sale, equity securities without readily determinable fair value that are written down to fair value when they are impaired and long-lived assets (including intangible assets and goodwill) that are written down to fair value when they are impaired. Assets that are written down to fair value when impaired are not subsequently adjusted to fair value unless further impairment occurs. Cash and Cash Equivalents The Company considers all cash and short-term investments purchased with maturities of three months or less when acquired to be cash equivalents. Cash and cash equivalents include: • cash held in checking and money market funds; • amounts in transit from payment processors for customer credit and debit card transactions; and • highly liquid investments with original maturities of three months or less at the time of purchase. Cash and cash equivalents are carried at cost, which approximates market value. The Company maintains its cash at financial institutions, and the balances, at times, may exceed Federal Deposit Insurance Corporation insurance limits. The Company has not experienced any losses in such accounts. The Company mitigates its risk by placing funds in high-credit quality financial institutions and utilizing nightly sweeps into U.S. Treasury funds for certain cash accounts. We regularly monitor the financial stability of the financial institutions and believe that we are not exposed to any significant credit risk in cash and cash equivalents. Restricted cash primarily consists of cash held related to an irrevocable letter of credit, see Note 11 , Debt , for additional information on the letter of credit. Inventory Inventory consists of raw materials, work in process, and finished goods. Inventory is accounted for using the first-in, first-out method and is valued at the lower of cost or net realizable value. The Company records adjustments to the carrying value of inventory based on assumptions regarding future demand for the Company’s products, anticipated margin, planned product discontinuances, and the physical condition (e.g. age and quality) of the inventory. Accounts Receivable, Net (included in Other Current Assets) The Company's accounts receivable primarily represents amounts due from third party sales. The allowance for credit losses is based on several factors, including the length of time accounts receivable are past due, the Company's previous loss history, the specific customer's ability to pay its obligations and any other forward looking data regarding customers' ability to pay which may be available. Content Assets, Net The Company capitalizes costs associated with the development and production of programs on its streaming platforms. The Company capitalizes production costs as customer usage and retention data supports that future revenue will be earned. These costs are classified as non-current assets in the consolidated balance sheets. Content assets are predominantly monetized as a film group and are amortized over the estimated useful life based on projected usage, which has been derived from historical viewing patterns, resulting in an accelerated amortization pattern. Amortization begins when the program is first available for streaming by customers and is recorded in the consolidated statements of operations as a component of digital cost of revenue. When an event or change in circumstances indicates a change in projected usage, content assets are reviewed for potential impairment in aggregate at a group level. To date, the Company has not identified any such event or changes in circumstances. Property and Equipment, Net Property and equipment, which includes computer software and web development costs, are recorded at cost less accumulated depreciation. Depreciation is recorded on a straight-line basis over the estimated useful lives of the assets, which primarily range from two to seven years and up to 39 years for buildings. Leasehold improvements are depreciated over the shorter of the life of the assets or the remaining life of the related lease. Costs of maintenance, repairs, and minor replacements are expensed when incurred, while expenditures for major renewals and betterments that extend the useful life of an asset or provide additional utility are capitalized. Software and web development projects in-process consist primarily of costs associated with internally developed software that has not yet been placed into service. The Company capitalizes eligible costs to acquire, develop, or modify internal-use software that are incurred subsequent to the preliminary project stage. Depreciation of these assets begins upon the initial usage of the software. When property is sold or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts and any resulting gain or loss is included in net income (loss). Business Combinations The Company accounts for business combinations under the acquisition method of accounting. The cost of an acquired company is assigned to the tangible and identifiable assets purchased and the liabilities assumed on the basis of their fair values at the date of acquisition. Any excess of the purchase price over the fair value of tangible and intangible assets acquired is assigned to goodwill. The transaction costs associated with business combinations are expensed as they are incurred. Goodwill and Indefinite-Lived Intangible Assets Goodwill represents the excess of the fair value of the consideration transferred in a business combination over the fair value of the underlying identifiable assets and liabilities acquired. Goodwill and intangible assets deemed to have an indefinite life are not amortized. Instead, goodwill and indefinite-lived intangible assets are assessed for impairment annually or more frequently if an event or change in circumstances occurs that, with respect to goodwill, would more likely than not reduce the fair value of a reporting unit ("RU") below its carrying value or, for indefinite-lived intangible assets, indicate that it is more likely than not that the asset is impaired. The Company has historically performed its annual goodwill impairment assessment as of October 1. During the fourth quarter of 2023, the Company decided to change the date of its annual impairment assessment from October 1 to December 31. The Company completed the required annual impairment test for goodwill as of October 1, 2023, prior to the change of the annual impairment test for goodwill to December 31. The change was made to more closely align the impairment assessment date with the Company's annual planning and forecasting process. The change in date of the annual impairment test is not deemed material as the new measurement date of December 31 is in relative close proximity to the previous measurement date and the change did not have any impact on goodwill or the impairment of goodwill. The change has been applied prospectively and would not have had an impact on a retrospective basis. As of December 31, 2023 and 2022, the Company had no indefinite-lived intangible assets. Long-Lived Assets Management reviews long-lived assets (including property and equipment, content assets, and definite-lived intangible assets) for impairment whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. Recoverability of assets is determined by first grouping the long-lived assets at the lowest level for which there are identifiable cash flows, and then comparing the carrying value of each asset group to its forecasted undiscounted cash flows. If the forecasted undiscounted cash flows indicates that the carrying value of the assets is not recoverable, an impairment test of the asset group is performed. Impairment is recognized if the carrying amount of the asset group exceeds its fair value. As of December 31, 2023 and 2022, the Company’s long-lived assets were located in the U.S. Leases The Company accounts for its leases of administrative offices and production studios under ASC 842, Leases ; the Company does not have any leases where it acts as a lessor as of December 31, 2023. Under this guidance, arrangements meeting the definition of a lease are classified as operating or finance leases based on the principle of whether or not the lease is effectively a financed purchase of the leased asset by the lessee and are recorded on the consolidated balance sheets as both a right-of-use ("ROU") asset and lease liability, calculated by discounting fixed lease payments over the lease term at the discount rate implicit in the lease or the Company’s incremental borrowing rate. Lease liabilities are increased by interest and reduced by payments each period, and the ROU asset is amortized over the lease term. For operating leases, interest on the lease liability and the amortization of the ROU asset results in straight-lined rent expense over the lease term. For finance leases, interest on the lease liability and the amortization of the ROU asset results in front-loaded expense over the lease term. Variable lease expenses are recorded when incurred. In calculating the ROU asset and lease liability, the Company elected the practical expedient to combine lease and non-lease components. Rental income on subleases is recognized on a straight-line basis over the estimated lease term. The Company excludes short-term leases having initial terms of 12 months or less as an accounting policy election and instead recognizes rent expense on a straight-line basis over the lease term for such leases. Warrant Liabilities The Company has issued warrants on several occasions including during its initial public offering process, the execution of its Term Loan (defined later) and in the Equity Offering (defined later), which have not met the criteria to be classified in stockholders equity. Public and Private Placement Warrants The Company has outstanding warrants for the purchase of 200,000 shares of the Company's Class A common stock at an exercise price of $ 575.00 per share (the “Public Warrants”) and outstanding warrants for the purchase of 106,667 shares of the Company's Class A common stock at an exercise price of $ 575.00 per share (the “Private Placement Warrants”). All of the Public and Private Placement Warrants remained outstanding as of December 31, 2023 and 2022. The Public Warrants were publicly traded on the New York Stock Exchange (the "NYSE") but were delisted by the NYSE on November 24, 2023 due to their abnormally low price levels. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a cashless basis, as described in the warrant agreement. In no event will the Company be required to net cash settle any warrant. The Private Placement Warrants are transferable, assignable or salable in certain limited exceptions. The Private Placement Warrants are exercisable for cash or on a cashless basis, at the holder’s option, and are non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will cease to be Private Placement Warrants and will become Public Warrants, and will be redeemable by the Company and exercisable by such holders on the same basis as the other Public Warrants. Term Loan Warrants In connection with the Term Loan (defined later), the Company issued warrants for the purchase of 94,335 shares of the Company’s Class A common stock at an exercise price of $ 92.50 per share to certain holders affiliated with Blue Torch Finance, LLC (the “Term Loan Warrants”). In connection with the Second Amendment (defined later), the Company also amended and restated the Term Loan Warrants. The amendment of the Term Loan Warrants amended the exercise price from $ 92.50 per share to $ 20.50 per share. The Term Loan warrants vest on a monthly basis over four years and have a seven-year term. In connection with the Equity Offering (defined later), the Term Loan Warrants conversion ratio was amended resulting in an increase in the number of shares purchased upon the exercise of the Term Loan Warrants to 97,482 shares of the Company's Class A common stock. Common Stock Warrants In connection with the Equity Offering (defined later), the Company issued warrants (the "Common Stock Warrants") to certain institutional investors to purchase 543,590 shares of Class A common stock at an exercise price of $ 11.24 per share. The Common Stock Warrants may be exercised at any time beginning June 13, 2024 and will expire on June 13, 2029. See Note 15, Stockholders' Equity , for additional information on the Equity Offering and the Common Stock Warrants. The Company evaluated the Public, Private Placement, Term Loan and Common Stock Warrants (collectively, the "Warrants") under ASC 815, Derivatives and Hedging—Contracts in Entity’s Own Equity , and concluded they do not meet the criteria to be classified in stockholders’ equity. Since the Warrants meet the definition of a derivative under ASC 815, the Company recorded these warrants as other liabilities in the consolidated balance sheets at fair value, with subsequent changes in their respective fair values recognized in the change in fair value of warrant liabilities within the consolidated statements of operations at each reporting date. The Public Warrants were publicly traded until November 24, 2023, when they were delisted by the NYSE due to the NYSE's determination that the Public Warrants were no longer suitable for listing, and thus had an observable market price to estimate fair value until the date that they were delisted. The Private Placement, Term Loan and Common Stock Warrants, as well as the Public Warrants after the date they were delisted, are valued using a Black-Scholes option-pricing model as described in Note 3, Fair Value Measurements to the consolidated financial statements. The change in the fair values of the Warrants for the years ended December 31, 2023 and 2022, resulted in a $ 2.7 million and $ 8.3 million non-cash change in fair value gain in the consolidated statements of operations for the years ended December 31, 2023 and 2022, respectively. Other Investment As of December 31, 2023 and 2022, the Company has an investment in equity securities of a privately-held company of $ 1.0 million and $ 5.0 million , with no readily determinable fair value. This equity investment is reported within other assets in the consolidated balance sheets. The Company uses the measurement alternative for this investment, and its carrying value is reported at cost, adjusted for impairments or any observable price changes in ordinary transactions with identical or similar instruments. As of December 31, 2023 the Company recorded a $ 4.0 million impairment on this investment based on an observable price change. As of December 31, 2022, no adjustments to the carrying value of this investment were made. On January 9, 2024 the Company sold this investment for $ 1.0 million. See Note 23, Subsequent Events to the consolidated financial statements for additional information on the sale of this investment. Revenue Recognition The Company’s primary sources of revenue are from sales of digital subscriptions, nutritional products, and connected fitness equipment. The Company determines revenue recognition through the five-step model which requires us to: (i) identify our contracts with a customer; (ii) identify our performance obligations in the contract; (iii) determine the transaction price in the contract; (iv) allocate the transaction price to our performance obligation in the contract; and (v) recognize revenue when each performance obligation under the contract is satisfied. The Company records revenue when it fulfills its performance obligation to transfer control of the goods or services to its customer and defers revenue when it receives payments in advance of fulfilling its performance obligations. Revenue that is deferred is included in deferred revenue (for the remaining deferral period that is less than one year) and in other liabilities (for the remaining deferral period that is more than one year) in the consolidated balance sheets. Control of shipped items is generally transferred when the product is delivered to the customer. Control of services, which are primarily digital subscriptions, transfers over time, and as such, revenue is recognized ratably over the subscription period (up to 38 months). Shipping and handling charges billed to customers are included in revenue. The Company markets and sells its products primarily in the United States, Canada, the United Kingdom, and France. The amount of revenue recognized is the consideration that the Company expects it will be entitled to receive in exchange for transferring goods or services to its customers. Revenue is recorded net of expected returns, discounts, and credit card chargebacks, which are estimated using the Company’s historical experience. If actual costs differ from previous estimates, the amount of the liability and corresponding revenue are adjusted in the period in which such costs occur. The Company sells a variety of bundled products that combine digital subscriptions, nutritional products, and/or other fitness products. The Company considers these sales to be revenue arrangements with multiple performance obligations. For customer contracts that include multiple performance obligations, the Company accounts for individual performance obligations if they are distinct. The transaction price is then allocated to each performance obligation based on its stand-alone selling price. The Company generally determines the standalone selling price based on the prices charged to customers. Revenue is presented net of sales taxes and value added taxes ("VAT") and GST/HST (Goods and Services Tax/Harmonized Sales Tax) which are collected from customers and remitted to applicable government agencies. The Company records fees paid to its third party financing partners as a reduction of revenue. A description of our principal revenue generating activities is as follows: Digital Subscriptions – Our digital subscription services provide access to BODi, which provides a vast library of workout content. Digital subscriptions represent a single, stand-ready obligation and are paid for either at the time of or in advance of service delivery. Revenue from these arrangements is recognized over the subscription period. Nutritional Products – We offer a comprehensive line of nutritional products including nutritional supplement subscriptions and one-time nutritional sales. We often sell bundled products that combine digital subscriptions, nutritional products and/or fitness products. Revenue is recognized when control of the goods is transferred to the customer, which typically occurs upon delivery. See below for discussion of bundled products. Connected Fitness – We offer a connected fitness system that includes in-home fitness equipment and associated digital content subscriptions. Some of our in-home fitness contracts have multiple performance obligations, which include both hardware and a subscription service commitment. Revenue is recognized when control of the equipment is transferred to the customer, usually upon delivery. See below for discussion of bundled products. In cases where a customer contract contains multiple performance obligations, which the Company refers to as bundled products, we account for each obligation individually if they are distinct. We allocate the transaction price, net of discounts, to each performance obligation based on its standalone selling price. Revenue from such arrangements is recognized when control of the product is transferred to the customer, usually upon delivery. For digital subscription service commitments, revenue is recognized over the subscription period. The Company operates primarily as the principal in its relationships where third parties sell or distribute the Company’s goods or services, payments made to the third parties are recorded in selling and marketing expenses within the consolidated statements of operations. The Company in certain instances serves as the agent in relationships with third parties, the activity in these relationships are immaterial. Cost of Revenue Digital Cost of Revenue Digital cost of revenue includes costs associated with digital content creation including amortization and revisions of content assets, depreciation of streaming platforms, digital streaming costs, and amortization of acquired digital platform intangible assets. It also includes customer service costs, payment processing fees, depreciation of production equipment, live trainer costs, facilities, and related personnel expenses. Nutrition and Other Cost of Revenue Nutrition and other cost of revenue includes product costs, shipping and handling, fulfillment and warehousing, customer service, and payment processing fees. It also includes depreciation of nutrition-related e-commerce websites and social commerce platforms, amortization of formulae intangible assets, facilities, and related personnel expenses. Connected Fitness Cost of Revenue Connected fitness cost of revenue consists of product costs, including bike and tablet hardware costs, duties and other applicable importing costs, shipping costs, warehousing and logistics costs, costs associated with service calls and repairs of the products under warranty, payment processing and financing fees, customer service expenses, and personnel-related expenses associated with supply chain and logistics. The Company utilizes the practical expedient under ASC 606-10-25-18B to account for shipping and handling costs incurred to deliver products to customers as fulfillment activities, rather than a promised service (a revenue element). Shipping and handling costs are included in Nutrition and other cost of revenue and Connected fitness cost of revenue in the consolidated statements of operations in the period during which the products ship. The costs associated with shipping connected fitness and nutrition and other products to customers were $ 22.5 million and $ 35.4 million for the years ended December 31, 2023 and 2022, respectively. Selling and Marketing Selling and marketing expenses primarily include the costs of Partner compensation, advertising, royalties, promotions and events, and third-party sales commissions as well as the personnel expenses for employees and consultants who support these areas. Selling and marketing expenses also include depreciation of certain software and amortization of contract-based intangible assets. The Company pays Partner and third-party sales commissions when commissionable sales are made. The third-party sales commissions are not material. In cases where the underlying revenue is deferred, the Company also defers the commissions and expenses these costs in the same period in which the underlying revenue is recognized. Deferred Partner commissions are included in other current assets and other assets in the consolidated balance sheets and were $ 37.1 million and $ 32.8 million as of December 31, 2023 and 2022, respectively. Partners are also eligible for various bonuses, recognition, and complimentary participation in events, including those based on sales volume. The Company expenses these costs in the period in which they are earned. These expenses as well as Partner commissions earned but not paid are included in accrued expenses in the consolidated balance sheets. Advertising costs are primarily comprised of social media, television media, and internet advertising expenses and also include print, radio, and infomercial production costs. Generally, the costs to produce television and web advertising are expensed as incurred, while television media costs are expensed at the time the media airs. Total advertising expense, including the costs to produce infomercials, was $ 31.5 million and $ 36.9 million for the years ended December 31, 2023 and 2022, respectively. Enterprise Technology and Development Enterprise technology and development expenses primarily include personnel-related expenses for employees and professional fees paid to consultants to maintain the Company’s enterprise systems applications, hardware, and software. Expenses also include payroll and related costs for employees involved in the research and development of new and existing products and services, enterprise technology hosting expenses, depreciation of enterprise technology-related assets, and equipment leases. Research and development costs, which are expensed as incurred, were $ 2.7 million and $ 4.4 million for the years ended December 31, 2023 and 2022 respectively. Equity-Based Compensation The Company measures and recognizes compensation expense for all equity-based awards based on their estimated grant date fair values. The Company recognizes the expense on a straight-line basis over the requisite service period, and forfeitures are accounted for as they occur. Equity-based compensation expense is included in cost of revenue, selling and marketing, enterprise technology and development, and general and administrative expense within the consolidated statements of operations. Derivative Financial Instruments The Company may use derivative instruments to manage the effects of fluctuations in foreign currency exchange rates on the Company’s net cash flows. The Company primarily enters into option contracts to hedge forecasted payments, typically for up to 12 months, for cost of revenue, selling and marketing expenses, general and administrative expenses, and intercompany transactions not denominated in the local currencies of the Company’s foreign operations. The Company designates certain of these instruments as cash flow hedges and records them at fair value as either assets or liabilities within the consolidated balance sheets. Certain of these instruments are freestanding derivatives for which hedge accounting does not apply. Changes in the fair value of cash flow hedges are recorded in accumulated other comprehensive income (loss) until the hedged forecasted transaction affects earnings. Deferred gains and losses associated with cash flow hedges of third-party payments are recognized in cost of revenue, selling and marketing, or general and administrative expenses, as applicable, during the period when the hedged underlying transaction affects earnings. Changes in the fair value of certain d

Revenue

Revenue	12 Months Ended
	Dec. 31, 2023
Revenue from Contract with Customer [Abstract]
Revenue	Note 2. Revenue The Company’s revenue disaggregated by geographic region is as follows (in thousands): Year Ended December 31, 2023 2022 Geographic region: United States $ 473,465 $ 620,942 Rest of world 1 53,644 71,257 Total revenue $ 527,109 $ 692,199 1 Consists of Canada, United Kingdom and France. Other than the United Sates, no single country accounted for more than 10% of the Company’s total revenue. The Company determined that, in addition to the preceding table, the disaggregation of revenue by revenue type as presented in the consolidated statements of operations achieves the disclosure requirement to disaggregate revenue into categories that depict how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. Deferred Revenue Deferred revenue is recorded for nonrefundable cash payments received for the Company’s performance obligation to transfer, or stand ready to transfer, goods or services in the future. Deferred revenue consists of subscription fees billed that have not been recognized and physical products sold that have not yet been delivered. The Company expects to recognize approximately 95 % of the remaining performance obligations as revenue in the next 12 months, and the remainder thereafter. During the year ended December 31, 2023, the Company recognized $ 95.6 million of revenue that was included in the deferred revenue balance as of December 31, 2022. During the year ended December 31, 2022, the Company recognized $ 106.5 million of revenue that was included in the deferred revenue balance as of December 31, 2021. The balance in deferred revenue as of December 31, 2021 was $ 107.1 million.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 3. Fair Value Measurements The Company’s financial assets and liabilities subject to fair value measurements on a recurring basis and the level of inputs used for such measurements were as follows (in thousands): December 31, 2023 Level 1 Level 2 Level 3 Assets Derivative assets $ — $ — $ — Restricted short-term investments — 4,250 — Total assets $ — $ 4,250 $ — Liabilities Public Warrants $ — $ — $ 17 Private Placement Warrants — — 9 Term Loan Warrants — — 392 Common Stock Warrants — — 2,707 Total liabilities $ — $ — $ 3,125 December 31, 2022 Level 1 Level 2 Level 3 Assets Derivative assets $ — $ 462 $ — Total assets $ — $ 462 $ — Liabilities Public Warrants $ 415 $ — $ — Private Placement Warrants — — 107 Term Loan Warrants — — 1,226 Total liabilities $ 415 $ — $ 1,333 Fair values of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses approximate their recorded values due to the short period of time to maturity. Restricted short-term investments of $ 4.3 million at December 31, 2023 consist of a one-year certificate of deposit (“CD”) that matures on July 26, 2024 with an interest rate of 4.8 %, which is restricted due to a contractual agreement. The fair value of the Public Warrants, which traded in active markets until November 24, 2023, was based on quoted market prices during the period it was traded in active markets. The fair value of derivative instruments is based on Level 2 inputs such as observable forward rates, spot rates, and foreign currency exchange rates. The Company’s Private Placement Warrants, Term Loan Warrants and Common Stock Warrants, and the Company's Public Warrants after they ceased trading on an active market, are classified within Level 3 of the fair value hierarchy because their fair values are based on significant inputs that are unobservable in the market. Private Placement Warrants The Company determined the fair value of the Private Placement Warrants using a Black-Scholes option-pricing model and the quoted price of the Company’s Class A common stock. Volatility was based on the implied volatility derived from the Company's historical volatility. The expected life was based on the remaining contractual term of the Private Placement Warrants, and the risk-free interest rate was based on the implied yield available on U.S. treasury securities with a maturity equivalent to the Private Placement Warrants expected life. The significant unobservable input used in the fair value measurement of the Private Placement Warrants is the implied volatility. Significant changes in the implied volatility would result in a significantly higher or lower fair value measurement, respectively. The following table presents significant assumptions utilized in the valuation of the Private Placement Warrants on December 31, 2023 and 2022: As of December 31, 2023 2022 Risk-free rate 4.1 % 4.2 % Dividend yield rate — — Volatility 97.6 % 75.0 % Contractual term (in years) 2.48 3.49 Exercise price $ 575.00 $ 575.00 The following table presents changes in the fair value of the Private Placement Warrants for the years ended December 31, 2023 and 2022 (in thousands): Year Ended December 31, 2023 2022 Balance, beginning of period $ 107 $ 2,133 Change in fair value ( 98 ) ( 2,026 ) Balance, end of period $ 9 $ 107 For the years ended December 31, 2023 and 2022, the change in the fair value of the Private Placement Warrants resulted from the change in price of the Company’s Class A common stock, remaining contractual term, and risk-free rate. The changes in fair value are included in the consolidated statements of operations as a component of change in fair value of warrant liabilities and in the consolidated balance sheets as other liabilities. Public Warrants The Company determined the fair value of the Public Warrants, which traded in active markets until November 24, 2023, based on quoted market prices during the period it was traded in active markets. The Company determined the fair value of the Public Warrants after November 24, 2023 using a Black-Scholes option-pricing model and the quoted price of the Company’s Class A common stock. Volatility was based on the implied volatility derived primarily from the Company's historical volatility. The expected life was based on the remaining contractual term of the Public Warrants, and the risk-free interest rate was based on the implied yield available on U.S. treasury securities with a maturity equivalent to the Public Warrants expected life. The significant unobservable input used in the fair value measurement of the Public Warrants is the implied volatility. Significant changes in the implied volatility would result in a significantly higher or lower fair value measurement, respectively. The following table presents significant assumptions utilized in the valuation of the Public Warrants on December 31, 2023: As of December 31, 2023 Risk-free rate 4.1 % Dividend yield rate — Volatility 97.6 % Contractual term (in years) 2.48 Exercise price $ 575.00 The following table presents changes in the fair value of the Public Warrants for the years ended December 31, 2023 and 2022 (in thousands): Year Ended December 31, 2023 2022 Balance, beginning of period $ 415 $ 2,701 Change in fair value ( 398 ) ( 2,286 ) Balance, end of period $ 17 $ 415 For the years ended December 31, 2023 and 2022, the change in the fair value of the Public Warrants resulted from the change in price of the Public Warrants as traded on an active market and after November 24, 2023 the change in the fair value of the Public Warrants resulted from the change in price of the Company’s Class A common stock, remaining contractual term, and risk-free rate. The changes in fair value are included in the consolidated statements of operations as a component of change in fair value of warrant liabilities and in the consolidated balance sheets as other liabilities. Common Stock Warrants The Company determined the fair value of the Common Stock Warrants, which were issued on December 13, 2023, using a Black-Scholes option-pricing model and the quoted price of the Company’s Class A common stock. Volatility was based on the implied volatility derived from the average of the actual market activity of the Company’s peer group and the Company's historical volatility. The expected life was based on the remaining contractual term of the Common Stock Warrants, and the risk-free interest rate was based on the implied yield available on U.S. treasury securities with a maturity equivalent to the Common Stock Warrants expected life. The significant unobservable input used in the fair value measurement of the Common Stock Warrants is the implied volatility. Significant changes in the implied volatility would result in a significantly higher or lower fair value measurement, respectively. The following table presents significant assumptions utilized in the valuation of the Common Stock Warrants on December 31, 2023: As of December 31, 2023 Risk-free rate 3.8 % Dividend yield rate — Volatility 75.2 % Contractual term (in years) 5.44 Exercise price $ 11.24 The following table presents changes in the fair value of the Common Stock Warrants for the year ended December 31, 2023 (in thousands): Year ended December 31, 2023 Balance, beginning of year $ — Issued in connection with Equity Offering 3,255 Change in fair value ( 548 ) Balance, end of year $ 2,707 For the year ended December 31, 2023, the change in the fair value of the Common Stock Warrants for the period from December 13, 2023 (the date they were issued) to December 31, 2023 resulted from the change in price of the Company’s Class A common stock, remaining contractual term, and risk-free rate. The changes in fair value are included in the consolidated statements of operations as a component of change in fair value of warrant liabilities and in the consolidated balance sheets as other liabilities. Term Loan Warrants The Company determined the fair value of the Term Loan Warrants using a Black-Scholes option-pricing model and the quoted price of the Company’s Class A common stock. Volatility was based on the implied volatility derived from the average of the actual market activity of the Company’s peer group and the Company's historical volatility. The expected life was based on the remaining contractual term of the Term Loan Warrants, and the risk-free interest rate was based on the implied yield available on U.S. treasury securities with a maturity equivalent to the Term Loan Warrants expected life. The significant unobservable input used in the fair value measurement of the Term Loan Warrants is the implied volatility. Significant changes in the implied volatility would result in a significantly higher or lower fair value measurement, respectively. See Note 11, Debt , for additional information regarding the Term Loan Warrants. The following table presents significant assumptions utilized in the valuation of the Term Loan Warrants at December 31, 2023 and 2022: As of December 31, 2023 2022 Risk-free rate 3.8 % 4.0 % Dividend yield rate — — Volatility 74.5 % 75.0 % Contractual term (in years) 5.60 6.61 Exercise price $ 20.50 $ 92.50 The following table presents changes in the fair value of the Term Loan Warrants for the year ended December 31, 2023 and 2022 (in thousands): Year ended December 31, 2023 2022 Balance, beginning of year $ 1,226 $ — Issued in connection with Term Loan — 5,236 Amended in connection with Second Amendment 802 — Change in fair value ( 1,636 ) ( 4,010 ) Balance, end of year $ 392 $ 1,226 For the year ended December 31, 2023, the change in the balance of the Term Loan Warrants was due to the amendment of the Term Loan Warrants, which reduced the exercise price from $ 92.50 per share to $ 20.50 per share which resulted in an increase in the fair value of the Term Loan Warrants of $ 0.8 million as of the Second Amendment Effective Date (defined later) and the change in the fair value of the Term Loan Warrants. For the years ended December 31, 2023 and 2022 the changes in fair value of the Term Loan Warrants was due to the change in price of the Company’s Class A common stock, the remaining contractual term and the risk-free rate. The changes in fair value are included in the consolidated statements of operations as a component of change in fair value of warrant liabilities and in the consolidated balance sheets as other liabilities. Fair Value on a Non-recurring Basis Certain assets have been measured at fair value on a non-recurring basis, using significant unobservable inputs (Level 3). The following table presents the non-recurring losses recognized for the year ended December 31, 2023 due to asset impairments, and the fair value and asset classification of the related assets as of the impairment date (in thousands): December 31, 2023 Fair Value Total Losses Goodwill $ 85,166 $ ( 40,000 ) Other investments 1,000 ( 4,000 ) Intangible assets — ( 3,092 ) Total $ 86,166 $ ( 47,092 )

Inventory, Net

Inventory, Net	12 Months Ended
	Dec. 31, 2023
Inventory Disclosure [Abstract]
Inventory, Net	Note 4. Inventory Inventory consists of the following (in thousands): December 31, 2023 2022 Raw materials and work in process $ 10,354 $ 13,380 Finished goods 14,622 40,680 Total inventory $ 24,976 $ 54,060 Adjustments to the carrying value of excess inventory and inventory on hand and inventory purchase commitments to net realizable value were $ 10.6 million and $ 39.8 million during the years ended December 31, 2023 and 2022, respectively. These adjustments are included in the consolidated statements of operations as a component of nutrition and other cost of revenue and connected fitness cost of revenue. The Company recorded $ 3.4 million and $ 11.6 million of these adjustments in nutrition and other cost of revenue for the years ended December 31, 2023 and, 2022, respectively. The Company also recorded $ 7.2 million and $ 28.1 million of these adjustments in connected fitness cost of revenue for the years ended December 31, 2023 and 2022, respectively.

Other Current Assets

Other Current Assets	12 Months Ended
	Dec. 31, 2023
Other Current Assets [Abstract]
Other Current Assets	Note 5. Other Current Assets Other current assets consist of the following (in thousands): December 31, 2023 2022 Deferred Partner costs $ 36,169 $ 31,270 Deposits 6,788 4,527 Accounts receivable, net 1,270 866 Other 1,696 2,585 Total other current assets $ 45,923 $ 39,248

Property and Equipment, Net

Property and Equipment, Net	12 Months Ended
	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	Note 6. Property and Equipment, Net Property and equipment, net consists of the following (in thousands): December 31, 2023 2022 Computer software and web development $ 229,527 $ 236,533 Computer equipment 23,738 24,240 Buildings 5,158 5,158 Leasehold improvements 4,600 4,600 Furniture, fixtures and equipment 1,166 1,222 Computer software and web development projects in-process 2,157 5,147 Property and equipment, gross 266,346 276,900 Less: Accumulated depreciation ( 221,291 ) ( 202,753 ) Property and equipment, net $ 45,055 $ 74,147 During the year ended December 31, 2022, primarily due to the consolidation of the Company’s digital platforms and office lease assignment, the Company disposed of certain property and equipment no longer in use. The Company recognized a net loss related to these disposals of $ 1.2 million during the year ended December 31, 2022 in the consolidated statements of operations. There were no similar dispositions in the year ended December 31, 2023. On February 29, 2024, the Company sold its Van Nuys production facility which had a net carrying value of $ 4.8 at December 31, 2023, million for $ 6.2 million. Simultaneous with the sale, the Company entered into a five year lease of the facility at an annual base rate of $ 0.3 million per year. See Note 23, Subsequent Events , for additional information on the sale and leaseback of the facility. The Company recorded depreciation expense related to property and equipment in the following expense categories of its consolidated statements of operations as follows (in thousands): Year Ended December 31, 2023 2022 Cost of revenue $ 17,994 $ 27,137 Selling and marketing - 381 Enterprise technology and development 16,463 28,833 General and administrative 3 242 Total depreciation $ 34,460 $ 56,593

Content Assets, Net

Content Assets, Net	12 Months Ended
	Dec. 31, 2023
Content Assets [Abstract]
Content Assets	Note 7. Content Assets, Net Content assets, net consists of the following (in thousands): December 31, 2023 2022 Released, less amortization $ 21,134 $ 34,713 In production 225 175 Content assets, net $ 21,359 $ 34,888 The Company expects $ 14.4 million of content assets to be amortized during the next 12 months and 100 % of the balance within three years . The Company recor ded amortization e xpense for content assets of $ 23.8 million and $ 24.3 million during the years ended December 31, 2023 and 2022, respectively. In the beginning of the fourth quarter of 2023, the Company prospectively modified the amortization of the content assets due to a change in customer streaming behavior. This resulted in an acceleration of the content asset amortization of $ 2.1 million for the year ended December 31, 2023.

Goodwill

Goodwill	12 Months Ended
	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	Note 8. Goodwill Changes in goodwill for the years ended December 31, 2023 and 2022 are as follows (in thousands): December 31, 2023 2022 Goodwill, beginning of year $ 125,166 $ 125,166 Impairment of goodwill ( 40,000 ) — Goodwill, end of year $ 85,166 $ 125,166 2023 Interim Goodwill Impairment Test Due to the sustained decline in the Company’s market capitalization and macro-economic conditions observed in the three months ended June 30, 2023, the Company performed an interim test for impairment of its goodwill as of June 30, 2023. In performing the interim impairment test for goodwill, the Company elected to bypass the optional qualitative test and proceeded to perform a quantitative test by comparing the carrying value of its RU to its estimated fair value. The Company previously tested its RU for impairment as of December 31, 2022. The results of the Company’s interim test for impairment at June 30, 2023 concluded that the fair value of its RU exceeded its carrying value, resulting in no impairment. 2023 Goodwill Impairment Test The Company completed the required annual impairment test for goodwill as of October 1, 2023, prior to the change of the annual impairment test for goodwill to December 31. The Company performed a qualitative assessment which leveraged information from the June 30, 2023 quantitative assessment, in which it estimated the fair value of its RU and determined that the fair value of its RU was greater than its carrying value, resulting in no impairment. 2023 Annual Goodwill Impairment Test The Company assessed its long-lived assets for impairment prior to its goodwill impairment test. See Note 9, Intangible Assets, Net , for information on the long-lived assets impairment review and the recording of an intangible asset impairment. In testing for goodwill impairment as of December 31, 2023, the Company elected to bypass the optional qualitative test and proceeded to perform a quantitative test by comparing the carrying value of its RU to estimated fair value. The determination of the fair value of the Company’s RU was based on a combination of a market approach that considered benchmark company market multiples, a market approach that considered market multiples derived from the value of recent transactions, and an income approach that utilized discounted cash flows for the RU. The Company applied a 50 % weighting to the income approach that utilized discounted cash flows with the other two valuation methodologies having a weighting of 25 % each, in determining the fair value of the RU. The significant assumptions under each of these approaches include, among others; revenue projections, which are dependent on future customer subscriptions, new product introductions, customer behavior and competitor pricing, long-term growth rates, discount rates used in a discounted cash flow model in the income approach, the control premium and the terminal growth rate. The cash flows used to determine fair value are dependent on a number of significant management assumptions such as the Company’s expectations of future performance and the expected future economic environment, which are partly based upon the Company’s historical experience. The Company’s estimates are subject to change given the inherent uncertainty in predicting future results. Additionally, the discount rate and the terminal growth rate are based on the Company’s judgment of the rates that would be utilized by a hypothetical market participant. The Company also considered its market capitalization in assessing the reasonableness of the combined fair values estimated for its RU. The results of the Company's annual test for impairment at December 31, 2023 concluded that the fair value of the Company's RU was less than its carrying value. As a result, the Company recorded an impairment charge of $ 40.0 million related to its goodwill, which reduced the goodwill to $ 85.2 million at December 31, 2023. The Company's accumulated goodwill impairment as of December 31, 2023 was $ 92.6 million. The impairment at December 31, 2023 was primarily due to the sustained decline in the Company's stock price, which decreased approximately 45 % from September 30, 2023 to December 31, 2023, and a decline in revenue of 24 % for the year ended December 31, 2023 as compared to the prior year. Management will continue to monitor the Company's RU for changes in the business environment that could impact its fair value. Examples of events or circumstances that could result in changes to the underlying key assumptions and judgments used in the Company's goodwill impairment tests, and ultimately impact the estimated fair value of its RU may include the demand for at-home fitness solutions, the Company's subscriber growth rates, adverse macroeconomic conditions, and volatility in the equity and debt markets which could result in higher weighted-average cost of capital. Changes in management's expectations of future performance could have a significant impact on the Company's RU fair value. It should be noted that revenue and expectations of revenue have a significant impact on the RU's fair value. For the year ended December 31, 2023 the Company's revenue decreased by 24 % from the prior year. Continual decreases in revenue could have an impact on the future fair value of the Company's RU. The fair value of the Company's RU has been impacted by and will continue to be impacted by the volatility in the market price of the Company's common stock. The Company's stock price declined by 68 % in the year ended December 31, 2023. Continued decreases in the Company's stock price may result in a decrease in the fair value of the Company's RU and potential for incremental goodwill impairment. Changes in any of the assumptions used in the valuation of the RU, or changes in the business environment could materially impact the expected cash flows, and such impacts could potentially result in a material non-cash impairment charge. 2022 Annual Goodwill Impairment Test The Company completed the required annual impairment test for goodwill as of October 1, 2022. The Company performed a quantitative assessment, in which it estimated the fair value of its RU and determined that the fair value of its RU was greater than its carrying value, resulting in no impairment. 2022 Interim Goodwill Impairment Test Due to the sustained decline in the Company’s market capitalization and macro-economic conditions observed in the second quarter of 2022, the Company performed an interim test for impairment of its goodwill as of June 30, 2022. In performing the interim impairment test for goodwill, the Company elected to bypass the optional qualitative test and proceeded to perform quantitative tests by comparing the carrying value of the RU to its estimated fair value. The results of the Company’ s interim test for impairment at June 30, 2022 concluded that the fair value of its Beachbody RU exceeded its carrying value, resulting in no impairment. As a result of the change in segment reporting discussed above, the Company completed a qualitative test for impairment of its goodwill by RU both prior to and subsequent to the change. The qualitative assessment is an evaluation of whether it is more likely than not that the fair value of a RU is less than its carrying amount. In performing its qualitative assessment, the Company considered the significant margin by which the fair value of its RU exceeded carrying value in its most recent quantitative test in addition to events and changes in circumstances since its most recent quantitative test that could have significantly impacted the assumptions used in the valuation. Based on this qualitative assessment, the Company concluded that no impairment indicators existed for goodwill both prior to and subsequent to the change in segment reporting. The Company also performed an interim test for impairment of its goodwill as of December 31, 2022 due to the sustained decline in the Company’s market capitalization observed in the fourth quarter of 2022. The Company elected to bypass the optional qualitative test and proceeded to perform a quantitative test by comparing the carrying value of its RU to estimated fair value. The fair value of the RU exceeded its carrying value, resulting in no impairment.

Intangible Assets, Net

Intangible Assets, Net	12 Months Ended
	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets, Net	Note 9. Intangible Assets, Net Intangible assets as of December 31, 2023 and 2022 consisted of the following (in thousands): December 31, 2023 December 31, 2022 Intangible Accumulated Intangibles Intangible Accumulated Intangibles Contract-based $ 300 $ ( 300 ) $ — $ 300 $ ( 300 ) $ — Customer-related 21,100 ( 21,100 ) — 21,100 ( 14,800 ) 6,300 Technology-based 20,200 ( 20,200 ) — 20,200 ( 19,400 ) 800 Talent and representation contracts 10,300 ( 10,300 ) — 10,300 ( 10,300 ) — Formulae 1,950 ( 1,950 ) — 1,950 ( 1,146 ) 804 Trade name 51,200 ( 51,200 ) — 51,200 ( 50,900 ) 300 $ 105,050 $ ( 105,050 ) $ — $ 105,050 $ ( 96,845 ) $ 8,204 Due to the reduced revenue and operating income forecasts, the Company tested its asset group for recoverability as of December 31, 2023. The Company assessed its long-lived assets for impairment prior to the goodwill impairment test. In assessing its long-lived assets, the Company tested the related asset group for recoverability by comparing the carrying value of the asset group to its forecasted undiscounted cash flows. Because the carrying value of the asset group exceeded its future undiscounted cash flows, the Company determined that it may not be recoverable. The fair value of the assets within the asset group was then calculated to determine whether an impairment loss should be recognized. The fair values of the customer-related, technology-based, and formulae intangible assets were estimated and calculated to be lower than the carrying value. As a result, the Company recorded an aggregate impairment charge of $ 3.1 million related to its intangible assets, which reduced its intangible asset balance to zero at December 31, 2023. The Company had performed a test for recoverability at June 30, 2023 and concluded that the carrying value of its long-lived assets was recoverable. Due to the reduced revenue and operating income forecasts, the Company tested its asset group for recoverability as of December 31, 2022 and determined that the asset group was not recoverable. The fair value of the assets within the asset group was then calculated to determine whether an impairment should be recognized. The fair value of the customer-related, technology-based and trade name intangible assets were estimated primarily using a relief-from-royalty approach and calculated to be lower than carrying value. As a result the Company recorded a $ 18.9 million non-cash impairment charge for these intangible assets for the year ended December 31, 2022. During the three months ended March 31, 2022, the Company determined that one of its acquired trade names no longer had an indefinite life. The Company tested the trade name for impairment before changing the useful life and determined there was no impairment based on its assessment of fair value. The Company is prospectively amortizing the trade name over its remaining estimated useful life of two years beginning January 1, 2022. The Company recorded $ 0.3 million and $ 7.5 million of amortization expense for this trade name as a component of selling and marketing expenses for the years ended December 31, 2023 and 2022, respectively. The Company performed an interim test for impairment of its indefinite-lived intangible asset as of September 30, 2022 due to reduced revenue and margin forecasts for certain products. The fair value of the indefinite-lived trade name was calculated using a relief-from-royalty approach and was determined to be lower than its carrying value, primarily as a result of reduced revenue and margin forecasts for certain supplements. As a result, the Company recorded a $ 1.0 million non-cash impairment charge for this intangible asset during the year ended December 31, 2022. Amortization expense for intangible assets was $ 5.1 million and $ 18.3 million for the years ended December 31, 2023 and 2022, respectively.

Accrued Expenses

Accrued Expenses	12 Months Ended
	Dec. 31, 2023
Payables and Accruals [Abstract]
Accrued Expenses	Note 10. Accrued Expenses Accrued expenses consist of the followings (in thousands): December 31, 2023 2022 Partner costs $ 13,971 $ 14,535 Inventory, shipping and fulfillment 6,869 11,687 Employee compensation and benefits 4,334 20,584 Sales and other taxes 3,963 4,818 Information technology 3,176 2,207 Advertising 872 1,176 Customer service expenses 437 956 Other accrued expenses 8,525 8,467 Total accrued expenses $ 42,147 $ 64,430 On September 29, 2023, the Company entered into a financing agreement with IPFS Corporation of California ("IPFS") to finance certain of its annual insurance premiums. The Company financed $ 2.5 million, which will be paid over a ten month period with the first payment due on November 1, 2023 . The financing has an interest rate of 8.83 % and IPFS has a security interest in the underlying policies that have been financed. The $ 1.8 million outstanding as of December 31, 2023 is recorded in other current liabilities in the consolidated balance sheet and the interest expense is recorded in interest expense in the consolidated statement of operations. On October 6, 2023, the Company entered into a financing agreement with First Insurance Funding ("FIF") to finance certain of its annual insurance premiums. The Company financed $ 2.0 million, which will be paid over a nine month period with the first payment due on November 1, 2023 . The financing has an interest rate of 8.75 % and FIF has a security interest in the underlying policies that have been financed. The $ 1.4 million outstanding as of December 31, 2023 is recorded in other current liabilities in the consolidated balance sheet and the interest expense is recorded in interest expense in the consolidated statement of operations.

Debt

Debt	12 Months Ended
	Dec. 31, 2023
Debt Disclosure [Abstract]
Debt	Note 11 . Debt On August 8, 2022 (the “Effective Date”), the Company, Beachbody, LLC as borrower (a wholly owned subsidiary of the Company), and certain other subsidiaries of the Company as guarantors (the “Guarantors”), the lenders (the “Lenders”), and Blue Torch Finance, LLC, ("Blue Torch") as administrative agent and collateral agent for such lenders (the “Term Loan Agent”) entered into a financing agreement which was subsequently amended (collectively with any amendments thereto, the “Financing Agreement”). The Financing Agreement provides for senior secured term loans on the Effective Date in an aggregate principal amount of $ 50.0 million (the “Term Loan”) which was drawn on the Effective Date. In addition, the Financing Agreement permits the Company to borrow up to an additional $ 25.0 million, subject to the terms and conditions set forth in the Financing Agreement. Borrowings under the Term Loan are unconditionally guaranteed by the Guarantors, and all present and future material U.S. and Canadian subsidiaries of the Company. Such security interest consists of a first-priority perfected lien on substantially all property and assets of the Company and subsidiaries, including stock pledges on the capital stock of the Company’s material and direct subsidiaries, subject to customary carveouts. In connection with the Financing Agreement, the Company incurred $ 4.5 million of third-party debt issuance costs which are recorded in the consolidated balance sheets as a reduction of long-term debt as of December 31, 2023 and 2022 and are being amortized over the term of the Term Loan using the effective-interest method. The Term Loan borrowings may take the form of base rate (“Reference Rate”) loans or Secured Overnight Financing Rate (“SOFR Rate”) loans. Reference Rate loans bear interest at a rate per annum equal to the sum of an applicable margin of 6.15 % per annum, plus the greater of (a) 2.00 % per annum, (b) the Federal Funds Rate plus 0.50 % per annum, (c) the SOFR Rate (based upon an interest period of one month) plus 1.00 % per annum, and (d) the rate last quoted by The Wall Street Journal. SOFR Rate loans bear interest at a rate per annum equal to the sum of an applicable margin of 7.15 % and the SOFR Rate (based upon an interest period of three months). The SOFR Rate is subject to a floor of 1.00 %. In addition, the Term Loan borrowings bear additional interest at 3.00 % per annum, paid in kind by capitalizing such interest and adding such capitalized interest to the outstanding principal amount of the Term Loan on each anniversary of the Effective Date. The Term Loan was a SOFR Rate loan, with a cash effective interest rate of 12.29 % for the year ended December 31, 2023. The Company recorded $ 8.8 million and $ 3.4 million of interest related to the Term Loan during the years ended December 31, 2023 and 2022. On July 24, 2023 (the "Second Amendment Effective Date"), the Company and Blue Torch entered into Amendment No. 2 to the Financing Agreement (the "Second Amendment"), which amended the Company's existing Financing Agreement. The Second Amendment, among other things, amended certain terms of the Financing Agreement including, but not limited to, (1) amended the minimum revenue financial covenant to test revenue levels for each fiscal quarter on a standalone basis, and to adjust the minimum revenue levels to (a) $ 100.0 million, commencing with the fiscal quarter ended June 30, 2023, for each fiscal quarter ending on or prior to March 31, 2024 and (b) $ 120.0 million for each fiscal quarter thereafter and or prior to December 31, 2025; (2) amended the minimum liquidity financial covenant to adjust the minimum liquidity levels to (a) $ 20.0 million at all times from the Second Amendment Effective Date through March 31, 2024 and (b) $ 25.0 million at all times thereafter through the maturity of the Term Loan; (3) modified the maturity date of the Term Loan from August 8, 2026 to February 8, 2026 ; and (4) amended certain financial definitions, reporting covenants and other covenants thereunder. The Company was in compliance with these covenants as of December 31, 2023.‌ In connection with the Second Amendment, on the Second Amendment Effective Date, the Company made a partial prepayment on the Term Loan of $ 15.0 million along with the related prepayment premium of 5 % ($ 0.8 million) and accrued interest ($ 0.1 million). The Company also incurred a 1 % fee as paid in kind on the outstanding Term Loan balance prior to the prepayment (fee of $ 0.5 million) which is recorded as incremental third party debt issuance costs and is being amortized over the amended term of the Term Loan using the effective-interest method. The partial prepayment of $ 15.0 million was accounted for as a partial debt extinguishment and the Company wrote off the proportionate amount of unamortized debt discount and debt issuance costs as of the Second Amendment Effective Date ($ 2.4 million) which in addition to the prepayment premium ($ 0.8 million) was recorded as a loss on partial debt extinguishment of $ 3.2 million in the year ended December 31, 2023. As of December 31, 2023, the principal balance outstanding (including capitalized paid in kind interest) under the Term Loan was $ 35.5 million .‌ On January 9, 2024 (the "Consent Effective Date"), the Company and Blue Torch entered into Consent No. 1 and Amendment No. 3 to the Financing Agreement (the "Third Amendment"), which among other things, amended the minimum liquidity financial covenant. On February 29, 2024, the Company and Blue Torch entered into Consent No. 2 and Amendment No. 4 to the Financing Agreement (the "Fourth Amendment"), which among other things, amended the minimum liquidity financial covenant. See Note 23, Subsequent Events , for additional information on the Third and Fourth Amendments, including amendments to the minimum liquidity financial covenant. If there is an event of default, including not being in compliance with either of the financial covenants, the Term Loan will bear interest from the date of such event of default until the event of default is cured or waived in writing by the Lenders at the Post Default Rate, which is the rate of interest in effect pursuant to the Financing Agreement plus 2.00 %. In the event of default, or voluntary prepayment of a portion of the Term Loan by the Company, the Lenders could also require repayment of the outstanding balance of the Term Loan including the prepayment premium of (a) 5.0 % if repaid before the 1st anniversary of the Effective Date, (b) 3.0 % if repaid before the 2nd anniversary of the Effective Date, (c) 2.0 % if repaid before the 3rd anniversary date of the Effective Date, and (d) 0.0 % if repaid after the 3rd anniversary date of the Effective Date. The Financing Agreement also contains customary representations, warranties, and covenants, which include, but are not limited to, restrictions on indebtedness, liens, payment of dividends, restricted payments, asset sales, affiliate transactions, changes in line of business, investments, negative pledges and amendments to organizational documents and material contracts. The Financing Agreement contains customary events of default, which among other things include (subject to certain exceptions and cure periods): (1) failure to pay principal, interest, or any fees or certain other amounts when due; (2) breach of any representation or warranty, covenant, or other agreement in the Financing Agreement and other related loan documents; (3) the occurrence of a bankruptcy or insolvency proceeding with respect to any Loan Party; (4) any failure by a Loan Party to make a payment with respect to indebtedness having an aggregate principal amount in excess of a specified threshold; and (5) certain other customary events of default.‌ In connection with the Term Loan, the Company issued to certain holders affiliated with Blue Torch warrants for the purchase of 94,335 shares of the Company’s Class A common stock at an exercise price of $ 92.50 per share. The Term Loan Warrants vest on a monthly basis over four years, with 30 %, 30 %, 20 % and 20 % vesting in the first, second, third and fourth years, respectively. The Term Loan Warrants have a seven-year term from the Effective Date. See Note 3, Fair Value Measurements , for information on the valuation of the Term Loan Warrants. The Term Loan Warrants were recorded in the consolidated balance sheet as warrant liabilities. The initial fair value of the Term Loan Warrants of $ 5.2 million, is being amortized as a debt discount over the term of the Term Loan using the effective interest method. In connection with the Second Amendment, the Company also amended and restated the Term Loan Warrants. The amendment of the Term Loan Warrants amended the exercise price from $ 92.50 per share to $ 20.50 per share. The amended exercise price increased the fair value of the Term Loan Warrants as of the Second Amendment Effective Date by $ 0.8 million and was recorded as of the Second Amendment Effective Date as an incremental debt discount, and in addition to the remaining debt discount, is being amortized over the amended term of the Term Loan using the effective-interest method. In connection with the Equity Offering (defined later), the Term Loan Warrants conversion ratio was amended resulting in an increase in the number of shares purchased upon the exercise of the Term Loan Warrants to 97,482 shares of the Company's Class A common stock. The aggregate amounts of payments due for the periods succeeding December 31, 2023 and reconciliation of the Company’s debt balances, net of debt discount and debt issuance costs, are as follows (in thousands): Year ending December 31, 2024 $ 8,068 Year ending December 31, 2025 2,500 Year ending December 31, 2026 24,527 Total debt 35,095 Less current portion ( 8,068 ) Less unamortized debt discount and debt issuance costs ( 5,960 ) Add capitalized paid-in-kind interest 424 Total long-term debt $ 21,491 The payments in the year ending December 31, 2024 include a partial prepayment of $ 1.0 million which was paid on January 9, 2024 as part of the Third Amendment and a partial prepayment of $ 5.5 million which was paid on February 29, 2024 as part of the Fourth Amendment. See Note 23, Subsequent Events , for more information on the amendments to the Term Loan. Principal payments on the Term Loan are $ 1.3 million per year from the Effective Date to September 30, 2024, payable on a quarterly basis, and thereafter, are $ 2.5 million per year, payable on a quarterly basis with the remaining principal amount due on the maturity date of February 8, 2026. At December 31, 2023 the Company had one irrevocable standby letter of credit outstanding, totaling $ 0.1 million which is collateralized by $ 0.1 million of cash. This letter of credit expires on December 6, 2024 and is automatically extended for one-year terms unless notice of non-renewal is provided 60 days prior to the end of the applicable term . At December 31, 2023, the cash collateralizing this letter of credit is classified as current restricted cash in our consolidated balance sheet.

Leases

Leases	12 Months Ended
	Dec. 31, 2023
Leases [Abstract]
Leases	Note 12. Leases The Company leases facilities under noncancelable operating leases expiring through 2027 and certain equipment under a finance lease expiring in 2024. As of December 31, 2023 and 2022, the Company had operating lease liabilities of $ 3.3 million and $ 5.3 million respectively, and ROU assets of $ 3.1 million and $ 5.0 million , respectively. As of December 31, 2023 and 2022, the Company had finance lease liabilities of approximately zero and $ 0.1 million , respectively, and ROU assets of approximately zero and $ 0.1 million , respectively. The Company’s leases do not require any contingent rental payments, impose any financial restrictions, or contain any residual value guarantees. Certain of the Company’s leases include renewal options and escalation clauses; renewal options have not been included in the calculation of lease liabilities and ROU assets as the Company is not reasonably certain to exercise these options. Variable expenses generally represent the Company’s share of the landlord operating expenses. The following summarizes the Company’s leases (in thousands): Year Ended December 31, 2023 2022 Finance lease costs: Amortization of right-of-use asset $ 73 $ 192 Interest on lease liabilities 2 8 Operating lease costs 2,097 2,150 Short-term lease costs 18 202 Variable lease costs 301 566 Short-term sublease income ( 32 ) ( 127 ) Total lease costs $ 2,459 $ 2,991 Year Ended December 31, 2023 2022 Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from finance leases $ 2 $ 8 Operating cash flows from operating leases 2,319 2,195 Financing cash flows from finance leases 121 153 Right-of-use asset obtained in exchange for new operating lease liabilities — 420 Weighted-average remaining lease term - finance leases 0.3 1.3 Weighted-average remaining lease term - operating leases 2.3 2.9 Weighted-average discount rate - finance leases 4.0 % 4.0 % Weighted-average discount rate - operating leases 4.1 % 4.5 % Maturities of operating and finance lease liabilities, excluding short-term leases, are as follows (in thousands): Operating Leases Finance Leases Total Year ended December 31, 2024 $ 2,079 $ 2 $ 2,081 Year ended December 31, 2025 687 — 687 Year ended December 31, 2026 712 — 712 Year ended December 31, 2027 132 — 132 Total 3,610 2 3,612 Less present value discount ( 352 ) - ( 352 ) Lease liabilities at December 31, 2023 $ 3,258 $ 2 $ 3,260 As the Company’s lease agreements do not provide an implicit rate, the discount rates used to determine the present value of lease payments are generally based on the Company’s estimated incremental borrowing rate for a secured borrowing of a similar term as the lease. In November 2021, the Company entered into an agreement effective January 2022, assigning its Santa Monica office lease to a third party with a lease term expiring in 2025 . Although the lease assignment requires the Company to remain secondarily liable as a surety with respect to the lease, the Company does not believe it is probable that it will be responsible for the obligations. The value of the associated guarantee liability is insignificant. On February 29, 2024, the Company sold its Van Nuys production facility and entered into a five year lease of the facility at an annual base rate of $ 0.3 million. See Note 23, Subsequent Events , for additional information on the lease of this facility.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 13. Commitments and Contingencies Inventory Purchase and Service Agreements The Company has noncancelable inventory purchase and service agreements with multiple service providers which expire at varying dates through 2028. During the year ended December 31, 2023 there were no losses on inventory purchase commitments. D uring the year ended December 31, 2022, the Company recorded $ 2.7 million for losses on inventory purchase commitments related to connected fitness hardware. These losses were included in accrued expenses in the consolidated balance sheets and connected fitness cost of revenue in the consolidated statements of operations. Service agreement obligations include amounts related to fitness and nutrition trainers, future events, information systems support, and other technology projects. Future minimum payments under noncancelable service and inventory purchase agreements for the periods succeeding December 31, 2023 are as follows (in thousands): Year ended December 31, 2024 $ 17,452 Year ended December 31, 2025 1,475 Year ended December 31, 2026 100 Year ended December 31, 2027 75 Year ended December 31, 2028 75 $ 19,177 The preceding table excludes royalty payments to fitness trainers, talent, and others that are based on future sales as such amounts cannot be reasonably estimated. During the year ended December 31, 2023 the Company paid $ 4.6 million of royalty payments exclusive of guaranteed payments. Contingencies The Company is subject to litigation from time to time in the ordinary course of business. Such claims typically involve its products, intellectual property, and relationships with suppliers, customers, distributors, employees, and others. Contingent liabilities are recorded when it is both probable that a loss has occurred and the amount of the loss can be reasonably estimated. Although it is not possible to predict how litigation and other claims will be resolved, the Company does not believe that any currently identified claims or litigation matters will have a material adverse effect on its consolidated financial position or results of operations. On April 7, 2022, the Company received a letter addressed to its Board of Directors (the “Board”) from a law firm on behalf of two purported stockholders. Among other matters, the stockholder letter addressed the approval of the Company’s Amended & Restated Certificate of Incorporation at the special meeting of stockholders held on June 24, 2021, which included (i) a 1.3 billion share increase in the number of authorized shares of Class A common stock (the “2021 Class A Increase Amendment”), and was approved by a majority of the then-outstanding shares of both the Company’s Class A and Class B common stock, voting as a single class. The stockholder letter alleged that the 2021 Class A Increase Amendment required a separate vote in favor by at least a majority of the then outstanding shares of Class A common stock under Section 242(b)(2) of the General Corporation Law of the State of Delaware (the “DGCL”), and that the 1.3 billion share increase was never properly approved in accordance with the DGCL. The Company continues to believe that a separate vote of Class A common stock was not required to approve the 2021 Class A Increase Amendment. However, in December 2022, a decision of the Delaware Court of Chancery (“Court of Chancery”) created uncertainty regarding this issue, and on December 29, 2022, the Company received a second letter on behalf of the two purported stockholders reiterating the Court of Chancery’s recent decision. The Company filed a petition under Section 205 of the DGCL (the “Section 205 Petition”) on February 16, 2023, in the Court of Chancery seeking to validate the Company Charter including, among other things, the 2021 Class A Increase Amendment. On March 14, 2023 the Court of Chancery granted the Section 205 Petition validating each of the following and eliminating the uncertainty with respect thereto: (1) the Company Charter and the 2021 Class A Increase Amendment as of the time of filing with the Delaware Secretary of State and (2) all shares of capital stock that the Company issued in reliance on the effectiveness of the 2021 Class A Increase Amendment and Company Charter as of the date such shares were issued. On May 22, 2023, Jessica Lyons, an individual, and a group of other plaintiffs filed a class action complaint with the Los Angeles County Superior Court alleging that the Company misclassified its Partners as contractors rather than as employees and committed other violations of the California Labor Code. The Company understands that the plaintiffs in this matter intend on filing additional claims under the Private Attorney General Act of 2004. The Company and certain executive officers are listed as defendants in the complaint. The plaintiffs are seeking monetary damages. This matter is pending as of the date of this annual report. On September 6, 2023 Dish Technologies LLC and SLING TV LLC (the "DISH Entities") filed a complaint with the United States District Court for the District of Delaware alleging that the Company infringed on the DISH Entities' patents and used technology belonging to the DISH Entities without their permission. The plaintiffs are seeking monetary damages and injunctive relief. This matter is pending as of the date of this annual report. The Company disputes the allegations in the above referenced active matters and intends to defend the matters vigorously. Some of our legal proceedings, such as the above referenced complaints, may be based on complex claims involving substantial uncertainties and unascertainable damages. Accordingly, it is not possible to determine the probability of loss or estimate damages for any of the above matters, and therefore the Company has not established reserves for any of these proceedings. When the Company determines that a loss is both probable and reasonably estimable, the Company records a liability, and, if the liability is material, discloses the amount of the liability reserved. Given that such proceedings are subject to uncertainty, there can be no assurance that such legal proceedings, either individually or in the aggregate, will not have a material adverse effect on our business, results of operations, financial condition or cash flows.

Restructuring

Restructuring	12 Months Ended
	Dec. 31, 2023
Restructuring and Related Activities [Abstract]
Restructuring	Note 14. Restructuring In 2023, restructuring charges primarily relate to activities focused on aligning the Company's operations with its key growth priorities. Restructuring charges in 2022 relate to the consolidation of our streaming fitness and nutrition offerings into a single Beachbody platform. The Company recognized restructuring costs of $ 6.5 million and $ 10.0 million during the years ended December 31, 2023 and 2022, respectively, comprised primarily of termination benefits related to headcount reductions, of which approximately zero and $ 0.5 million is included in accrued expenses in the consolidated balance sheets at December 31, 2023 and 2022, respectively. In accordance with GAAP, employee termination benefits were recognized at the date employees were notified and post-employment benefits were accrued as the obligation was probable and estimable. Benefits for employees who provided service greater than 60 days from the date of notification were recognized ratably over the service period. The following table summarizes activity in the Company’s restructuring-related liability during the years ended December 31, 2023 and 2022 (in thousands): Balance at Restructuring Charges Payments / Utilizations Liability at December 31, 2023 Employee-related costs $ 469 $ 6,497 $ ( 6,948 ) $ 18 Total costs $ 469 $ 6,497 $ ( 6,948 ) $ 18 Balance at Restructuring Charges Payments / Utilizations Liability at December 31, 2022 Employee-related costs $ — $ 10,047 $ ( 9,578 ) $ 469 Total costs $ — $ 10,047 $ ( 9,578 ) $ 469 During the year ended December 31, 2022, the Company determined that the useful life of certain computer software and web development assets, and content assets would end upon the completion of its platform consolidation. The Company accelerated depreciation of these computer software and web development assets and recorded $ 3.4 million of additional depreciation expense as a component of digital cost of revenue and nutrition and other cost of revenue during the year ended December 31, 2022. The Company also accelerated amortization of these content assets and recorded $ 2.7 million of additional amortization as a component of digital cost of revenue during the year ended December 31, 2022. See Note 23, Subsequent Events , for information related to a restructuring in January 2024.

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2023
Stockholders' Equity Note [Abstract]
Stockholders' Equity	Note 15. Stockholders' Equity As of December 31, 2023, 2,000,000,000 shares, $ 0.0001 par value per share are authorized, of which, 1,600,000,000 shares are designated as Class A common stock, 200,000,000 shares are designated as Class X common stock, 100,000,000 shares are designated as Class C common stock, and 100,000,000 shares are designated as preferred stock. Common Stock Holders of each share of each class of common stock are entitled to dividends when, as, and if declared by the Company’s board of directors (the "Board"), subject to the rights and preferences of any holders of preferred stock outstanding at the time. As of December 31, 2023, the Company had no t declared any dividends. The holder of each Class A common stock is entitled to one vote , the holder of each share of Class X common stock is entitled to ten votes and except as otherwise required by law, the holder of each share of Class C common stock is not entitled to any voting powers. On June 15, 2023, the Company and Carl Daikeler, the Company’s co-founder and CEO entered into a forfeiture agreement (“the Forfeiture Agreement”), pursuant to which Mr. Daikeler as of June 15, 2023 forfeited 160,000 shares of the Company’s common stock that he owned, comprised of 63,999 shares of Class A common stock and 96,001 shares of Class X common stock, each with a par value of $ 0.0001 . No consideration was provided to Mr. Daikeler for the forfeiture of these shares. On December 10, 2023, the Company entered into a securities purchase agreement for the issuance and sale of 420,769 shares of Class A common stock at a purchase price of $ 9.75 per share and pre-funded warrants to purchase up to 122,821 shares of Class A common stock at a pre-funded purchase price of $ 9.7499 per share with certain institutional investors in a registered direct offering. The pre-funded warrants are immediately exercisable and have an exercise price of $ 0.0001 per share. The Company received proceeds of $ 4.9 million, net of placement agent fees. The pre-funded warrants are exercisable at any time after their original issuance at the option of the holder, in the holder's discretion, by (1) payment in full in cash for the number of shares of common stock purchased upon such exercise or (2) a cashless exercise, in which case the holder would receive upon such exercise the net number of shares of common stock determined accruing to the formula set forth in the pre-funded warrant. The Company also issued 543,590 Common Stock Warrants to purchase 543,590 shares of Class A common stock at an exercise price of $ 11.24 per share in a concurrent private placement. The Common Stock Warrants may be exercised at any time beginning June 13, 2024 and will expire on June 13, 2029 . In the event of certain fundamental transactions involving the Company as described in the Common Stock Warrant agreement, the holders of the Common Stock Warrants may require the Company to make a payment based on a Black-Scholes valuation, using specific inputs. The holders of the pre-funded warrants do not have similar rights. Therefore, the Company accounted for the Common Stock Warrants as liabilities which were recorded at the fair value at their issuance date of $ 3.3 million. The gross proceeds were allocated to the Common Stock Warrants at their fair value ($ 3.3 million) with the remainder allocated proportionally to common stock ($ 1.6 million) and pre-funded warrants ($ 0.4 million) based on the gross proceeds received. The issuance of the Class A common stock, the pre-funded warrants and the Common Stock Warrants is collectively called the "Equity Offering". The pre-funded warrants were classified as a component of stockholder's equity within additional paid in capital. The pre-funded warrants are equity classified because they (1) are freestanding financial instruments that are legally detachable and separately exercisable from the common stock, (2) are immediately exercisable, (3) do not embody an obligation for the Company to repurchase its shares, (4) permit the holder to receive a fixed number of shares of common stock upon exercise, (5) are indexed to the Company's common stock and (6) meet the equity classification criteria. The Company valued the pre-funded warrants at issuance, concluding that their sales price approximated their fair value, and allocated gross proceeds from the Equity Offering after recording the Common Stock Warrant liability proportionately to the common stock and pre-funded warrants. As of December 31, 2023, all of the pre-funded warrants were outstanding. On January 12, 2024, all of the pre-funded warrants were exercised by the investor and converted into 122,821 shares of Class A common stock. Reverse Stock Split At the 2023 Annual Shareholder Meeting, which was held on November 20, 2023, our stockholders approved an amendment to our second amended and restated certificate of incorporation to effect a reverse stock split of all of our issued and outstanding common stock by a ratio in the range of 1-for-10 to 1-for-50 . On November 21, 2023, we effected a 1-for-50 reverse stock split of our issued and outstanding common stock. The reverse stock split ratio and the implementation and the timing of the reverse stock split were determined by our Board. The reverse stock split did not change the authorized number of shares or the par value of our common stock or preferred stock, but did effect a proportional adjustment to the number of common stock outstanding, the per share exercise price and the number of shares of common stock issuable upon the exercise of outstanding stock options, the number of shares of common stock issuable upon the vesting of restricted stock awards ("RSU's"), the number of shares of common stock under the Employee Stock Purchase Plan (the "ESPP"), the conversion rate of our outstanding warrants into common stock and the number of shares of common stock eligible for issuance under our 2021 Stock Plan (the "2021 Plan"). No fractional shares were issued in connection with the reverse stock split. Each stockholder's percentage ownership and proportional voting power generally remained unchanged as a result of the reverse stock split. All applicable outstanding equity awards discussed below in Note 16, Equity-Based Compensation, have been adjusted retroactively for the 1-for-50 reverse stock split. Accumulated Other Comprehensive Income (Loss) The following table summarizes changes in accumulated other comprehensive income (loss), by component during the years ended December 31, 2023 and 2022 (in thousands): Unrealized Gain (Loss) on Derivatives Foreign Currency Translation Adjustment Total Balances at December 31, 2021 $ ( 32 ) $ 11 $ ( 21 ) Other comprehensive income (loss) before reclassifications 24 ( 105 ) ( 81 ) Amounts reclassified from accumulated other comprehensive income (loss) 108 — 108 Tax effect 31 — 31 Balances at December 31, 2022 131 ( 94 ) 37 Other comprehensive income (loss) before reclassifications ( 334 ) 78 ( 256 ) Amounts reclassified from accumulated other comprehensive income (loss) 222 — 222 Tax effect ( 26 ) — ( 26 ) Balances at December 31, 2023 $ ( 7 ) $ ( 16 ) $ ( 23 )

Equity-Based Compensation

Equity-Based Compensation	12 Months Ended
	Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]
Equity-Based Compensation	Note 16. Equity-Based Compensation Equity Compensation Plans Prior to June 25, 2021, the Company maintained its 2020 Beachbody Company Group LLC Equity Compensation Plan (the “2020 Plan”), under which, grants were awarded to certain employees, consultants, and members of the Company’s board of managers through the granting of one or more of the following types of awards: (a) nonqualified unit options, (b) unit awards, and (c) unit appreciation rights. The Company granted nonqualified unit options with vesting periods typically ranging from three to five years under the 2020 Plan. After June 25, 2021, awards under the 2020 Plan were converted at the Exchange Ratio, and the Company’s Board approved the 2021 Incentive Award Plan (the “2021 Plan”). The 2021 Plan provides for the grant of stock options, stock appreciation rights, restricted stock, dividend equivalents, RSUs, and other stock or cash-based awards. Grants under the 2021 Plan may be awarded to employees, consultants, and members of the Company ’ s Board. Under the 2021 Plan, all awards settle in shares of Class A common stock, and up to 608,851 shares of Class A common stock were initially available for issuance. The number of shares of Class A common stock available for issuance under the 2021 Plan is increased on January 1 of each calendar year beginning in 2022 and ending in 2031 by an amount equal to the lesser of (i) five percent of the total number of shares of Class A and Class X common stock outstanding on the final day of the immediately preceding calendar year and (ii) the number of shares determined by the Company’s Board. As of December 31, 2023, 254,995 shares of Class A common stock remain available for issuance under the 2021 Plan. All options typically expire ten years from the date of grant if not exercised. In the event of a termination of employment, all unvested options are forfeited immediately. Generally, any vested options may be exercised within three months, depending upon the circumstances of termination, except for instances of termination “with cause” whereby any vested options or awards are forfeited immediately. A summary of the option activity under the Company's equity compensation plans is as follows: Time Vested Options Outstanding Number of Options Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term Aggregate Intrinsic Value Outstanding at December 31, 2022 968,293 $ 132.50 6.35 $ — Granted 261,288 23.58 Forfeited ( 193,886 ) 130.82 Expired ( 196,216 ) 108.69 Outstanding at December 31, 2023 839,479 $ 32.53 7.25 $ — Exercisable at December 31, 2023 325,767 $ 36.96 5.14 $ — Performance Vested Options Outstanding Number of Options Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term Aggregate Intrinsic Value Outstanding at December 31, 2022 — $ — — $ — Granted 318,440 22.02 Outstanding at December 31, 2023 318,440 $ 22.02 9.45 $ — Exercisable at December 31, 2023 — $ — — $ — A summary of the unvested option activity is as follows: Number of Time Vested Options Weighted-Average Grant Date Fair Value (per option) Unvested at December 31, 2022 533,173 $ 69.00 Granted 261,288 13.23 Vested ( 170,507 ) 56.50 Forfeited ( 110,242 ) 60.63 Unvested at December 31, 2023 513,712 $ 33.49 Number of Performance Vested Options Weighted-Average Grant Date Fair Value (per option) Unvested at December 31, 2022 — $ — Granted 318,440 12.77 Unvested at December 31, 2023 318,440 $ 12.77 The Company does not use cash to settle equity instruments issued under equity-based compensation awards. The total fair value of awards which vested during the years ended December 31, 2023 and 2022 was $ 9.6 million and $ 14.4 million , respectively. The intrinsic value of options exercised during the year ended December 31, 2022 was $ 0.8 million . There were no options exercised during the year ended December 31, 2023. A summary of RSU activity is as follows: RSUs Outstanding Number of RSUs Weighted-Average Fair Value Outstanding at December 31, 2022 63,184 $ 72.50 Granted 496,176 28.37 Vested ( 230,340 ) 34.11 Forfeited ( 27,139 ) 34.58 Outstanding at December 31, 2023 301,881 $ 31.97 RSUs granted to employees generally vest over four years , based on continued employment, while RSUs granted to members of the Board generally vest approximately one year after grant date. The fair value of RSUs vested during the year ended December 31, 2023 and 2022 was $ 7.9 million and $ 2.2 million , respectively. On January 1, 2023, the number of shares available for issuance under the 2021 Incentive Award Plan (the “2021 Plan”) increased by 312,162 pursuant to the terms of the 2021 Plan. As of December 31, 2023, 254,995 shares of Class A common stock were available for issuance under the 2021 Plan. Vested RSUs included shares of common stock that the Company withheld on behalf of certain employees to satisfy the minimum statutory tax withholding requirements, as defined by the Company. The Company withheld shares of common stock with an aggregate fair value and remitted taxes of $ 2.2 million and $ 0.2 million during the years ended December 31, 2023 and 2022, respectively, which were classified as financing cash outflows in the consolidated statements of cash flows. The Company canceled and returned these shares to the 2021 Plan, which are available under the plan terms for future issuance. On June 14, 2023, the Board adopted the Company’s 2023 Employment Inducement Incentive Award Plan (the “Inducement Plan”) for the grant of non-qualified stock options, stock appreciation rights, restricted stock, RSU's, dividend equivalents and other stock or cash-based awards to prospective employees. The Board reserved 477,661 shares of the Company’s common stock for issuance pursuant to the awards granted under the Inducement Plan.‌ Effective as of June 15, 2023, the Company appointed Mark Goldston as Executive Chairman, replacing the service of Mr. Daikeler in his capacity as Chairman of the Board. Mr. Daikeler continues to serve as the Company’s CEO and as a director. In connection with the employment offer letter to Mr. Goldston, he was granted a stock option under the Inducement Plan, covering an aggregate of‌ 477,661 shares of the Company’s Class A common stock, par value $ 0.0001 per share (the “Option”). Of this amount, 159,221 shares subject to the Option will vest based on continued service (the “Time-Vesting Options”) and 318,440 shares will vest based on the attainment of applicable performance goals and continued service (the “Performance-Vesting Options”). The Time-Vesting Options will vest and become exercisable with respect to 25 % of the Time-Vesting Options subject to the Option on each of the first four anniversaries of June 15, 2023. The Performance-Vesting Options will vest and become exercisable based on both (1) the achievement of pre-determined price per share goals and (2) Mr. Goldston’s service through the applicable vesting date. Any earned Performance-Vesting Options will vest and become exercisable as of the later of (1) June 15, 2024, and (2) the date on which the applicable price per share goal is achieved. The weighted average exercise price of the Performance-Vesting Options was $ 22.02 per option and none of the Performance-Vesting Options were exercisable as of December 31, 2023. Vesting tranche Number of Performance -Vesting Options Price per share goal Tranche 1 79,610 $ 50.00 Tranche 2 79,610 $ 75.00 Tranche 3 79,610 $ 100.00 Tranche 4 79,610 $ 125.00 The share price is measured by averaging the fair market value (as defined in the Inducement Plan) per share over any 30 consecutive trading-day period. Employee Stock Purchase Plan ‌ In May 2022, the Company established an ESPP, the terms of which allow for qualified employees to participate in the purchase of designated shares of the Company’s common stock at a price equal to 85 % of the lower of the closing price at the beginning or ending of each six-month purchase period.‌ The number of shares of Class A common stock available under the ESPP is increased on January 1 of each calendar year beginning on January 1, 2022 and ending on January 1, 2031 by an amount equal to the lesser of (i) 1 % of the total number of shares of Class A and Class X common stock outstanding as of the final day of the immediately preceding calendar year and (ii) the number of shares determined by the Company's Board. As of December 31, 2023, 137,976 shares of Class A common stock remain available for issuance under the ESPP. During the year ended December 31, 2023, 47,257 shares of the Company’s common stock were issued pursuant to the ESPP at an average price of $ 13.78 per share.‌ Stock-based compensation expense associated with the Company’s ESPP is based on fair value estimated on the date of grant using the Black-Scholes option pricing valuation model and the following weighted-average assumptions for grants during the year ended December 31, 2023: December 31, 2023 Weighted-average risk-free rate 4.7 % Dividend yield rate — Weighted-average volatility 54.4 % Expected term (in years) 0.50 Weighted-average grant date fair value $ 5.32 Compensation Warrants During the year ended December 31, 2020, the Company issued warrants for the purchase of 79,612 of the Company's Class A common stock at an exercise price of $ 126.00 per share. These warrants vest 25 % at the grant date and 25 % at each of the first, second, and third anniversaries of the grant date. The warrants have a 10-year contractual term. As of December 31, 2023, 79,612 warrants were exercisable. Compensation cost associated with the warrants was recognized over the requisite service period, which was 4.25 years. Repricing of Stock Options The Company determined that a significant portion of its outstanding stock options had an exercise price per share that was significantly higher than the current fair market value of the Company’s common stock (the “Underwater Options”). In order to help retain and motivate holders of Underwater Options, and align their interests with those of stockholders, on September 14, 2023, the Compensation Committee of the Board resolved that it was in the best interests of the Company and its stockholders to amend certain of the Underwater Options (the “Amended Underwater Options”) for current employees and consultants of the Company that were either (1) not maturing in fiscal 2023 or (2) that had not been issued at an exercise price of less than $ 50 in the prior twelve months, to reduce the exercise price of each Amended Underwater Option to the closing per share price of the Company’s common stock on September 14, 2023 (the “Repricing”). The Company had 531,515 Amended Underwater Options which had their exercise price amended to $ 17.35 per option.‌ Excluded from the Repricing were, among others, Underwater Options held by members of the Board, the Company's CEO and Executive Chairman; any Underwater Options with an exercise price less than $ 50.00 ; and options granted to consultants who are no longer providing services to the Company. Except for the modification of the exercise price, all other terms and conditions of the Amended Underwater Options remain in effect.‌ The Company determined that the Repricing represented a modification of share-based awards under ASC 718. Accordingly, the Company recognized incremental stock-based compensation of $ 1.6 million which was recorded as of the Repricing, related to 255,174 vested Amended Underwater Options as of the Repricing. As of the Repricing $ 1.5 million incremental unrecognized compensation expense related to 276,341 unvested Amended Underwater Options will be recognized as expense over the requisite service period in which the options vest, or 1.6 years. Equity-Based Compensation Expense Equity-based compensation expense, which also includes the Repricing and modifications for the years ended December 31, 2023 and 2022 was as follows (in thousands): Year Ended December 31, 2023 2022 Cost of revenue $ 2,992 $ 1,416 Selling and marketing 9,852 7,015 Enterprise technology and development 1,330 1,403 General and administrative 9,717 7,786 Total equity-based compensation $ 23,891 $ 17,620 As of December 31, 2023, the total unrecognized equity-based compensation expense was $ 33.1 million , which will be recognized over a weighted-average remaining period of 2.41 years. In connection with the restructuring activities that took place during the year ended December 31, 2023, the Company modified certain stock awards of terminated employees (approximately 25 employees in the three month period ended September 30, 2023 and approximately 100 employees in the three months ended March 31, 2023). The modifications included accelerating the vesting of any options that would have vested within three months of the employees termination date, and all vested options will be available for exercise for a total of six months after the employees’ termination date (that is, three months in addition to the standard three months per the original agreement). As a result of these modifications, the Company recognized approximately $ 1.0 million reduction to equity-based compensation expense within general and administrative expense in the consolidated statements of operations for the year ended December 31, 2023. The fair value of each award that vests solely based on time as of the date of grant is estimated using a Black-Scholes option-pricing model. The following table summarizes the weighted average assumptions used to determine the fair value of time vested option grants: December 31, 2023 2022 Risk-free rate 3.9 % 3.0 % Dividend yield rate — — Volatility 62.2 % 52.9 % Expected term (in years) 5.18 6.16 Weighted-average grant date fair value $ 13.65 $ 31.50 The vesting periods are based on the terms of the option grant agreements, generally four to five years . The risk-free interest rates are based on the U.S. Treasury rates as of the grant dates for the expected terms of the options. The price volatilities represent calculated values based on the historical price volatilities of publicly traded companies within the Company’s industry group and the Company's historical volatility over the options’ expected terms. The expected terms of the options granted were estimated using the simplified method by taking an average of the vesting periods and the original contractual terms. The fair value of the Performance-Vesting Options as of the date of grant is estimated using a Monte Carlo simulation. The following table summarizes the weighted average assumptions used to determine the fair value of the Performance-Vesting Options: December 31, 2023 Risk-free rate 3.7 % Dividend yield rate — Volatility 53.7 % Expected term (in years) 10.00 Weighted-average grant date fair value $ 13.00 The vesting periods are based on the terms of the option grant agreements, generally four to five years . The risk-free interest rates are based on the U.S. Treasury rates as of the grant dates for the expected terms of the options. The price volatilities represent calculated values based on the historical price volatilities of publicly traded companies within the Company’s industry group and the Company's historical volatility over the options’ expected terms. The expected terms of the options granted were estimated using the simplified method by taking an average of the vesting periods and the original contractual terms.

Derivative Financial Instrument

Derivative Financial Instruments	12 Months Ended
	Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Note 17. Derivative Financial Instruments As of December 31, 2023 and 2022, the notional amount of the Company’s outstanding foreign exchange options was $ 4.4 million and $ 17.6 million , respectively. In the year ended December 31, 2023, management made a determination to cease entering into any further foreign exchange options at this time, which resulted in the decrease in the notional amount of the Company's outstanding foreign exchange options at December 31, 2023. The Company's foreign exchange options outstanding at December 31, 2023 will all expire prior to March 31, 2024. There were no outstanding forward contracts as of December 31, 2023 and 2022. The following table presents the fair value of the Company’s derivative instruments which are included in other current assets in the consolidated balance sheets (in thousands): December 31, 2023 2022 Derivatives designated as hedging instruments $ — $ 343 Derivatives not designated as hedging instruments — 119 Total derivative assets $ — $ 462 There were no derivative liabilities as of December 31, 2023 and 2022. The Company expects that $ 0.1 million of existing losses recorded in accumulated other comprehensive loss will be reclassified into net income (loss) over the next 12 months . The Company assessed its derivative instruments and determined that they were effective during the years ended December 31, 2023 and 2022. The following table shows the pre-tax effects of the Company’s derivative instruments on its consolidated statements of operations (in thousands): Year Ended December 31, Financial Statement Line Item 2023 2022 Unrealized gains (losses) Other comprehensive income (loss) $ ( 334 ) $ 24 Losses reclassified from accumulated other Cost of revenue $ ( 101 ) $ ( 45 ) comprehensive income (loss) into net loss General and administrative ( 121 ) ( 63 ) Total amounts reclassified $ ( 222 ) $ ( 108 ) Gains (losses) recognized on derivatives Cost of revenue $ ( 98 ) $ 13

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Note 18. Income Taxes The components of the Company’s loss before income taxes were as follows (in thousands): Year Ended December 31, 2023 2022 U.S. $ ( 154,571 ) $ ( 198,245 ) Foreign 1,967 1,000 Loss before income taxes $ ( 152,604 ) $ ( 197,245 ) The components of the income tax benefit (provision), net were as follows (in thousands): Year Ended December 31, 2023 2022 Current: Federal $ — $ 31 State and local ( 113 ) 202 Foreign ( 115 ) ( 141 ) $ ( 228 ) $ 92 Deferred: Federal $ ( 23 ) $ 1,963 State and local 71 870 Foreign 143 128 191 2,961 Income tax (provision) benefit, net $ ( 37 ) $ 3,053 The Company has continued to record a full VA against its DTAs at December 31, 2023 and 2022. The Company has certain net DTLs that will reverse in a different period than its DTAs and has DTLs with an indefinite reversal period resulting in a net DTL, after recording a VA, at December 31, 2023 and 2022 of $ 0.0 million and $ 0.2 million , respectively. The actual tax rate on loss before income taxes reconciles to the applicable statutory federal income tax rate as follows: Year Ended December 31, 2023 2022 Federal statutory rate 21.0 % 21.0 % State income taxes, net of federal benefit 2.5 % 3.6 % Valuation allowance on deferred tax assets ( 17.2 %) ( 24.2 %) Goodwill impairment ( 5.5 %) — Equity-based compensation ( 1.1 %) ( 1.1 %) Adjustments to prior year provision 0.7 % 1.4 % Note revaluation ( 0.6 %) — Common stock warrant liability 0.4 % 0.9 % Other ( 0.2 %) ( 0.1 %) Effective tax rate — 1.5 % DTAs and DTLs are as follows (in thousands): As of December 31, 2023 2022 Deferred tax assets: Net operating losses $ 91,585 $ 74,038 Equity-based compensation 13,358 10,652 Inventory 12,339 18,525 Tax basis step-up 11,570 13,240 Capitalized research expense 9,592 6,057 Intangible assets 6,552 4,915 R & D credit carryover 3,886 3,886 Accrued expenses 1,064 1,438 Lease obligations 837 1,663 Accrued employee compensation and benefits 546 4,246 Other 4,517 2,164 Total deferred tax assets 155,846 140,824 Deferred tax liabilities: Property and equipment ( 5,853 ) ( 13,377 ) Content assets ( 4,448 ) ( 7,408 ) Prepaid expenses ( 1,969 ) ( 2,425 ) Right-of-use assets ( 750 ) ( 1,231 ) Total deferred tax liabilities ( 13,020 ) ( 24,441 ) Net deferred tax assets before valuation allowance 142,826 116,383 Valuation allowance ( 142,836 ) ( 116,564 ) Net deferred tax liabilities $ ( 10 ) $ ( 181 ) Taxes on the net income of foreign corporate subsidiaries in excess of a deemed return on their tangible assets, or global intangible low-taxed income (“GILTI”), are recognized as an expense in the period the tax is incurred. Accordingly, the Company has not provided deferred taxes related to temporary differences that, on their reversal, will affect the amount of income subject to GILTI in the period tax is incurred. As of December 31, 2023, the Company has accumulated U.S. federal and state net operating loss ("NOL") carryforwards of $ 339.9 million and $ 384.7 million , respectively. Of the federal NOL carryforwards, $ 2.3 million was generated before January 1, 2018 and subject to a 20-year carryforward period. The remaining $ 337.6 million can b e carried forward indefinitely but is subject to an 80% taxable income limitation . The U.S. federal losses subject to carryforward limitations and state NOL carryforwards will begin to expire in 2037 and 2025 , respectively. As of December 31, 2023, the Company has accumulated U.S. federal and state research tax credits of $ 3.5 million and $ 1.7 million , respectively. The U.S. federal research tax credits will begin to expire in 2039 . The U.S. state research tax credits do not expire. Uncertain Tax Positions The following table summarizes the activity related to the Company ’ s gross unrecognized tax benefits (in thousands): Year Ended December 31, 2023 2022 Unrecognized tax benefits, beginning of year $ 1,044 $ 568 Additions for current year tax positions — 476 Unrecognized tax benefits (excluding interest and penalties), end of year 1,044 1,044 Interest and penalties associated with unrecognized tax benefits — — Unrecognized tax benefits including interest and penalties, end of year $ 1,044 $ 1,044 All of the unrecognized tax benefits was recorded as a reduction in the Company ’ s gross DTAs. If the unrecognized tax benefits were not recorded it would affect the Company’ s effective tax rate. The Company files U.S. federal, numerous state and local income, franchise, U.K., and Canada tax returns. With a few exceptions, the Company is no longer subject to U.S. federal, state, local, or Canada tax examination by taxing authorities for years prior to 2020. For the U.K., the Company is no longer subject to tax examinations by the taxing authorities for years prior to 2021.

Employee Benefit Plan

Employee Benefit Plan	12 Months Ended
	Dec. 31, 2023
Employee Benefit Plans [Abstract]
Employee Benefit Plans	Note 19. Employee Benefit Plan The Company maintains a defined contribution 401(k) plan for the benefit of all employees who have met the eligibility requirements. Participants may contribute up to 75 % of their eligible compensation, subject only to annual limitations set by the Internal Revenue Service. The Company matched 50 % of participant contributions, up to 6 % of the participant’s total compensation. For the years ended December 31, 2023 and 2022, the Company recorded expense for matching contributions of $ 1.9 million and $ 2.9 million , respectively.

Earnings (Loss) Per Share

Earnings (Loss) Per Share	12 Months Ended
	Dec. 31, 2023
Earnings Per Share [Abstract]
Earnings (Loss) Per Share	Note 20. Earnings (Loss) per Share The computation of loss per share of Class A and Class X common stock is as follows (in thousands, except share and per share information): Year Ended December 31, 2023 2022 Numerator: Net loss $ ( 152,641 ) $ ( 194,192 ) Denominator: Weighted-average common shares outstanding, basic and diluted 6,238,777 6,149,784 Net loss per common share, basic and diluted $ ( 24.47 ) $ ( 31.58 ) Basic net loss per common share is the same as dilutive net loss per common share for the years ended December 31, 2023 and 2022 as the inclusion of all potential common shares would have been antidilutive. The weighted average‌ common shares outstanding (basic and diluted) in the above table exclude the 160,000 shares that were forfeited by Mr. Daikeler for the period of time after they were forfeited (June 15, 2023) and includes (1) the 420,769 shares that were issued in the Equity Offering on December 13, 2023 for the period of time after they were issued and (2) the pre-funded warrants to purchase up to 122,821 shares of Class A common stock issued in the Equity Offering on December 13, 2023 for the period of time after they were issued, as the exercise of the pre-funded warrants requires nominal consideration for the delivery of the common stock. The following table presents the common shares that are excluded from the computation of diluted net loss per common share as of the periods presented because including them would have been antidilutive: Year Ended December 31, 2023 2022 Time Vested Options 839,479 968,293 Performance Vested Options 318,440 — RSUs 301,881 63,184 Compensation warrants 79,612 79,612 Public and Private Placement Warrants 306,667 306,667 Term Loan warrants 97,482 94,335 Common Stock Warrants 543,590 — Forest Road Earn-out Shares 75,000 75,000 2,562,151 1,587,091 The Forest Road Earn-out Shares are unvested and are subject to forfeiture if certain earnout conditions are not satisfied. Subject to certain other terms and conditions, the Forest Road Earn-out Shares will vest, in equal tranches of 10 % each, commencing on December 22, 2021, upon the occurrence of the Company's last sale price on the NYSE exceeding each of the following price per share thresholds for any 20 trading days within any consecutive 30 -day trading period: $ 600.00 , $ 650.00 , $ 700.00 , $ 750.00 and $ 800.00 . Any Forest Road Earn-out Shares that do not vest within ten years will be forfeited. The Forest Road Earn-out Shares are accounted for as equity-classified equity instruments and recorded in additional paid in capital. As of December 31, 2023, all Forest Road Earn-out Shares are unvested. The Forest Road Earn-out Shares are considered participating securities as they would share in any dividends declared by the Company. However, as there is no specific requirement to allocate any losses of the Company to the holders of the Forest Road Earn-out Shares and there is no legal requirement to have them fund such losses, the two-class method for earnings per share is not applicable for loss periods.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2023
Related Party Transactions [Abstract]
Related Party Transactions	Note 21. Related Party Transactions The Company has a royalty agreement with a company related to the controlling shareholder. The related party assisted the Company with the development of several products and receives royalties based on the sales of these products. Total payments to the related party were approximately $ 0.4 million and $ 0.5 million during the years ended December 31, 2023 and 2022, respectively. As of each December 31, 2023 and 2022, $ 0.2 million and $ 0.2 million was due to the related party pursuant to the royalty agreement. A minority shareholder and director of the Company is also a shareholder in a law firm that provides legal services to the Company. Total payments to the related party were $ 0.5 million and $ 1.3 million during the years ended December 31, 2023 and 2022, respectively. The Company’s accounts payable to the firm was zero and $ 0.1 million as of each December 31, 2023 and 2022. A minority shareholder affiliated with a director of the Company provided financial advisory services to the Company in connection with the August 2022 Financing Agreement. Total payments to the related party were $ 1.0 million during the year ended December 31, 2022. There were no amounts paid or due to the related party as of or for the year ended December 31, 2023.

Parent Only Financial Statement

Parent Only Financial Statements	12 Months Ended
	Dec. 31, 2023
Condensed Financial Information Disclosure [Abstract]
Parent Only Financial Statements	Note 22. Parent Only Financial Statements The Beachbody Company, Inc. has no material assets or standalone operations other than its ownership in its consolidated subsidiaries. There are restrictions under the Financing Agreement described in Note 11, Debt , on the Company's ability to obtain funds from any of its subsidiaries through dividends. Accordingly, the following condensed financial information is presented on a "Parent Only" basis in which The Beachbody Company, Inc.'s investment in its consolidated subsidiaries are presented under the equity method of accounting. Schedule I The Beachbody Company, Inc. (Parent Company Only) Condensed Balance Sheet (in thousands, except share data) As of December 31, 2023 Assets Current assets: Cash and cash equivalents $ 25 Prepaid expenses 12 Investment in subsidiaries 463,955 Total current assets 463,992 Total assets $ 463,992 Liabilities and Stockholders’ Equity Current liabilities: Accrued expenses $ 7 Due to subsidiaries 378,100 Total current liabilities 378,107 Warrant liabilities 3,125 Total liabilities 381,232 Stockholders’ equity: Class A: 3,978,356 shares issued and 1 Class X: 2,729,003 shares issued and 1 Additional paid-in capital 654,657 Accumulated deficit ( 571,899 ) Total stockholders’ equity 82,760 Total liabilities and stockholders’ equity $ 463,992 See note to condensed financial statements. Schedule I The Beachbody Company, Inc. (Parent Company Only) Condensed Statement of Operations and Comprehensive Loss (in thousands) Year Ended December 31, 2023 Change in fair value of warrant liabilities $ 2,679 Other income 127 Equity in net loss of subsidiaries ( 155,507 ) Net loss and total comprehensive loss $ ( 152,701 ) See note to condensed financial statements. Schedule I The Beachbody Company, Inc. (Parent Company Only) Condensed Statement of Cash Flows (in thousands) Year Ended December 31, 2023 Cash flows from operating activities: Net loss $ ( 152,701 ) Adjustments to reconcile net loss to net cash provided by operating activities: Change in fair value of warrant liabilities ( 2,679 ) Equity in net loss of subsidiaries 155,507 Changes in operating assets and liabilities: Prepaid expenses 8 Accrued expenses 9 Net cash provided by operating activities 144 Cash flows from investing activities: Net cash used in investing activities — Cash flows from financing activities: Decrease in due to subsidiaries ( 8,299 ) Proceeds from issuance of common shares in the Employee Stock Purchase Plan 553 Tax withholdings payments for vesting of restricted stock ( 2,178 ) Proceeds from issuance of Equity Offering, net of issuance costs 4,908 Net cash used in financing activities ( 5,016 ) Net decrease in cash and cash equivalents ( 4,872 ) Cash and cash equivalents, beginning of year 4,897 Cash and cash equivalents, end of year $ 25 See note to condensed financial statements. Note to Condensed Financial Statements of The Beachbody Company, Inc. (Parent Company Only) Basis of Presentation These condensed parent company-only financial statements have been prepared in accordance with Rule 12-04, Schedule I of Regulation S-X, as the restricted net assets of the subsidiaries of The Beachbody Company, Inc. (as defined in Rule 4-08(e)(3) of Regulation S-X) exceed the specified threshold amount of the consolidated net assets of the Company. The ability of The Beachbody Company, Inc.'s operating subsidiaries to pay dividends may be restricted due to the terms of the subsidiaries’ outstanding Term Loan as described in Note 11, Debt , to the audited consolidated financial statements. These condensed parent company-only financial statements have been prepared using the same accounting principles and policies described in the notes to the consolidated financial statements, with the only exception being that the parent company accounts for its subsidiaries using the equity method. These condensed parent company-only financial statements should be read in conjunction with the consolidated financial statements and related notes. The Company has omitted the condensed parent company only consolidated financial statements as of and for the year ended December 31, 2022 since the Financing Agreement was only in place for a portion of the year ended December 31, 2022 and would therefore not be meaningful.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2023
Subsequent Events [Abstract]
Subsequent Events	Note 23. Subsequent Events As mentioned in Note 1, Description of Business and Summary of Significant Accounting Policies and Note 11, Debt, on January 9, 2024, the Company sold its investment in equity securities of a privately-held company for $ 1.0 million. On the Consent Effective Date, the Company made a partial prepayment of $ 1.0 million on the Term Loan (which amount was classified as a current obligation at December 31, 2023) and the related prepayment premium of 3 %. The amounts related to this partial prepayment will be recorded in the quarter ending March 31, 2024. As mentioned in Note 11, Debt , the Company on the Consent Effective Date entered into the Third Amendment, which among other things, (i) consents to the sale of certain assets by the Company and (ii) amends certain terms of the Financing Agreement, including without limitation, the minimum liquidity financial covenants thereunder, such that the minimum liquidity levels shall be (1) $ 19.0 million at all times from the Consent Effective Date through and including March 31, 2024 and (2) $ 24.0 million at all times thereafter through the maturity of the Term Loan. As mentioned in Note 6, Property and Equipment, Net , Note 11, Debt and Note 12, Leases , on February 29, 2024, the Company sold its Van Nuys production facility which had a net carrying value of $ 4.8 million at December 31, 2023, for $ 6.2 million. Simultaneous with the sale, the Company entered into a five year lease of the facility, with two options to extend the lease for a period of three years each. The lease has an annual base rate of $ 0.3 million which increases by 3 % each year. The Company used the net proceeds received from the sale to make a partial prepayment of $ 5.5 million on the Term Loan (which was classified as a current obligation as of December 31, 2023) and the related prepayment premium of 3 %. The amounts related to the sale of the facility and the partial prepayment will be recorded in the quarter ended March 31, 2024. The facility served as collateral on the Term Loan, which required the Company to obtain the approval of Blue Torch to sell the facility. The approval to sell the facility from Blue Torch was not obtained until February 2024. As mentioned in Note 11, Debt , the Company on February 29, 2024 entered into the Fourth Amendment which among other things, (1) consents to the sale of certain assets by the Company and (2) amends certain terms of the Financing Agreement, including without limitation, the minimum liquidity financial covenant thereunder, such that the minimum liquidity levels shall be (1) $ 17.0 million at all times from February 29, 2024 through and including March 31, 2024 and (2) $ 22.0 million at all times thereafter through the maturity of the Term Loan. After the prepayments on January 9, 2024 and February 29, 2024, the principal amount outstanding on the Term Loan was $ 28.6 million. As mentioned in Note 14, R estructuring , in January 2024, the Company executed cost-reduction initiatives intended to streamline the business. These actions are expected to result in approximately $ 1.7 million in costs consisting primarily of termination benefits during the first quarter of 2024.

Financial Statement Schedule

Financial Statement Schedule	12 Months Ended
	Dec. 31, 2022
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]
Financial Statement Schedule	Financial Statement Schedule The following financial statement schedule for the years ended December 31, 2023 and 2022 are filed as part of this report and should be read in conjunction with the consolidated financial statements (in thousands). December 31, 2023 2022 Deferred tax asset valuation allowance, beginning of year $ 116,564 $ 68,109 Additions charged to earnings 26,272 47,640 Other (1) — 815 Deferred tax asset valuation allowance, end of year $ 142,836 $ 116,564 (1) The valuation allowance was adjusted for acquisitions and deferred taxes related to tax-deductible transaction costs included in additional paid in capital in the financial statements.

Description of Business and S_2

Description of Business and Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation The Company prepares its consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) as determined by the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) and pursuant to the regulations of the U.S. Securities and Exchange Commission ("SEC"). The consolidated financial statements include the accounts of the Company and its controlled subsidiaries. All intercompany transactions and balances with or among our consolidated subsidiaries have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that may impact the amounts reported in the consolidated financial statements and accompanying notes. Significant estimates in our consolidated financial statements include, but are not limited to, the useful life and recoverability of long-lived assets, the valuation of warrant liabilities, the recognition and measurement of income tax assets and liabilities, the valuation of intangible assets, impairment of goodwill and intangible assets, and the net realizable value of inventory. The Company bases these estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying amounts of assets and liabilities. Our actual results could differ from our estimates. We periodically review estimates and assumptions and we reflect the effects of changes, if any, in the consolidated financial statements in the period that they are determined.
Segments	Segments The Company has one operating and reporting segment. In reaching this conclusion, management considered the definition of the Chief Operating Decision Maker (“CODM”); how the business is defined by the CODM; the nature of the information provided to the CODM and how that information is used to make operating decisions; and how resources and performance are accessed. The Company's CODM is the chief executive officer ("CEO"). The results of the operations are provided to and analyzed by the CODM at the Company level and accordingly, key resource decisions and assessment of performance are performed at the Company level based on the Company’s consolidated net revenues and operating income. Prior to the third quarter of 2022, the Company concluded it had two operating segments, Beachbody and Other, and one reportable segment, Beachbody. During the third quarter of 2022, in connection with the consolidation of its Openfit streaming fitness offering onto a single Beachbody digital platform, the Company determined that it had one operating and reportable segment and changed its segment reporting accordingly.
Reverse Stock Split	Reverse Stock Split On November 21, 2023, we effected a 1-for-50 reverse stock split of our issued and outstanding common stock. Each stockholder's percentage ownership and proportional voting power generally remained unchanged as a result of the reverse stock split. All applicable share data, per share amounts and related information in the consolidated financial statements and notes thereto have been adjusted retroactively to give effect to the 1-for-50 reverse stock split. See Note 15 Stockholders' Equity for additional information regarding the reverse stock split.
Fair Value Measurements	Recurring Fair Value Measurements For assets and liabilities that are measured using quoted prices (unadjusted) in active markets for identical assets or liabilities, the total fair value is the published market price per unit multiplied by the number of units held without consideration of transaction costs (Level 1). Assets and liabilities that are measured using significant other observable inputs are valued by reference to similar assets or liabilities, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data (Level 2). For all remaining assets and liabilities for which there are no significant observable inputs, fair value is derived using an assessment of various discount rates, default risk, credit quality, and the overall capital market liquidity (Level 3). These valuations require significant judgment. Non-Recurring Fair Value Measurements Certain assets are measured at fair value on a non-recurring basis. These assets are not measured at fair value on an ongoing basis but are subject to fair value adjustments only in certain circumstances. These assets can include long-lived assets that have been reduced to fair value when they are held for sale, equity securities without readily determinable fair value that are written down to fair value when they are impaired and long-lived assets (including intangible assets and goodwill) that are written down to fair value when they are impaired. Assets that are written down to fair value when impaired are not subsequently adjusted to fair value unless further impairment occurs.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all cash and short-term investments purchased with maturities of three months or less when acquired to be cash equivalents. Cash and cash equivalents include: • cash held in checking and money market funds; • amounts in transit from payment processors for customer credit and debit card transactions; and • highly liquid investments with original maturities of three months or less at the time of purchase. Cash and cash equivalents are carried at cost, which approximates market value. The Company maintains its cash at financial institutions, and the balances, at times, may exceed Federal Deposit Insurance Corporation insurance limits. The Company has not experienced any losses in such accounts. The Company mitigates its risk by placing funds in high-credit quality financial institutions and utilizing nightly sweeps into U.S. Treasury funds for certain cash accounts. We regularly monitor the financial stability of the financial institutions and believe that we are not exposed to any significant credit risk in cash and cash equivalents. Restricted cash primarily consists of cash held related to an irrevocable letter of credit, see Note 11 , Debt , for additional information on the letter of credit.
Inventory	Inventory Inventory consists of raw materials, work in process, and finished goods. Inventory is accounted for using the first-in, first-out method and is valued at the lower of cost or net realizable value. The Company records adjustments to the carrying value of inventory based on assumptions regarding future demand for the Company’s products, anticipated margin, planned product discontinuances, and the physical condition (e.g. age and quality) of the inventory.
Accounts Receivable, Net (included in Other Current Assets)	Accounts Receivable, Net (included in Other Current Assets) The Company's accounts receivable primarily represents amounts due from third party sales. The allowance for credit losses is based on several factors, including the length of time accounts receivable are past due, the Company's previous loss history, the specific customer's ability to pay its obligations and any other forward looking data regarding customers' ability to pay which may be available.
Content Assets, Net	Content Assets, Net The Company capitalizes costs associated with the development and production of programs on its streaming platforms. The Company capitalizes production costs as customer usage and retention data supports that future revenue will be earned. These costs are classified as non-current assets in the consolidated balance sheets. Content assets are predominantly monetized as a film group and are amortized over the estimated useful life based on projected usage, which has been derived from historical viewing patterns, resulting in an accelerated amortization pattern. Amortization begins when the program is first available for streaming by customers and is recorded in the consolidated statements of operations as a component of digital cost of revenue. When an event or change in circumstances indicates a change in projected usage, content assets are reviewed for potential impairment in aggregate at a group level. To date, the Company has not identified any such event or changes in circumstances.
Property and Equipment, Net	Property and Equipment, Net Property and equipment, which includes computer software and web development costs, are recorded at cost less accumulated depreciation. Depreciation is recorded on a straight-line basis over the estimated useful lives of the assets, which primarily range from two to seven years and up to 39 years for buildings. Leasehold improvements are depreciated over the shorter of the life of the assets or the remaining life of the related lease. Costs of maintenance, repairs, and minor replacements are expensed when incurred, while expenditures for major renewals and betterments that extend the useful life of an asset or provide additional utility are capitalized. Software and web development projects in-process consist primarily of costs associated with internally developed software that has not yet been placed into service. The Company capitalizes eligible costs to acquire, develop, or modify internal-use software that are incurred subsequent to the preliminary project stage. Depreciation of these assets begins upon the initial usage of the software. When property is sold or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts and any resulting gain or loss is included in net income (loss).
Business Combinations	Business Combinations The Company accounts for business combinations under the acquisition method of accounting. The cost of an acquired company is assigned to the tangible and identifiable assets purchased and the liabilities assumed on the basis of their fair values at the date of acquisition. Any excess of the purchase price over the fair value of tangible and intangible assets acquired is assigned to goodwill. The transaction costs associated with business combinations are expensed as they are incurred.
Goodwill and Indefinite-Lived Intangible Assets	Goodwill and Indefinite-Lived Intangible Assets Goodwill represents the excess of the fair value of the consideration transferred in a business combination over the fair value of the underlying identifiable assets and liabilities acquired. Goodwill and intangible assets deemed to have an indefinite life are not amortized. Instead, goodwill and indefinite-lived intangible assets are assessed for impairment annually or more frequently if an event or change in circumstances occurs that, with respect to goodwill, would more likely than not reduce the fair value of a reporting unit ("RU") below its carrying value or, for indefinite-lived intangible assets, indicate that it is more likely than not that the asset is impaired. The Company has historically performed its annual goodwill impairment assessment as of October 1. During the fourth quarter of 2023, the Company decided to change the date of its annual impairment assessment from October 1 to December 31. The Company completed the required annual impairment test for goodwill as of October 1, 2023, prior to the change of the annual impairment test for goodwill to December 31. The change was made to more closely align the impairment assessment date with the Company's annual planning and forecasting process. The change in date of the annual impairment test is not deemed material as the new measurement date of December 31 is in relative close proximity to the previous measurement date and the change did not have any impact on goodwill or the impairment of goodwill. The change has been applied prospectively and would not have had an impact on a retrospective basis. As of December 31, 2023 and 2022, the Company had no indefinite-lived intangible assets.
Long-Lived Assets	Long-Lived Assets Management reviews long-lived assets (including property and equipment, content assets, and definite-lived intangible assets) for impairment whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. Recoverability of assets is determined by first grouping the long-lived assets at the lowest level for which there are identifiable cash flows, and then comparing the carrying value of each asset group to its forecasted undiscounted cash flows. If the forecasted undiscounted cash flows indicates that the carrying value of the assets is not recoverable, an impairment test of the asset group is performed. Impairment is recognized if the carrying amount of the asset group exceeds its fair value. As of December 31, 2023 and 2022, the Company’s long-lived assets were located in the U.S.
Leases	Leases The Company accounts for its leases of administrative offices and production studios under ASC 842, Leases ; the Company does not have any leases where it acts as a lessor as of December 31, 2023. Under this guidance, arrangements meeting the definition of a lease are classified as operating or finance leases based on the principle of whether or not the lease is effectively a financed purchase of the leased asset by the lessee and are recorded on the consolidated balance sheets as both a right-of-use ("ROU") asset and lease liability, calculated by discounting fixed lease payments over the lease term at the discount rate implicit in the lease or the Company’s incremental borrowing rate. Lease liabilities are increased by interest and reduced by payments each period, and the ROU asset is amortized over the lease term. For operating leases, interest on the lease liability and the amortization of the ROU asset results in straight-lined rent expense over the lease term. For finance leases, interest on the lease liability and the amortization of the ROU asset results in front-loaded expense over the lease term. Variable lease expenses are recorded when incurred. In calculating the ROU asset and lease liability, the Company elected the practical expedient to combine lease and non-lease components. Rental income on subleases is recognized on a straight-line basis over the estimated lease term. The Company excludes short-term leases having initial terms of 12 months or less as an accounting policy election and instead recognizes rent expense on a straight-line basis over the lease term for such leases.
Warrant Liabilities	Warrant Liabilities The Company has issued warrants on several occasions including during its initial public offering process, the execution of its Term Loan (defined later) and in the Equity Offering (defined later), which have not met the criteria to be classified in stockholders equity. Public and Private Placement Warrants The Company has outstanding warrants for the purchase of 200,000 shares of the Company's Class A common stock at an exercise price of $ 575.00 per share (the “Public Warrants”) and outstanding warrants for the purchase of 106,667 shares of the Company's Class A common stock at an exercise price of $ 575.00 per share (the “Private Placement Warrants”). All of the Public and Private Placement Warrants remained outstanding as of December 31, 2023 and 2022. The Public Warrants were publicly traded on the New York Stock Exchange (the "NYSE") but were delisted by the NYSE on November 24, 2023 due to their abnormally low price levels. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a cashless basis, as described in the warrant agreement. In no event will the Company be required to net cash settle any warrant. The Private Placement Warrants are transferable, assignable or salable in certain limited exceptions. The Private Placement Warrants are exercisable for cash or on a cashless basis, at the holder’s option, and are non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will cease to be Private Placement Warrants and will become Public Warrants, and will be redeemable by the Company and exercisable by such holders on the same basis as the other Public Warrants. Term Loan Warrants In connection with the Term Loan (defined later), the Company issued warrants for the purchase of 94,335 shares of the Company’s Class A common stock at an exercise price of $ 92.50 per share to certain holders affiliated with Blue Torch Finance, LLC (the “Term Loan Warrants”). In connection with the Second Amendment (defined later), the Company also amended and restated the Term Loan Warrants. The amendment of the Term Loan Warrants amended the exercise price from $ 92.50 per share to $ 20.50 per share. The Term Loan warrants vest on a monthly basis over four years and have a seven-year term. In connection with the Equity Offering (defined later), the Term Loan Warrants conversion ratio was amended resulting in an increase in the number of shares purchased upon the exercise of the Term Loan Warrants to 97,482 shares of the Company's Class A common stock. Common Stock Warrants In connection with the Equity Offering (defined later), the Company issued warrants (the "Common Stock Warrants") to certain institutional investors to purchase 543,590 shares of Class A common stock at an exercise price of $ 11.24 per share. The Common Stock Warrants may be exercised at any time beginning June 13, 2024 and will expire on June 13, 2029. See Note 15, Stockholders' Equity , for additional information on the Equity Offering and the Common Stock Warrants. The Company evaluated the Public, Private Placement, Term Loan and Common Stock Warrants (collectively, the "Warrants") under ASC 815, Derivatives and Hedging—Contracts in Entity’s Own Equity , and concluded they do not meet the criteria to be classified in stockholders’ equity. Since the Warrants meet the definition of a derivative under ASC 815, the Company recorded these warrants as other liabilities in the consolidated balance sheets at fair value, with subsequent changes in their respective fair values recognized in the change in fair value of warrant liabilities within the consolidated statements of operations at each reporting date. The Public Warrants were publicly traded until November 24, 2023, when they were delisted by the NYSE due to the NYSE's determination that the Public Warrants were no longer suitable for listing, and thus had an observable market price to estimate fair value until the date that they were delisted. The Private Placement, Term Loan and Common Stock Warrants, as well as the Public Warrants after the date they were delisted, are valued using a Black-Scholes option-pricing model as described in Note 3, Fair Value Measurements to the consolidated financial statements. The change in the fair values of the Warrants for the years ended December 31, 2023 and 2022, resulted in a $ 2.7 million and $ 8.3 million non-cash change in fair value gain in the consolidated statements of operations for the years ended December 31, 2023 and 2022, respectively.
Other Investment	Other Investment As of December 31, 2023 and 2022, the Company has an investment in equity securities of a privately-held company of $ 1.0 million and $ 5.0 million , with no readily determinable fair value. This equity investment is reported within other assets in the consolidated balance sheets. The Company uses the measurement alternative for this investment, and its carrying value is reported at cost, adjusted for impairments or any observable price changes in ordinary transactions with identical or similar instruments. As of December 31, 2023 the Company recorded a $ 4.0 million impairment on this investment based on an observable price change. As of December 31, 2022, no adjustments to the carrying value of this investment were made. On January 9, 2024 the Company sold this investment for $ 1.0 million. See Note 23, Subsequent Events to the consolidated financial statements for additional information on the sale of this investment.
Revenue Recognition	Revenue Recognition The Company’s primary sources of revenue are from sales of digital subscriptions, nutritional products, and connected fitness equipment. The Company determines revenue recognition through the five-step model which requires us to: (i) identify our contracts with a customer; (ii) identify our performance obligations in the contract; (iii) determine the transaction price in the contract; (iv) allocate the transaction price to our performance obligation in the contract; and (v) recognize revenue when each performance obligation under the contract is satisfied. The Company records revenue when it fulfills its performance obligation to transfer control of the goods or services to its customer and defers revenue when it receives payments in advance of fulfilling its performance obligations. Revenue that is deferred is included in deferred revenue (for the remaining deferral period that is less than one year) and in other liabilities (for the remaining deferral period that is more than one year) in the consolidated balance sheets. Control of shipped items is generally transferred when the product is delivered to the customer. Control of services, which are primarily digital subscriptions, transfers over time, and as such, revenue is recognized ratably over the subscription period (up to 38 months). Shipping and handling charges billed to customers are included in revenue. The Company markets and sells its products primarily in the United States, Canada, the United Kingdom, and France. The amount of revenue recognized is the consideration that the Company expects it will be entitled to receive in exchange for transferring goods or services to its customers. Revenue is recorded net of expected returns, discounts, and credit card chargebacks, which are estimated using the Company’s historical experience. If actual costs differ from previous estimates, the amount of the liability and corresponding revenue are adjusted in the period in which such costs occur. The Company sells a variety of bundled products that combine digital subscriptions, nutritional products, and/or other fitness products. The Company considers these sales to be revenue arrangements with multiple performance obligations. For customer contracts that include multiple performance obligations, the Company accounts for individual performance obligations if they are distinct. The transaction price is then allocated to each performance obligation based on its stand-alone selling price. The Company generally determines the standalone selling price based on the prices charged to customers. Revenue is presented net of sales taxes and value added taxes ("VAT") and GST/HST (Goods and Services Tax/Harmonized Sales Tax) which are collected from customers and remitted to applicable government agencies. The Company records fees paid to its third party financing partners as a reduction of revenue. A description of our principal revenue generating activities is as follows: Digital Subscriptions – Our digital subscription services provide access to BODi, which provides a vast library of workout content. Digital subscriptions represent a single, stand-ready obligation and are paid for either at the time of or in advance of service delivery. Revenue from these arrangements is recognized over the subscription period. Nutritional Products – We offer a comprehensive line of nutritional products including nutritional supplement subscriptions and one-time nutritional sales. We often sell bundled products that combine digital subscriptions, nutritional products and/or fitness products. Revenue is recognized when control of the goods is transferred to the customer, which typically occurs upon delivery. See below for discussion of bundled products. Connected Fitness – We offer a connected fitness system that includes in-home fitness equipment and associated digital content subscriptions. Some of our in-home fitness contracts have multiple performance obligations, which include both hardware and a subscription service commitment. Revenue is recognized when control of the equipment is transferred to the customer, usually upon delivery. See below for discussion of bundled products. In cases where a customer contract contains multiple performance obligations, which the Company refers to as bundled products, we account for each obligation individually if they are distinct. We allocate the transaction price, net of discounts, to each performance obligation based on its standalone selling price. Revenue from such arrangements is recognized when control of the product is transferred to the customer, usually upon delivery. For digital subscription service commitments, revenue is recognized over the subscription period. The Company operates primarily as the principal in its relationships where third parties sell or distribute the Company’s goods or services, payments made to the third parties are recorded in selling and marketing expenses within the consolidated statements of operations. The Company in certain instances serves as the agent in relationships with third parties, the activity in these relationships are immaterial.
Cost of Revenue	Cost of Revenue Digital Cost of Revenue Digital cost of revenue includes costs associated with digital content creation including amortization and revisions of content assets, depreciation of streaming platforms, digital streaming costs, and amortization of acquired digital platform intangible assets. It also includes customer service costs, payment processing fees, depreciation of production equipment, live trainer costs, facilities, and related personnel expenses. Nutrition and Other Cost of Revenue Nutrition and other cost of revenue includes product costs, shipping and handling, fulfillment and warehousing, customer service, and payment processing fees. It also includes depreciation of nutrition-related e-commerce websites and social commerce platforms, amortization of formulae intangible assets, facilities, and related personnel expenses. Connected Fitness Cost of Revenue Connected fitness cost of revenue consists of product costs, including bike and tablet hardware costs, duties and other applicable importing costs, shipping costs, warehousing and logistics costs, costs associated with service calls and repairs of the products under warranty, payment processing and financing fees, customer service expenses, and personnel-related expenses associated with supply chain and logistics. The Company utilizes the practical expedient under ASC 606-10-25-18B to account for shipping and handling costs incurred to deliver products to customers as fulfillment activities, rather than a promised service (a revenue element). Shipping and handling costs are included in Nutrition and other cost of revenue and Connected fitness cost of revenue in the consolidated statements of operations in the period during which the products ship. The costs associated with shipping connected fitness and nutrition and other products to customers were $ 22.5 million and $ 35.4 million for the years ended December 31, 2023 and 2022, respectively.
Selling and Marketing	Selling and Marketing Selling and marketing expenses primarily include the costs of Partner compensation, advertising, royalties, promotions and events, and third-party sales commissions as well as the personnel expenses for employees and consultants who support these areas. Selling and marketing expenses also include depreciation of certain software and amortization of contract-based intangible assets. The Company pays Partner and third-party sales commissions when commissionable sales are made. The third-party sales commissions are not material. In cases where the underlying revenue is deferred, the Company also defers the commissions and expenses these costs in the same period in which the underlying revenue is recognized. Deferred Partner commissions are included in other current assets and other assets in the consolidated balance sheets and were $ 37.1 million and $ 32.8 million as of December 31, 2023 and 2022, respectively. Partners are also eligible for various bonuses, recognition, and complimentary participation in events, including those based on sales volume. The Company expenses these costs in the period in which they are earned. These expenses as well as Partner commissions earned but not paid are included in accrued expenses in the consolidated balance sheets. Advertising costs are primarily comprised of social media, television media, and internet advertising expenses and also include print, radio, and infomercial production costs. Generally, the costs to produce television and web advertising are expensed as incurred, while television media costs are expensed at the time the media airs. Total advertising expense, including the costs to produce infomercials, was $ 31.5 million and $ 36.9 million for the years ended December 31, 2023 and 2022, respectively.
Enterprise Technology and Development	Enterprise Technology and Development Enterprise technology and development expenses primarily include personnel-related expenses for employees and professional fees paid to consultants to maintain the Company’s enterprise systems applications, hardware, and software. Expenses also include payroll and related costs for employees involved in the research and development of new and existing products and services, enterprise technology hosting expenses, depreciation of enterprise technology-related assets, and equipment leases. Research and development costs, which are expensed as incurred, were $ 2.7 million and $ 4.4 million for the years ended December 31, 2023 and 2022 respectively.
Equity-Based Compensation	Equity-Based Compensation The Company measures and recognizes compensation expense for all equity-based awards based on their estimated grant date fair values. The Company recognizes the expense on a straight-line basis over the requisite service period, and forfeitures are accounted for as they occur. Equity-based compensation expense is included in cost of revenue, selling and marketing, enterprise technology and development, and general and administrative expense within the consolidated statements of operations.
Derivative Financial Instruments	Derivative Financial Instruments The Company may use derivative instruments to manage the effects of fluctuations in foreign currency exchange rates on the Company’s net cash flows. The Company primarily enters into option contracts to hedge forecasted payments, typically for up to 12 months, for cost of revenue, selling and marketing expenses, general and administrative expenses, and intercompany transactions not denominated in the local currencies of the Company’s foreign operations. The Company designates certain of these instruments as cash flow hedges and records them at fair value as either assets or liabilities within the consolidated balance sheets. Certain of these instruments are freestanding derivatives for which hedge accounting does not apply. Changes in the fair value of cash flow hedges are recorded in accumulated other comprehensive income (loss) until the hedged forecasted transaction affects earnings. Deferred gains and losses associated with cash flow hedges of third-party payments are recognized in cost of revenue, selling and marketing, or general and administrative expenses, as applicable, during the period when the hedged underlying transaction affects earnings. Changes in the fair value of certain derivatives for which hedge accounting does not apply are immediately recognized directly in earnings to cost of revenue. The Company classifies cash flows related to derivative financial instruments as operating activities in the consolidated statements of cash flows.
Income Taxes	Income Taxes The Company is subject to income taxes in the United States, Canada, and the United Kingdom. The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets ("DTAs") and liabilities ("DTLs") for the expected future tax consequences of events to be included in the financial statements. Under this method, DTAs and DTLs are determined on the basis of the differences between the financial statement and tax basis of assets and liabilities by using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on DTAs and DTLs is recognized in income in the period that includes the enactment date. In evaluating the Company’s ability to recover DTAs, all available positive and negative evidence is analyzed, including historical and current operating results, ongoing tax planning, and forecasts of future taxable income on a jurisdiction-by-jurisdiction basis. Based on the level of losses, the Company has established a valuation allowance ("VA") to reduce its net DTAs to the amount that is more likely than not to be realized. To the extent we establish a VA or increase or decrease this allowance in a given period, we would include the related tax expense or tax benefit within the tax provision in the consolidated statement of operations in that period. In the future, if we determine that we would be able to realize our DTAs in excess of their net recorded amount, we would make an adjustment to the DTA VA and record an income tax benefit within the tax provision in the consolidated statement of operations in that period. The Company records uncertain tax positions on the basis of a two-step process in which (1) the Company determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more than 50% likely to be realized upon ultimate settlement with the related tax authority. The Company recognizes interest and penalties related to unrecognized tax benefits in interest expense and other income, net, respectively, in the consolidated statements of operations. Accrued interest and penalties are included in accrued expenses and other liabilities in the consolidated balance sheets.
Foreign Currency	Foreign Currency The reporting currency for the consolidated financial statements of the Company is the U.S. dollar. The functional currency of the Company’s foreign subsidiaries is the local currency of the subsidiaries. The assets and liabilities of these subsidiaries are translated into U.S. dollars at exchange rates in effect at the end of each reporting period. Revenues and expenses for these subsidiaries are translated at average exchange rates in effect during the applicable period. Translation adjustments are included in accumulated other comprehensive income (loss) as a component of stockholders’ equity. Gains and losses related to the recurring measurement and settlement of foreign currency transactions are included as a component of other income, net in the consolidated statements of operations and were a loss of $ 0.2 million and a gain of $ 0.6 million during the years ended December 31, 2023 and 2022, respectively.
Earnings (loss) per share	Earnings (loss) per share Basic net loss per common share is calculated by dividing net loss allocable to common shareholders by the weighed-average number of common shares outstanding during the period. The weighted average number of common shares outstanding for basic and diluted earnings per share includes the weighted average affect of the pre-funded warrants issued in connection with the Equity Offering (defined later) that closed on December 13, 2023, the exercise of which requires nominal consideration for the delivery of the common shares. See note 15, Stockholders' Equity , for information on the pre-funded warrants. Diluted net loss per common share adjusts net loss and net loss per common share for the effect of all potentially dilutive shares of the Company’s common stock. Basic and diluted loss per common share are the same for each class of common stock because they are entitled to the same liquidation and dividend rights.
Recently Adopted Accounting Pronouncement or Accounting Pronouncement Not Yet Adopted	Recently Adopted Accounting Pronouncement In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers , which requires an acquirer to apply ASC 606 to recognize and measure contract assets and liabilities from contracts with customers acquired in a business combination on the acquisition date rather than the general guidance in ASC 805. The Company adopted this new accounting guidance on a prospective basis on January 1, 2023, and the adoption did not have a material effect on its consolidated financial statements. In September 2022, the FASB issued ASU 2022-04 , Liabilities-Supplier Finance Programs (Topic 405-50) - Disclosure of Supplier Finance Program Obligations, which requires that a buyer in a supplier finance program disclose sufficient information about the program to allow a user of financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The Company adopted this new accounting guidance on a prospective basis on January 1, 2023 , and the adoption did not have a material effect on its consolidated financial statements. Accounting Pronouncements Not Yet Adopted In November 2023, the FASB issued ASU 2023-07, Improvements to Reportable Segment Disclosures , to improve disclosures about a public entity's reportable segments through enhanced disclosures about significant segment expenses. The guidance in this update will be effective for public companies for annual periods beginning after December 15, 2023 and interim periods for years beginning after December 15, 2024. The Company is evaluating the potential impact of adopting this guidance on its consolidated financial statements. In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures, to improve disclosures about a companies income taxes paid and the effective rate reconciliation table. The guidance in this update will be effective for public companies for annual periods beginning after December 15, 2024 and interim periods for years beginning after December 15, 2025. The Company is evaluating the potential impact of adopting this guidance on its consolidated financial statements.

Revenue (Tables)

Revenue (Tables)	12 Months Ended
	Dec. 31, 2023
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	The Company’s revenue disaggregated by geographic region is as follows (in thousands): Year Ended December 31, 2023 2022 Geographic region: United States $ 473,465 $ 620,942 Rest of world 1 53,644 71,257 Total revenue $ 527,109 $ 692,199 1 Consists of Canada, United Kingdom and France. Other than the United Sates, no single country accounted for more than 10% of the Company’s total revenue.

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2023
Fair Value Disclosures [Abstract]
Summary of Fair Value Measurements, Recurring and Nonrecurring	The Company’s financial assets and liabilities subject to fair value measurements on a recurring basis and the level of inputs used for such measurements were as follows (in thousands): December 31, 2023 Level 1 Level 2 Level 3 Assets Derivative assets $ — $ — $ — Restricted short-term investments — 4,250 — Total assets $ — $ 4,250 $ — Liabilities Public Warrants $ — $ — $ 17 Private Placement Warrants — — 9 Term Loan Warrants — — 392 Common Stock Warrants — — 2,707 Total liabilities $ — $ — $ 3,125 December 31, 2022 Level 1 Level 2 Level 3 Assets Derivative assets $ — $ 462 $ — Total assets $ — $ 462 $ — Liabilities Public Warrants $ 415 $ — $ — Private Placement Warrants — — 107 Term Loan Warrants — — 1,226 Total liabilities $ 415 $ — $ 1,333
Summary of Fair Value of Significant Assumptions Utilized in the Valuation	The following table presents significant assumptions utilized in the valuation of the Private Placement Warrants on December 31, 2023 and 2022: As of December 31, 2023 2022 Risk-free rate 4.1 % 4.2 % Dividend yield rate — — Volatility 97.6 % 75.0 % Contractual term (in years) 2.48 3.49 Exercise price $ 575.00 $ 575.00 The following table presents significant assumptions utilized in the valuation of the Public Warrants on December 31, 2023: As of December 31, 2023 Risk-free rate 4.1 % Dividend yield rate — Volatility 97.6 % Contractual term (in years) 2.48 Exercise price $ 575.00 The following table presents significant assumptions utilized in the valuation of the Common Stock Warrants on December 31, 2023: As of December 31, 2023 Risk-free rate 3.8 % Dividend yield rate — Volatility 75.2 % Contractual term (in years) 5.44 Exercise price $ 11.24 The following table presents significant assumptions utilized in the valuation of the Term Loan Warrants at December 31, 2023 and 2022: As of December 31, 2023 2022 Risk-free rate 3.8 % 4.0 % Dividend yield rate — — Volatility 74.5 % 75.0 % Contractual term (in years) 5.60 6.61 Exercise price $ 20.50 $ 92.50
Summary of Change in the Fair Value of the Warrants	The following table presents changes in the fair value of the Private Placement Warrants for the years ended December 31, 2023 and 2022 (in thousands): Year Ended December 31, 2023 2022 Balance, beginning of period $ 107 $ 2,133 Change in fair value ( 98 ) ( 2,026 ) Balance, end of period $ 9 $ 107 The following table presents changes in the fair value of the Public Warrants for the years ended December 31, 2023 and 2022 (in thousands): Year Ended December 31, 2023 2022 Balance, beginning of period $ 415 $ 2,701 Change in fair value ( 398 ) ( 2,286 ) Balance, end of period $ 17 $ 415 The following table presents changes in the fair value of the Common Stock Warrants for the year ended December 31, 2023 (in thousands): Year ended December 31, 2023 Balance, beginning of year $ — Issued in connection with Equity Offering 3,255 Change in fair value ( 548 ) Balance, end of year $ 2,707 The following table presents changes in the fair value of the Term Loan Warrants for the year ended December 31, 2023 and 2022 (in thousands): Year ended December 31, 2023 2022 Balance, beginning of year $ 1,226 $ — Issued in connection with Term Loan — 5,236 Amended in connection with Second Amendment 802 — Change in fair value ( 1,636 ) ( 4,010 ) Balance, end of year $ 392 $ 1,226
Summary of Fair Value, Assets Measured on Nonrecurring Basis Using Unobservable Inputs	The following table presents the non-recurring losses recognized for the year ended December 31, 2023 due to asset impairments, and the fair value and asset classification of the related assets as of the impairment date (in thousands): December 31, 2023 Fair Value Total Losses Goodwill $ 85,166 $ ( 40,000 ) Other investments 1,000 ( 4,000 ) Intangible assets — ( 3,092 ) Total $ 86,166 $ ( 47,092 )

Inventory, Net (Tables)

Inventory, Net (Tables)	12 Months Ended
	Dec. 31, 2023
Inventory Disclosure [Abstract]
Schedule of Inventory, Current	Inventory consists of the following (in thousands): December 31, 2023 2022 Raw materials and work in process $ 10,354 $ 13,380 Finished goods 14,622 40,680 Total inventory $ 24,976 $ 54,060

Other Current Assets (Tables)

Other Current Assets (Tables)	12 Months Ended
	Dec. 31, 2023
Other Current Assets [Abstract]
Summary of Other Current Assets	Other current assets consist of the following (in thousands): December 31, 2023 2022 Deferred Partner costs $ 36,169 $ 31,270 Deposits 6,788 4,527 Accounts receivable, net 1,270 866 Other 1,696 2,585 Total other current assets $ 45,923 $ 39,248

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	12 Months Ended
	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
Summary of Property and equipment, net	Property and equipment, net consists of the following (in thousands): December 31, 2023 2022 Computer software and web development $ 229,527 $ 236,533 Computer equipment 23,738 24,240 Buildings 5,158 5,158 Leasehold improvements 4,600 4,600 Furniture, fixtures and equipment 1,166 1,222 Computer software and web development projects in-process 2,157 5,147 Property and equipment, gross 266,346 276,900 Less: Accumulated depreciation ( 221,291 ) ( 202,753 ) Property and equipment, net $ 45,055 $ 74,147
Summary of depreciation expense related to property and equipment	The Company recorded depreciation expense related to property and equipment in the following expense categories of its consolidated statements of operations as follows (in thousands): Year Ended December 31, 2023 2022 Cost of revenue $ 17,994 $ 27,137 Selling and marketing - 381 Enterprise technology and development 16,463 28,833 General and administrative 3 242 Total depreciation $ 34,460 $ 56,593

Content Assets, Net (Tables)

Content Assets, Net (Tables)	12 Months Ended
	Dec. 31, 2023
Content Assets [Abstract]
Summary of film cost	Content assets, net consists of the following (in thousands): December 31, 2023 2022 Released, less amortization $ 21,134 $ 34,713 In production 225 175 Content assets, net $ 21,359 $ 34,888

Goodwill (Tables)

Goodwill (Tables)	12 Months Ended
	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of Goodwill	Changes in goodwill for the years ended December 31, 2023 and 2022 are as follows (in thousands): December 31, 2023 2022 Goodwill, beginning of year $ 125,166 $ 125,166 Impairment of goodwill ( 40,000 ) — Goodwill, end of year $ 85,166 $ 125,166

Intangible Assets, Net (Tables)

Intangible Assets, Net (Tables)	12 Months Ended
	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets	Intangible assets as of December 31, 2023 and 2022 consisted of the following (in thousands): December 31, 2023 December 31, 2022 Intangible Accumulated Intangibles Intangible Accumulated Intangibles Contract-based $ 300 $ ( 300 ) $ — $ 300 $ ( 300 ) $ — Customer-related 21,100 ( 21,100 ) — 21,100 ( 14,800 ) 6,300 Technology-based 20,200 ( 20,200 ) — 20,200 ( 19,400 ) 800 Talent and representation contracts 10,300 ( 10,300 ) — 10,300 ( 10,300 ) — Formulae 1,950 ( 1,950 ) — 1,950 ( 1,146 ) 804 Trade name 51,200 ( 51,200 ) — 51,200 ( 50,900 ) 300 $ 105,050 $ ( 105,050 ) $ — $ 105,050 $ ( 96,845 ) $ 8,204

Accrued Expenses (Tables)

Accrued Expenses (Tables)	12 Months Ended
	Dec. 31, 2023
Payables and Accruals [Abstract]
Summary of Accrued Expenses	Accrued expenses consist of the followings (in thousands): December 31, 2023 2022 Partner costs $ 13,971 $ 14,535 Inventory, shipping and fulfillment 6,869 11,687 Employee compensation and benefits 4,334 20,584 Sales and other taxes 3,963 4,818 Information technology 3,176 2,207 Advertising 872 1,176 Customer service expenses 437 956 Other accrued expenses 8,525 8,467 Total accrued expenses $ 42,147 $ 64,430

Debt (Tables)

Debt (Tables)	12 Months Ended
	Dec. 31, 2023
Debt Disclosure [Abstract]
Schedule of Aggregate Amounts of Payments Due and Reconciliation of Debt Balances, Net of Debt Discount and Debt Issuance Costs	The aggregate amounts of payments due for the periods succeeding December 31, 2023 and reconciliation of the Company’s debt balances, net of debt discount and debt issuance costs, are as follows (in thousands): Year ending December 31, 2024 $ 8,068 Year ending December 31, 2025 2,500 Year ending December 31, 2026 24,527 Total debt 35,095 Less current portion ( 8,068 ) Less unamortized debt discount and debt issuance costs ( 5,960 ) Add capitalized paid-in-kind interest 424 Total long-term debt $ 21,491

Leases (Tables)

Leases (Tables)	12 Months Ended
	Dec. 31, 2023
Leases [Abstract]
Summary of Lease Cost	The following summarizes the Company’s leases (in thousands): Year Ended December 31, 2023 2022 Finance lease costs: Amortization of right-of-use asset $ 73 $ 192 Interest on lease liabilities 2 8 Operating lease costs 2,097 2,150 Short-term lease costs 18 202 Variable lease costs 301 566 Short-term sublease income ( 32 ) ( 127 ) Total lease costs $ 2,459 $ 2,991
Summary of Lease Other Information	Year Ended December 31, 2023 2022 Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from finance leases $ 2 $ 8 Operating cash flows from operating leases 2,319 2,195 Financing cash flows from finance leases 121 153 Right-of-use asset obtained in exchange for new operating lease liabilities — 420 Weighted-average remaining lease term - finance leases 0.3 1.3 Weighted-average remaining lease term - operating leases 2.3 2.9 Weighted-average discount rate - finance leases 4.0 % 4.0 % Weighted-average discount rate - operating leases 4.1 % 4.5 %
Summary of Maturities of Operating and Finance Lease Liability, Excluding Short-term Leases	Maturities of operating and finance lease liabilities, excluding short-term leases, are as follows (in thousands): Operating Leases Finance Leases Total Year ended December 31, 2024 $ 2,079 $ 2 $ 2,081 Year ended December 31, 2025 687 — 687 Year ended December 31, 2026 712 — 712 Year ended December 31, 2027 132 — 132 Total 3,610 2 3,612 Less present value discount ( 352 ) - ( 352 ) Lease liabilities at December 31, 2023 $ 3,258 $ 2 $ 3,260

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2023
Purchase Obligation, Fiscal Year Maturity [Abstract]
Summary of Purchase Obligation, Fiscal Year Maturity	Future minimum payments under noncancelable service and inventory purchase agreements for the periods succeeding December 31, 2023 are as follows (in thousands): Year ended December 31, 2024 $ 17,452 Year ended December 31, 2025 1,475 Year ended December 31, 2026 100 Year ended December 31, 2027 75 Year ended December 31, 2028 75 $ 19,177

Restructuring (Tables)

Restructuring (Tables)	12 Months Ended
	Dec. 31, 2023
Restructuring and Related Activities [Abstract]
Summary of Restructuring Related Liability and Restructuring Costs Activity	The following table summarizes activity in the Company’s restructuring-related liability during the years ended December 31, 2023 and 2022 (in thousands): Balance at Restructuring Charges Payments / Utilizations Liability at December 31, 2023 Employee-related costs $ 469 $ 6,497 $ ( 6,948 ) $ 18 Total costs $ 469 $ 6,497 $ ( 6,948 ) $ 18 Balance at Restructuring Charges Payments / Utilizations Liability at December 31, 2022 Employee-related costs $ — $ 10,047 $ ( 9,578 ) $ 469 Total costs $ — $ 10,047 $ ( 9,578 ) $ 469

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2023
Stockholders' Equity Note [Abstract]
Summarize Changes in Accumulated Other Comprehensive Income (Loss), Net of Tax	The following table summarizes changes in accumulated other comprehensive income (loss), by component during the years ended December 31, 2023 and 2022 (in thousands): Unrealized Gain (Loss) on Derivatives Foreign Currency Translation Adjustment Total Balances at December 31, 2021 $ ( 32 ) $ 11 $ ( 21 ) Other comprehensive income (loss) before reclassifications 24 ( 105 ) ( 81 ) Amounts reclassified from accumulated other comprehensive income (loss) 108 — 108 Tax effect 31 — 31 Balances at December 31, 2022 131 ( 94 ) 37 Other comprehensive income (loss) before reclassifications ( 334 ) 78 ( 256 ) Amounts reclassified from accumulated other comprehensive income (loss) 222 — 222 Tax effect ( 26 ) — ( 26 ) Balances at December 31, 2023 $ ( 7 ) $ ( 16 ) $ ( 23 )

Equity-Based Compensation (Tabl

Equity-Based Compensation (Tables)	12 Months Ended
	Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Summary of the Option Activity under the Equity Compensation Plans	A summary of the option activity under the Company's equity compensation plans is as follows: Time Vested Options Outstanding Number of Options Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term Aggregate Intrinsic Value Outstanding at December 31, 2022 968,293 $ 132.50 6.35 $ — Granted 261,288 23.58 Forfeited ( 193,886 ) 130.82 Expired ( 196,216 ) 108.69 Outstanding at December 31, 2023 839,479 $ 32.53 7.25 $ — Exercisable at December 31, 2023 325,767 $ 36.96 5.14 $ — Performance Vested Options Outstanding Number of Options Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term Aggregate Intrinsic Value Outstanding at December 31, 2022 — $ — — $ — Granted 318,440 22.02 Outstanding at December 31, 2023 318,440 $ 22.02 9.45 $ — Exercisable at December 31, 2023 — $ — — $ —
Summary of the Unvested Option Activity	A summary of the unvested option activity is as follows: Number of Time Vested Options Weighted-Average Grant Date Fair Value (per option) Unvested at December 31, 2022 533,173 $ 69.00 Granted 261,288 13.23 Vested ( 170,507 ) 56.50 Forfeited ( 110,242 ) 60.63 Unvested at December 31, 2023 513,712 $ 33.49 Number of Performance Vested Options Weighted-Average Grant Date Fair Value (per option) Unvested at December 31, 2022 — $ — Granted 318,440 12.77 Unvested at December 31, 2023 318,440 $ 12.77
Summary of RSU Activity	A summary of RSU activity is as follows: RSUs Outstanding Number of RSUs Weighted-Average Fair Value Outstanding at December 31, 2022 63,184 $ 72.50 Granted 496,176 28.37 Vested ( 230,340 ) 34.11 Forfeited ( 27,139 ) 34.58 Outstanding at December 31, 2023 301,881 $ 31.97
Summary of Equity-Based Compensation Expense	Equity-based compensation expense, which also includes the Repricing and modifications for the years ended December 31, 2023 and 2022 was as follows (in thousands): Year Ended December 31, 2023 2022 Cost of revenue $ 2,992 $ 1,416 Selling and marketing 9,852 7,015 Enterprise technology and development 1,330 1,403 General and administrative 9,717 7,786 Total equity-based compensation $ 23,891 $ 17,620
Performance Vesting Options [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Summary of Assumptions Used to Determine the Fair Value of Option Grants	The following table summarizes the weighted average assumptions used to determine the fair value of the Performance-Vesting Options: December 31, 2023 Risk-free rate 3.7 % Dividend yield rate — Volatility 53.7 % Expected term (in years) 10.00 Weighted-average grant date fair value $ 13.00
Time Vesting Options [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Summary of Assumptions Used to Determine the Fair Value of Option Grants	The following table summarizes the weighted average assumptions used to determine the fair value of time vested option grants: December 31, 2023 2022 Risk-free rate 3.9 % 3.0 % Dividend yield rate — — Volatility 62.2 % 52.9 % Expected term (in years) 5.18 6.16 Weighted-average grant date fair value $ 13.65 $ 31.50
Employee Stock Purchase Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Summary of Assumptions Used to Determine the Fair Value of Option Grants	Stock-based compensation expense associated with the Company’s ESPP is based on fair value estimated on the date of grant using the Black-Scholes option pricing valuation model and the following weighted-average assumptions for grants during the year ended December 31, 2023: December 31, 2023 Weighted-average risk-free rate 4.7 % Dividend yield rate — Weighted-average volatility 54.4 % Expected term (in years) 0.50 Weighted-average grant date fair value $ 5.32

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Summary of Derivative Instrument	The following table presents the fair value of the Company’s derivative instruments which are included in other current assets in the consolidated balance sheets (in thousands): December 31, 2023 2022 Derivatives designated as hedging instruments $ — $ 343 Derivatives not designated as hedging instruments — 119 Total derivative assets $ — $ 462
Summary of Pre-Tax Effects of the Company's Derivative Instruments on its Unaudited Condensed Consolidated Statements of Operations	The following table shows the pre-tax effects of the Company’s derivative instruments on its consolidated statements of operations (in thousands): Year Ended December 31, Financial Statement Line Item 2023 2022 Unrealized gains (losses) Other comprehensive income (loss) $ ( 334 ) $ 24 Losses reclassified from accumulated other Cost of revenue $ ( 101 ) $ ( 45 ) comprehensive income (loss) into net loss General and administrative ( 121 ) ( 63 ) Total amounts reclassified $ ( 222 ) $ ( 108 ) Gains (losses) recognized on derivatives Cost of revenue $ ( 98 ) $ 13

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Components of Loss Before Income Taxes	The components of the Company’s loss before income taxes were as follows (in thousands): Year Ended December 31, 2023 2022 U.S. $ ( 154,571 ) $ ( 198,245 ) Foreign 1,967 1,000 Loss before income taxes $ ( 152,604 ) $ ( 197,245 )
Components of Income Tax Benefit (Provision)	The components of the income tax benefit (provision), net were as follows (in thousands): Year Ended December 31, 2023 2022 Current: Federal $ — $ 31 State and local ( 113 ) 202 Foreign ( 115 ) ( 141 ) $ ( 228 ) $ 92 Deferred: Federal $ ( 23 ) $ 1,963 State and local 71 870 Foreign 143 128 191 2,961 Income tax (provision) benefit, net $ ( 37 ) $ 3,053
Actual Tax Rate on Loss Before Income Taxes Reconciles	The actual tax rate on loss before income taxes reconciles to the applicable statutory federal income tax rate as follows: Year Ended December 31, 2023 2022 Federal statutory rate 21.0 % 21.0 % State income taxes, net of federal benefit 2.5 % 3.6 % Valuation allowance on deferred tax assets ( 17.2 %) ( 24.2 %) Goodwill impairment ( 5.5 %) — Equity-based compensation ( 1.1 %) ( 1.1 %) Adjustments to prior year provision 0.7 % 1.4 % Note revaluation ( 0.6 %) — Common stock warrant liability 0.4 % 0.9 % Other ( 0.2 %) ( 0.1 %) Effective tax rate — 1.5 % DTAs
Schedule of Components of Deferred Tax Assets and Liabilities	and DTLs are as follows (in thousands): As of December 31, 2023 2022 Deferred tax assets: Net operating losses $ 91,585 $ 74,038 Equity-based compensation 13,358 10,652 Inventory 12,339 18,525 Tax basis step-up 11,570 13,240 Capitalized research expense 9,592 6,057 Intangible assets 6,552 4,915 R & D credit carryover 3,886 3,886 Accrued expenses 1,064 1,438 Lease obligations 837 1,663 Accrued employee compensation and benefits 546 4,246 Other 4,517 2,164 Total deferred tax assets 155,846 140,824 Deferred tax liabilities: Property and equipment ( 5,853 ) ( 13,377 ) Content assets ( 4,448 ) ( 7,408 ) Prepaid expenses ( 1,969 ) ( 2,425 ) Right-of-use assets ( 750 ) ( 1,231 ) Total deferred tax liabilities ( 13,020 ) ( 24,441 ) Net deferred tax assets before valuation allowance 142,826 116,383 Valuation allowance ( 142,836 ) ( 116,564 ) Net deferred tax liabilities $ ( 10 ) $ ( 181 )
Summary of Activity Related to Gross Unrecognized Tax Benefits	The following table summarizes the activity related to the Company ’ s gross unrecognized tax benefits (in thousands): Year Ended December 31, 2023 2022 Unrecognized tax benefits, beginning of year $ 1,044 $ 568 Additions for current year tax positions — 476 Unrecognized tax benefits (excluding interest and penalties), end of year 1,044 1,044 Interest and penalties associated with unrecognized tax benefits — — Unrecognized tax benefits including interest and penalties, end of year $ 1,044 $ 1,044 All of the unrecognized tax benefits was recorded as a reduction in the Company ’ s gross DTAs. If the unrecognized tax benefits were not recorded it would affect the Company’ s effective tax rate.

Earnings (Loss) Per Share (Tabl

Earnings (Loss) Per Share (Tables)	12 Months Ended
	Dec. 31, 2023
Earnings Per Share [Abstract]
Summary of the Computation of Earnings (Loss) Per Share of Class A and Class X Common Stock	The computation of loss per share of Class A and Class X common stock is as follows (in thousands, except share and per share information): Year Ended December 31, 2023 2022 Numerator: Net loss $ ( 152,641 ) $ ( 194,192 ) Denominator: Weighted-average common shares outstanding, basic and diluted 6,238,777 6,149,784 Net loss per common share, basic and diluted $ ( 24.47 ) $ ( 31.58 )
Summary of Common Shares That Are Excluded From the Computation of Diluted Net Income (Loss) Per Common Share	The following table presents the common shares that are excluded from the computation of diluted net loss per common share as of the periods presented because including them would have been antidilutive: Year Ended December 31, 2023 2022 Time Vested Options 839,479 968,293 Performance Vested Options 318,440 — RSUs 301,881 63,184 Compensation warrants 79,612 79,612 Public and Private Placement Warrants 306,667 306,667 Term Loan warrants 97,482 94,335 Common Stock Warrants 543,590 — Forest Road Earn-out Shares 75,000 75,000 2,562,151 1,587,091

Parent Only Financial Stateme_2

Parent Only Financial Statements (Tables)	12 Months Ended
	Dec. 31, 2023
Table Text Block [Abstract]
Condensed Balance Sheet	Condensed Balance Sheet (in thousands, except share data) As of December 31, 2023 Assets Current assets: Cash and cash equivalents $ 25 Prepaid expenses 12 Investment in subsidiaries 463,955 Total current assets 463,992 Total assets $ 463,992 Liabilities and Stockholders’ Equity Current liabilities: Accrued expenses $ 7 Due to subsidiaries 378,100 Total current liabilities 378,107 Warrant liabilities 3,125 Total liabilities 381,232 Stockholders’ equity: Class A: 3,978,356 shares issued and 1 Class X: 2,729,003 shares issued and 1 Additional paid-in capital 654,657 Accumulated deficit ( 571,899 ) Total stockholders’ equity 82,760 Total liabilities and stockholders’ equity $ 463,992
Condensed Statement of Operations and Comprehensive Loss	Condensed Statement of Operations and Comprehensive Loss (in thousands) Year Ended December 31, 2023 Change in fair value of warrant liabilities $ 2,679 Other income 127 Equity in net loss of subsidiaries ( 155,507 ) Net loss and total comprehensive loss $ ( 152,701 )
Condensed Statement of Cash Flows	Condensed Statement of Cash Flows (in thousands) Year Ended December 31, 2023 Cash flows from operating activities: Net loss $ ( 152,701 ) Adjustments to reconcile net loss to net cash provided by operating activities: Change in fair value of warrant liabilities ( 2,679 ) Equity in net loss of subsidiaries 155,507 Changes in operating assets and liabilities: Prepaid expenses 8 Accrued expenses 9 Net cash provided by operating activities 144 Cash flows from investing activities: Net cash used in investing activities — Cash flows from financing activities: Decrease in due to subsidiaries ( 8,299 ) Proceeds from issuance of common shares in the Employee Stock Purchase Plan 553 Tax withholdings payments for vesting of restricted stock ( 2,178 ) Proceeds from issuance of Equity Offering, net of issuance costs 4,908 Net cash used in financing activities ( 5,016 ) Net decrease in cash and cash equivalents ( 4,872 ) Cash and cash equivalents, beginning of year 4,897 Cash and cash equivalents, end of year $ 25

Description of Business and S_3

Description of Business and Summary of Significant Accounting Policies - Additional Information (Details)				12 Months Ended
	Jan. 09, 2024 USD ($)	Nov. 21, 2023	Nov. 20, 2023	Dec. 31, 2023 USD ($) Segment $ / shares shares	Dec. 31, 2022 USD ($)	Dec. 13, 2023 shares	Jul. 24, 2023 $ / shares	Aug. 08, 2022 $ / shares shares	Dec. 31, 2020 $ / shares shares
Description Of Business And Summary Of Significant Accounting Policies [Line Items]
Indefinite-lived Intangible Assets				$ 0
Number of warrants issued | shares									79,612
Warrants or rights exercise price per share | $ / shares									$ 126
Warrants and rights outstanding, term				7 years					10 years
Common stock shares exchange ratio		0.02
Change in fair value of warrant liabilities				$ (2,679,000)	$ (8,322,000)
Investment in equity securities of privately-held company				1,000,000	5,000,000
Impairment investment on observable price				4,000,000
Adjustments to the carrying value of equity investment					0
Total advertising expense				31,500,000	36,900,000
Research and development costs				2,700,000	4,400,000
Gains (losses) related to recurring measurement and settlement of foreign currency transactions				$ 200,000	600,000
Number of operating segments | Segment				2
Number of reportable segments | Segment				1
Common Stock [Member]
Description Of Business And Summary Of Significant Accounting Policies [Line Items]
Common stock shares exchange ratio		0.02
Subsequent Event [Member]
Description Of Business And Summary Of Significant Accounting Policies [Line Items]
Investment sold	$ 1,000,000
Common Class A [Member]
Description Of Business And Summary Of Significant Accounting Policies [Line Items]
Number of warrants issued | shares				543,590
Warrants or rights exercise price per share | $ / shares				$ 11.24
Term Loan [Member]
Description Of Business And Summary Of Significant Accounting Policies [Line Items]
Warrants and rights outstanding, term								7 years
Term Loan [Member] | Subsequent Event [Member]
Description Of Business And Summary Of Significant Accounting Policies [Line Items]
Investment in equity securities of privately-held company	$ 1,000,000
Term Loan [Member] | Common Class A [Member]
Description Of Business And Summary Of Significant Accounting Policies [Line Items]
Number of warrants issued | shares				94,335				94,335
Warrants or rights exercise price per share | $ / shares				$ 92.5			$ 20.5	$ 92.5
Other Current Assets and Other Assets [Member]
Description Of Business And Summary Of Significant Accounting Policies [Line Items]
Deferred commissions				$ 37,100,000	32,800,000
Minimum [Member]
Description Of Business And Summary Of Significant Accounting Policies [Line Items]
Estimated useful lives of assets				2 years
Common stock shares exchange ratio			0.1
Maximum [Member]
Description Of Business And Summary Of Significant Accounting Policies [Line Items]
Estimated useful lives of assets				7 years
Common stock shares exchange ratio			0.02
Maximum [Member] | Common Class A [Member]
Description Of Business And Summary Of Significant Accounting Policies [Line Items]
Class of warrants of rights outstanding | shares						122,821
Maximum [Member] | Building [Member]
Description Of Business And Summary Of Significant Accounting Policies [Line Items]
Estimated useful lives of assets				39 years
Second Amendment | Term Loan [Member] | Common Class A [Member]
Description Of Business And Summary Of Significant Accounting Policies [Line Items]
Number of warrants issued | shares				97,482
Second Amendment | Minimum [Member] | Term Loan [Member] | Common Class A [Member]
Description Of Business And Summary Of Significant Accounting Policies [Line Items]
Warrants or rights exercise price per share | $ / shares				$ 20.5
Second Amendment | Maximum [Member] | Term Loan [Member] | Common Class A [Member]
Description Of Business And Summary Of Significant Accounting Policies [Line Items]
Warrants or rights exercise price per share | $ / shares				$ 92.5
ASU 2022-04 [Member]
Description Of Business And Summary Of Significant Accounting Policies [Line Items]
Change in accounting principle, accounting standards update, adopted [true false]				true
Change in accounting principle, accounting standards update adoption date				Jan. 01, 2023
Change in accounting principle, accounting standards update, immaterial effect [true false]				true
Public Warrants [Member]
Description Of Business And Summary Of Significant Accounting Policies [Line Items]
Class of warrants of rights outstanding | shares				200,000
Warrants or rights exercise price per share | $ / shares				$ 575
Private Placement Warrants [Member]
Description Of Business And Summary Of Significant Accounting Policies [Line Items]
Class of warrants of rights outstanding | shares				106,667
Warrants or rights exercise price per share | $ / shares				$ 575
Shipping Connected Fitness and Nutrition and Other Product [Member]
Description Of Business And Summary Of Significant Accounting Policies [Line Items]
Shipping costs				$ 22,500,000	$ 35,400,000

Revenue - Disaggregation of Rev

Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022
Disaggregation of Revenue [Line Items]
Revenue		$ 527,109	$ 692,199
United States [Member]
Disaggregation of Revenue [Line Items]
Revenue		473,465	620,942
Rest of world [Member]
Disaggregation of Revenue [Line Items]
Revenue	[1]	$ 53,644	$ 71,257
[1] Consists of Canada, United Kingdom and France. Other than the United Sates, no single country accounted for more than 10% of the Company’s total revenue.

Revenue - Additional Informatio

Revenue - Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Deferred Revenue [Member]
Disaggregation of Revenue [Line Items]
Contract with customer liability, Current	$ 95.6	$ 106.5	$ 107.1

Revenue - Additional Informat_2

Revenue - Additional Information (Details)1 - Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01	Dec. 31, 2023
Disaggregation of Revenue [Line Items]
Remaining performance obligation, percentage	95%
Revenue remaining performance obligation expected timing	12 months

Fair Value Measurements - Summa

Fair Value Measurements - Summary of Fair Value Measurements, Recurring and Nonrecurring (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets		$ 462
Derivative Asset, Statement of Financial Position [Extensible Enumeration]	Other Assets, Noncurrent	Other Assets, Noncurrent
Derivative Liability, Statement of Financial Position [Extensible Enumeration]	Other Liabilities, Noncurrent	Other Liabilities, Noncurrent
Fair Value, Recurring [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities		$ 415
Fair Value, Recurring [Member] | Level 1 [Member] | Public Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants		415
Fair Value, Recurring [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets		462
Total assets	$ 4,250	462
Fair Value, Recurring [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities	3,125	1,333
Fair Value, Recurring [Member] | Level 3 [Member] | Public Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants	17
Fair Value, Recurring [Member] | Level 3 [Member] | Private Placement Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants	9	107
Fair Value, Recurring [Member] | Level 3 [Member] | Term Loan Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants	392	$ 1,226
Fair Value, Recurring [Member] | Level 3 [Member] | Common Stock Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants	2,707
Fair Value, Recurring [Member] | Restricted short-term investments [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets	$ 4,250

Fair Value Measurements - Sum_2

Fair Value Measurements - Summary of Fair Value of Significant Assumptions Utilized in the Valuation (Details)	Dec. 31, 2023 yr	Dec. 31, 2022 yr
Private Placement Warrants [Member] | Risk-free Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value, Measurement Input	0.041	0.042
Private Placement Warrants [Member] | Dividend Yield Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value, Measurement Input	0	0
Private Placement Warrants [Member] | Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value, Measurement Input	0.976	0.75
Private Placement Warrants [Member] | Contractual Term (in years) [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value, Measurement Input	2.48	3.49
Private Placement Warrants [Member] | Exercise Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value, Measurement Input	575	575
Public Warrants [Member] | Risk-free Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value, Measurement Input	0.041
Public Warrants [Member] | Dividend Yield Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value, Measurement Input	0
Public Warrants [Member] | Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value, Measurement Input	0.976
Public Warrants [Member] | Contractual Term (in years) [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value, Measurement Input	2.48
Public Warrants [Member] | Exercise Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value, Measurement Input	575
Common Stock Warrants [Member] | Risk-free Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value, Measurement Input	0.038
Common Stock Warrants [Member] | Dividend Yield Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value, Measurement Input	0
Common Stock Warrants [Member] | Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value, Measurement Input	0.752
Common Stock Warrants [Member] | Contractual Term (in years) [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value, Measurement Input	5.44
Common Stock Warrants [Member] | Exercise Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value, Measurement Input	11.24
Term Loan Warrants [Member] | Risk-free Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value, Measurement Input	0.038	0.04
Term Loan Warrants [Member] | Dividend Yield Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value, Measurement Input	0	0
Term Loan Warrants [Member] | Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value, Measurement Input	0.745	0.75
Term Loan Warrants [Member] | Contractual Term (in years) [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value, Measurement Input	5.6	6.61
Term Loan Warrants [Member] | Exercise Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value, Measurement Input	20.5	92.5

Fair Value Measurements - Sum_3

Fair Value Measurements - Summary of Change in the Fair Value of the Warrants (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Private Placement Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance, beginning of period	$ 107	$ 2,133
Change in fair value	$ (98)	$ (2,026)
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Fair Value Adjustment of Warrants	Fair Value Adjustment of Warrants
Balance, end of period	$ 9	$ 107
Public Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance, beginning of period	415	2,701
Change in fair value	$ (398)	$ (2,286)
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Fair Value Adjustment of Warrants	Fair Value Adjustment of Warrants
Balance, end of period	$ 17	$ 415
Common Stock Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Issued in connection with Equity Offering / Issued in Connection with Term Loan	3,255
Change in fair value	$ (548)
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Fair Value Adjustment of Warrants
Balance, end of period	$ 2,707
Term Loan Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance, beginning of period	1,226
Issued in connection with Equity Offering / Issued in Connection with Term Loan		5,236
Amended in connection with Second Amendment	802
Change in fair value	$ (1,636)	$ (4,010)
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Fair Value Adjustment of Warrants	Fair Value Adjustment of Warrants
Balance, end of period	$ 392	$ 1,226

Fair Value Measurements -Additi

Fair Value Measurements -Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands	Dec. 31, 2023	Jul. 24, 2023	Aug. 08, 2022	Dec. 31, 2020
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Restricted short-term investments	$ 4,250
Class of warrants or rights exercise price per share				$ 126
Restricted short-term investments [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Restricted short-term investments	$ 4,300
Investments maturity date	Jul. 26, 2024
Investments interest rate	4.80%
Term Loan warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value of warrant liabilities		$ 800
Class A Common Stock [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Class of warrants or rights exercise price per share	$ 11.24
Term Loan [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value of warrant liabilities			$ 5,200
Term Loan [Member] | Class A Common Stock [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Class of warrants or rights exercise price per share	$ 92.5	$ 20.5	$ 92.5

Fair Value Measurements - Sum_4

Fair Value Measurements - Summary of Fair Value, Assets Measured on Nonrecurring Basis Using Unobservable Inputs (Details) - Fair Value, Nonrecurring [Member] $ in Thousands	12 Months Ended
	Dec. 31, 2023 USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	$ 86,166
Total Losses	(47,092)
Goodwill [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	85,166
Total Losses	(40,000)
Other Investments [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	1,000
Total Losses	(4,000)
Intangible Assets [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0
Total Losses	$ (3,092)

Inventory, Net - Schedule of In

Inventory, Net - Schedule of Inventory, Current (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Inventory, Net [Abstract]
Raw materials and work in process	$ 10,354	$ 13,380
Finished goods	14,622	40,680
Total inventory	$ 24,976	$ 54,060

Inventory, Net - Additional Inf

Inventory, Net - Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Inventory [Line Items]
Inventory Write-down	$ 10.6	$ 39.8
Nutrition And Other [Member]
Inventory [Line Items]
Inventory Write-down	3.4	11.6
Connected Fitness [Member]
Inventory [Line Items]
Inventory Write-down	$ 7.2	$ 28.1

Other Current Assets - Summary

Other Current Assets - Summary of Other Current Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Other Current Assets [Abstract]
Deferred Partner costs	$ 36,169	$ 31,270
Deposits	6,788	4,527
Accounts receivable, net	1,270	866
Other	1,696	2,585
Total other current assets	$ 45,923	$ 39,248

Property and Equipment, Net - S

Property and Equipment, Net - Summary of Property and Equipment, Net (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 266,346	$ 276,900
Less: Accumulated depreciation	(221,291)	(202,753)
Property and equipment, net	45,055	74,147
Computer software and web development [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	229,527	236,533
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	23,738	24,240
Building [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	5,158	5,158
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	4,600	4,600
Furniture, fixtures and equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	1,166	1,222
Computer Software and Web Development Projects In-process [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 2,157	$ 5,147

Property and Equipment, Net - A

Property and Equipment, Net - Additional Information (Details) - USD ($)		12 Months Ended
	Feb. 29, 2024	Dec. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Net loss recognized			$ 1,200,000
Disposal of property and equipment		$ 0
Annual lease base rate		2,459,000	2,991,000
Property and equipment, gross		266,346,000	276,900,000
Net carrying value		45,055,000	$ 74,147,000
Van Nuys Production Facility [Member]
Property, Plant and Equipment [Line Items]
Net carrying value		$ 4,800,000
Subsequent Event [Member] | Van Nuys Production Facility [Member]
Property, Plant and Equipment [Line Items]
Annual lease base rate	$ 300,000
Lease term	5 years
Proceed from sale of plant and equipment	$ 6,200,000

Property and Equipment, Net -_2

Property and Equipment, Net - Summary of Depreciation Expense Related to Property and Equipment (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Schedule of depreciation expense related to property and equipment [Line Items]
Depreciation	$ 34,460	$ 56,593
Cost of Revenue [Member]
Schedule of depreciation expense related to property and equipment [Line Items]
Depreciation	17,994	27,137
Selling and Marketing [Member]
Schedule of depreciation expense related to property and equipment [Line Items]
Depreciation		381
Enterprise Technology and Development [Member]
Schedule of depreciation expense related to property and equipment [Line Items]
Depreciation	16,463	28,833
General and Administrative [Member]
Schedule of depreciation expense related to property and equipment [Line Items]
Depreciation	$ 3	$ 242

Content Assets, Net - Summary o

Content Assets, Net - Summary of Film Cost (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Film, Monetized on Its Own, Capitalized Cost [Abstract]
Released, less amortization	$ 21,134	$ 34,713
In production	225	175
Content assets, net	$ 21,359	$ 34,888

Content Assets, Net - Additiona

Content Assets, Net - Additional Information (Details) $ in Millions	12 Months Ended
	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Entertainment, Film [Abstract]
Film, Monetized on Its Own, Released Film, Expected Amortization, Year One	$ 14.4
Film, Monetized on Its Own, Released Film,Percentage Of Expected Amortization	100
Film, Monetized on Its Own, Amortization Expense	$ 23.8	$ 24.3
Film, Monetized on Its Own, Amortization Expense, Statement of Income or Comprehensive Income [Extensible Enumeration]	Operating Expenses	Operating Expenses
Content assets maximum amortization term	3 years
Modified content assets amortization cost	$ 2.1

Acquisitions - Summary of Recog

Acquisitions - Summary of Recognized Identified Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Schedule Of Recognized Identified Assets Acquired And Liabilities Assumed [Line Items]
Goodwill	$ 85,166	$ 125,166	$ 125,166

Goodwill - Summary of Goodwill

Goodwill - Summary of Goodwill (Details) - USD ($) $ in Thousands			6 Months Ended		12 Months Ended
	Oct. 01, 2023	Oct. 01, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill, beginning of year			$ 125,166	$ 125,166	$ 125,166	$ 125,166
Impairment of goodwill	$ 0	$ 0	$ 0	$ 0	(40,000)	0
Goodwill, end of year					$ 85,166	$ 125,166

Goodwill - Additional Informati

Goodwill - Additional Information (Details) - USD ($) $ in Thousands			3 Months Ended	6 Months Ended		12 Months Ended
	Oct. 01, 2023	Oct. 01, 2022	Dec. 31, 2023	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Goodwill [Line Items]
Goodwill impairment charge	$ 0	$ 0		$ 0	$ 0	$ 40,000	$ 0
Accumulated goodwill impairment			$ 92,600			$ 92,600
Percentage of decline in stock price			45%			68%
Percentage of decline in revenue						24%
Goodwill			$ 85,166			$ 85,166	$ 125,166	$ 125,166
Valuation Technique, Discounted Cash Flow [Member]
Goodwill [Line Items]
Percentage of fair value reporting units						50%
Valuation Methodologies One [Member]
Goodwill [Line Items]
Percentage of fair value reporting units						25%
Valuation Methodologies Two [Member]
Goodwill [Line Items]
Percentage of fair value reporting units						25%

Intangible Assets, Net - Schedu

Intangible Assets, Net - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Schedule Of Finite Lived And Indefinite Lived Intangible Assets Excluding Goodwill [Line Items]
Intangible Assets, Gross	$ 105,050	$ 105,050
Accumulated Amortization and Impairment	(105,050)	(96,845)
Intangible Assets, Net	0	8,204
Contract-based [Member]
Schedule Of Finite Lived And Indefinite Lived Intangible Assets Excluding Goodwill [Line Items]
Intangible Assets, Gross	300	300
Accumulated Amortization and Impairment	(300)	(300)
Intangible Assets, Net	0
Customer-Related [Member]
Schedule Of Finite Lived And Indefinite Lived Intangible Assets Excluding Goodwill [Line Items]
Intangible Assets, Gross	21,100	21,100
Accumulated Amortization and Impairment	(21,100)	(14,800)
Intangible Assets, Net	0	6,300
Technology-based [Member]
Schedule Of Finite Lived And Indefinite Lived Intangible Assets Excluding Goodwill [Line Items]
Intangible Assets, Gross	20,200	20,200
Accumulated Amortization and Impairment	(20,200)	(19,400)
Intangible Assets, Net	0	800
Talent and Representation Contracts [Member]
Schedule Of Finite Lived And Indefinite Lived Intangible Assets Excluding Goodwill [Line Items]
Intangible Assets, Gross	10,300	10,300
Accumulated Amortization and Impairment	(10,300)	(10,300)
Intangible Assets, Net	0
Formulae [Member]
Schedule Of Finite Lived And Indefinite Lived Intangible Assets Excluding Goodwill [Line Items]
Intangible Assets, Gross	1,950	1,950
Accumulated Amortization and Impairment	(1,950)	(1,146)
Intangible Assets, Net	0	804
Trade Names [Member]
Schedule Of Finite Lived And Indefinite Lived Intangible Assets Excluding Goodwill [Line Items]
Intangible Assets, Gross	51,200	51,200
Accumulated Amortization and Impairment	(51,200)	(50,900)
Intangible Assets, Net	$ 0	$ 300

Intangible Assets, Net (Additio

Intangible Assets, Net (Additional Information) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Non-cash impairment charge	$ 3,092	$ 19,907
Amortization expense of intangible assets	5,100	18,300
Customer Relationships Developed Technology and Trade Secrets [Member]
Finite-Lived Intangible Assets [Line Items]
Cash impairment charge	3,100
Intangible assets, net	$ 0
Non-cash impairment charge		18,900
Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Non-cash impairment charge		1,000
Finite-lived intangible assets useful life	2 years
Trade Names [Member] | Selling and Marketing Expense [Member]
Finite-Lived Intangible Assets [Line Items]
Amortization expense of intangible assets	$ 300	$ 7,500

Accrued Expenses - Summary of A

Accrued Expenses - Summary of Accrued Expenses (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Payables and Accruals [Abstract]
Partner costs	$ 13,971	$ 14,535
Inventory, shipping and fulfillment	6,869	11,687
Employee compensation and benefits	4,334	20,584
Sales and other taxes	3,963	4,818
Information technology	3,176	2,207
Advertising	872	1,176
Customer service expenses	437	956
Other accrued expenses	8,525	8,467
Total accrued expenses	$ 42,147	$ 64,430

Accrued Expenses - Additional I

Accrued Expenses - Additional Information (Details) - USD ($)	Oct. 06, 2023	Sep. 29, 2023	Dec. 31, 2023
Financing Agreement with IPFS [Member]
Debt Instrument [Line Items]
Financing agreement amount		$ 2,500,000
Financing agreement term		10 months
Financing agreement first payment due date		Nov. 01, 2023
Percentage of interest rate on agreement		8.83%
Financing Agreement with IPFS [Member] | Other Current Liabilities [Member]
Debt Instrument [Line Items]
Financing agreement outstanding amount			$ 1,800,000
Financing Agreement with FIF [Member]
Debt Instrument [Line Items]
Financing agreement amount	$ 2,000,000
Financing agreement term	9 months
Financing agreement first payment due date	Nov. 01, 2023
Percentage of interest rate on agreement	8.75%
Financing Agreement with FIF [Member] | Other Current Liabilities [Member]
Debt Instrument [Line Items]
Financing agreement outstanding amount			$ 1,400,000

Debt - Additional Information (

Debt - Additional Information (Details) - USD ($)					12 Months Ended
	Feb. 29, 2024	Jan. 09, 2024	Jul. 24, 2023	Aug. 08, 2022	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2020
Debt Instrument [Line Items]
Borrowings outstanding					$ 35,095,000
Interest expense					$ 8,874,000	$ 3,368,000
Number of warrants issued							79,612
Warrants or rights exercise price per share							$ 126
Warrants and rights outstanding, term					7 years		10 years
Loss on partial debt extinguishment					$ (3,168,000)
Irrevocable standby letter of credit					$ 100,000
Common Class A [Member]
Debt Instrument [Line Items]
Number of warrants issued					543,590
Warrants or rights exercise price per share					$ 11.24
Term Loan Warrants [Member]
Debt Instrument [Line Items]
Fair value of warrant liabilities			$ 800,000
Before 1st Anniversary [Member]
Debt Instrument [Line Items]
Percentage of repayment of debt instrument					5%
Before 2nd Anniversary [Member]
Debt Instrument [Line Items]
Percentage of repayment of debt instrument					3%
Before 3rd Anniversary [Member]
Debt Instrument [Line Items]
Percentage of repayment of debt instrument					2%
After 3rd Anniversary [Member]
Debt Instrument [Line Items]
Percentage of repayment of debt instrument					0%
Letter of Credit [Member]
Debt Instrument [Line Items]
Debt instrument, maturity date					Dec. 06, 2024
Irrevocable standby letter of credit					$ 100,000
Debt instrument, maturity date description					This letter of credit expires on December 6, 2024 and is automatically extended for one-year terms unless notice of non-renewal is provided 60 days prior to the end of the applicable term
Term Loan [Member]
Debt Instrument [Line Items]
Credit line				$ 50,000,000
Borrowings outstanding					$ 35,500,000
Debt instrument, maturity date			Feb. 08, 2026		Aug. 08, 2026
Percentage of interest rate during period				2%
Percentage of interest paid in kind			1%
Interest expense			$ 100,000		$ 8,800,000	$ 3,400,000
Financial covenants, minimum revenue levels required each quarter prior to March 31, 2024			100,000,000
Financial covenants, minimum revenue levels required, thereafter and prior to December 31, 2025			120,000,000
Financial covenants, minimum liquidity levels required each quarter prior to March 31, 2024			20,000,000
Financial covenants, minimum liquidity levels required, thereafter and prior to December 31, 2025			$ 25,000,000
Third-party debt issuance costs				$ 4,500,000
Warrants vesting percentage first year				30%
Warrants vesting percentage second year				30%
Warrants vesting percentage third year				20%
Warrants vesting percentage fourth year				20%
Warrants and rights outstanding, term				7 years
Fair value of warrant liabilities				$ 5,200,000
Annual amortization, periodic payment				quarterly
Principal payments on Term Loan for first year				$ 1,300,000
Principal payments on Term Loan Thereafter				$ 2,500,000
Increase in rate of interest					2%
Percentage of repayment of debt instrument			5%
Partial prepayment on term loan			$ 15,000,000
Write off of unamortized debt discount and debt issuance costs			2,400,000
Loss on partial debt extinguishment					$ (3,200,000)
Partial prepayment premium			800,000
Paid in kind interest			$ 500,000
Term Loan [Member] | Common Class A [Member]
Debt Instrument [Line Items]
Number of warrants issued				94,335	94,335
Increase in number of shares purchased upon exercise				97,482
Warrants or rights exercise price per share			$ 20.5	$ 92.5	$ 92.5
Term Loan [Member] | Secured Overnight Financing Rate [Member]
Debt Instrument [Line Items]
Percentage of interest rate on agreement				6.15%
Percentage of interest rate during period				7.15%
Debt instrument, cash interest rate					12.29%
Percentage of interest paid in kind				3%
Term Loan [Member] | Secured Overnight Financing Rate [Member] | Floor Rate [Member]
Debt Instrument [Line Items]
Percentage of interest rate during period				1%
Term Loan [Member] | Federal Funds Rate [Member]
Debt Instrument [Line Items]
Percentage of interest rate during period				0.50%
Term Loan [Member] | One Month SOFR [Member]
Debt Instrument [Line Items]
Percentage of interest rate during period				1%
Term Loan [Member] | Maximum [Member]
Debt Instrument [Line Items]
Line of credit facility, additional amount of incremental facility				$ 25,000,000
Term Loan [Member] | Subsequent Event [Member]
Debt Instrument [Line Items]
Borrowings outstanding	$ 28,600,000
Percentage of repayment of debt instrument		3%
Partial prepayment on term loan		$ 1,000,000
Partial prepayment premium	$ 5,500,000	$ 1,000,000

Debt - Schedule of Aggregate Am

Debt - Schedule of Aggregate Amounts of Payments Due and Reconciliation of Debt Balances, Net of Debt Discount and Debt Issuance Costs (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Debt Disclosure [Abstract]
Year ending December 31, 2024	$ 8,068
Year ending December 31, 2025	2,500
Year ending December 31, 2026	24,527
Total debt	35,095
Less current portion	(8,068)	$ (1,250)
Less unamortized debt discount and debt issuance costs	(5,960)
Add capitalized paid-in-kind interest	424
Total long-term debt	$ 21,491	$ 39,735

Leases - Additional Information

Leases - Additional Information (Details) - USD ($) $ in Thousands		1 Months Ended	12 Months Ended
	Feb. 29, 2024	Nov. 30, 2021	Dec. 31, 2023	Dec. 31, 2022
Lessee, Lease, Description [Line Items]
Operating lease expiring term			leases facilities under noncancelable operating leases expiring through 2027
Finance lease expiring term			certain equipment under a finance lease expiring in 2024.
Office lease expiration year		2025
Operating lease liabilities			$ 3,258	$ 5,300
Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration]			Operating lease liabilities	Operating lease liabilities
Operating lease, right-of-use asset			$ 3,100	$ 5,000
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]			Lease Right Of Use Asset	Lease Right Of Use Asset
Finance lease liabilities			$ 2	$ 100
Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]			Lease Liabilities	Lease Liabilities
Finance lease, right-of-use asset			$ 0	$ 100
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]			Lease Right Of Use Asset	Lease Right Of Use Asset
Annual lease base rate			$ 2,459	$ 2,991
Subsequent Event [Member] | Van Nuys Production Facility [Member]
Lessee, Lease, Description [Line Items]
Lease term	5 years
Annual lease base rate	$ 300

Leases - Summary of Lease Cost

Leases - Summary of Lease Cost (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Finance lease costs:
Amortization of right-of-use asset	$ 73	$ 192
Interest on lease liabilities	2	8
Operating lease costs	2,097	2,150
Short-term lease costs	18	202
Variable lease costs	301	566
Short-term sublease income	(32)	(127)
Total lease costs	$ 2,459	$ 2,991

Leases - Summary of Lease Other

Leases - Summary of Lease Other Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from finance leases	$ 2	$ 8
Operating cash flows from operating leases	2,319	2,195
Financing cash flows from finance leases	$ 121	153
Right-of-use asset obtained in exchange for new operating lease liabilities		$ 420
Weighted-average remaining lease term - finance leases	3 months 18 days	1 year 3 months 18 days
Weighted-average remaining lease term - operating leases	2 years 3 months 18 days	2 years 10 months 24 days
Weighted-average discount rate - finance leases	4%	4%
Weighted-average discount rate - operating leases	4.10%	4.50%

Leases - Summary of Maturities

Leases - Summary of Maturities of Operating and Finance Lease Liabilities, Excluding Short-term Leases (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Leases [Abstract]
Operating Leases, Year ended December 31, 2024	$ 2,079
Operating Leases, Year ended December 31, 2025	687
Operating Leases, Year ended December 31, 2026	712
Operating Leases, Year ended December 31, 2027	132
Operating Leases, Total	3,610
Operating Leases, Less present value discount	(352)
Operating lease liabilities	3,258	$ 5,300
Finance Leases, Year ended December 31, 2024	2
Finance Leases, Total	2
Finance lease liabilities	2	$ 100
Year ended December 31, 2024	2,081
Year ended December 31, 2025	687
Year ended December 31, 2026	712
Year ended December 31, 2027	132
Total	3,612
Less present value discount	(352)
Lease liabilities at December 31, 2022	$ 3,260

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details) - USD ($) shares in Billions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Apr. 07, 2022	Jun. 24, 2021
Product Liability Contingency [Line Items]
Royalty payments	$ 4,600,000
Loss on Inventory Purchase Commitments [Abstract]
Losses on inventory purchase commitments	$ 0	$ 2,700,000
Common Class A [Member]
Loss Contingency, Information about Litigation Matters [Abstract]
Increase in number of authorized shares				1.3
Common Class A [Member] | Letter Issued by General Corporation Law of State of Delaware For Shares Not Approved [Member]
Loss Contingency, Information about Litigation Matters [Abstract]
Increase in number of authorized shares			1.3

Commitments and Contingencies_2

Commitments and Contingencies - Summary of Purchase Obligation, Fiscal Year Maturity (Details) $ in Thousands	Dec. 31, 2023 USD ($)
Purchase Obligation, Fiscal Year Maturity [Abstract]
Year ended December 31, 2024	$ 17,452
Year ended December 31, 2025	1,475
Year ended December 31, 2026	100
Year ended December 31, 2027	75
Year ended December 31, 2028	75
Purchase Obligation	$ 19,177

Restructuring - Additional Info

Restructuring - Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Restructuring Cost and Reserve [Line Items]
Restructuring costs	$ 6,500	$ 10,000
Termination benefit related to headcount reductions	$ 18	469
Computer software and web development [Member]
Restructuring Cost and Reserve [Line Items]
Accelerated depreciation / amortization		3,400
Digital Content Assets
Restructuring Cost and Reserve [Line Items]
Accelerated depreciation / amortization		$ 2,700

Restructuring - Summary of Rest

Restructuring - Summary of Restructuring Related Liability and Restructuring Costs Activity (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Restructuring Cost and Reserve [Line Items]
Balance, beginning of period	$ 469
Restructuring Charges	6,497	$ 10,047
Payments / Utilizations	(6,948)	(9,578)
Balance, end of period	18	469
Employee-Related Costs
Restructuring Cost and Reserve [Line Items]
Balance, beginning of period	469
Restructuring Charges	6,497	10,047
Payments / Utilizations	(6,948)	(9,578)
Balance, end of period	$ 18	$ 469

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Details)							12 Months Ended
	Jan. 12, 2024 shares	Dec. 13, 2023 shares	Dec. 10, 2023 USD ($) $ / shares shares	Nov. 21, 2023	Nov. 20, 2023	Jun. 15, 2023 USD ($) $ / shares shares	Dec. 31, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2020 $ / shares
Stockholders Equity Note [Line Items]
Number of shares authorized							2,000,000,000
Par value of shares authorized | $ / shares							$ 0.0001
Common stock, shares authorized							1,900,000,000	1,900,000,000
Preferred stock, shares authorized							100,000,000	100,000,000
Common stock dividends declared | $							$ 0
Common stock shares voting rights							The holder of each Class A common stock is entitled to one vote, the holder of each share of Class X common stock is entitled to ten votes and except as otherwise required by law, the holder of each share of Class C common stock is not entitled to any voting powers.
Common stock, par value | $ / shares							$ 0.0001	$ 0.0001
Issuance and sale of shares		420,769
Warrants or rights exercise price per share | $ / shares									$ 126
Warrant expiry date			Jun. 13, 2029
Change in FV of warrant liabilities | $							$ (2,679,000)	$ (8,322,000)
Gross proceeds from common stock warrants | $			$ 3,300,000
Reverse stock split				0.02
Reverse stock split term							At the 2023 Annual Shareholder Meeting, which was held on November 20, 2023, our stockholders approved an amendment to our second amended and restated certificate of incorporation to effect a reverse stock split of all of our issued and outstanding common stock by a ratio in the range of 1-for-10 to 1-for-50. On November 21, 2023, we effected a 1-for-50 reverse stock split of our issued and outstanding common stock. The reverse stock split ratio and the implementation and the timing of the reverse stock split were determined by our Board. The reverse stock split did not change the authorized number of shares or the par value of our common stock or preferred stock, but did effect a proportional adjustment to the number of common stock outstanding, the per share exercise price and the number of shares of common stock issuable upon the exercise of outstanding stock options, the number of shares of common stock issuable upon the vesting of restricted stock awards ("RSU's"), the number of shares of common stock under the Employee Stock Purchase Plan (the "ESPP"), the conversion rate of our outstanding warrants into common stock and the number of shares of common stock eligible for issuance under our 2021 Stock Plan (the "2021 Plan"). No fractional shares were issued in connection with the reverse stock split. Each stockholder's percentage ownership and proportional voting power generally remained unchanged as a result of the reverse stock split.
Maximum [Member]
Stockholders Equity Note [Line Items]
Reverse stock split					0.02
Minimum [Member]
Stockholders Equity Note [Line Items]
Reverse stock split					0.1
Pre-Funded Warrants [Member]
Stockholders Equity Note [Line Items]
Change in FV of warrant liabilities | $			3,300,000
Gross proceeds from common stock warrants | $			400,000
Common Stock [Member]
Stockholders Equity Note [Line Items]
Gross proceeds from common stock warrants | $			1,600,000
Reverse stock split				0.02
The Forfeiture Agreement [Member]
Stockholders Equity Note [Line Items]
Number of shares, forfeited						160,000
Consideration paid for forfeiture of shares | $						$ 0
Securities Purchase Agreement [Member]
Stockholders Equity Note [Line Items]
Proceeds from issuance, net of placement agent fees | $			$ 4,900,000
Securities Purchase Agreement [Member] | Pre-Funded Warrants [Member]
Stockholders Equity Note [Line Items]
Shares issued issue price per share | $ / shares			$ 9.7499
Warrants or rights exercise price per share | $ / shares			$ 0.0001
Securities Purchase Agreement [Member] | Pre-Funded Warrants [Member] | Maximum [Member]
Stockholders Equity Note [Line Items]
Issuance and sale of shares			122,821
Private Placement [Member] | Pre-Funded Warrants [Member]
Stockholders Equity Note [Line Items]
Issuance and sale of shares			543,590
Warrants or rights exercise price per share | $ / shares			$ 11.24
Private Placement [Member] | Common Stock [Member]
Stockholders Equity Note [Line Items]
Issuance and sale of shares			543,590
Common Class A [Member]
Stockholders Equity Note [Line Items]
Common stock, shares authorized							1,600,000,000	1,600,000,000
Common stock shares voting rights							one vote
Common stock, par value | $ / shares						$ 0.0001	$ 0.0001	$ 0.0001
Warrants or rights exercise price per share | $ / shares							$ 11.24
Common Class A [Member] | Pre-Funded Warrants [Member] | Subsequent Event [Member]
Stockholders Equity Note [Line Items]
Conversion of stock, shares converted	122,821
Common Class A [Member] | The Forfeiture Agreement [Member]
Stockholders Equity Note [Line Items]
Number of shares, forfeited						63,999
Common Class A [Member] | Securities Purchase Agreement [Member]
Stockholders Equity Note [Line Items]
Issuance and sale of shares			420,769
Shares issued issue price per share | $ / shares			$ 9.75
Common Class X [Member]
Stockholders Equity Note [Line Items]
Common stock, shares authorized							200,000,000
Common stock shares voting rights							ten votes
Common Class X [Member] | The Forfeiture Agreement [Member]
Stockholders Equity Note [Line Items]
Number of shares, forfeited						96,001
Common stock, par value | $ / shares						$ 0.0001
Common Class C [Member]
Stockholders Equity Note [Line Items]
Common stock, shares authorized							100,000,000	100,000,000
Common stock, par value | $ / shares							$ 0.0001	$ 0.0001

Stockholders' Equity - Summariz

Stockholders' Equity - Summarize Changes in Accumulated Other Comprehensive Income (Loss), Net of Tax (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Stockholders' Equity Note [Abstract]
Unrealized Gain (Loss) on Derivatives, Balances at Beginning	$ 131	$ (32)
Unrealized Gain (Loss) on Derivatives, Other comprehensive income (loss) before reclassifications	(334)	24
Unrealized Gain (Loss) on Derivatives, Amounts reclassified from accumulated other comprehensive income (loss)	222	108
Unrealized Gain (Loss) on Derivatives, Tax effect	(26)	31
Unrealized Gain (Loss) on Derivatives, Balance at Ending	(7)	131
Foreign Currency Translation Adjustment, Balances at Beginning	(94)	11
Foreign Currency Translation Adjustment, Other comprehensive income (loss) before reclassifications	78	(105)
Foreign Currency Translation Adjustment, Balance at Ending	(16)	(94)
Balances at Beginning	37	(21)
Other comprehensive income (loss) before reclassifications	(256)	(81)
Amounts reclassified from accumulated other comprehensive income (loss)	222	108
Tax effect	(26)	31
Balance at Ending	$ (23)	$ 37

Equity-Based Compensation - Add

Equity-Based Compensation - Additional Information (Details)

1 Months Ended

3 Months Ended

12 Months Ended

Jun. 15, 2023 $ / shares shares

May 31, 2023

May 31, 2022

Sep. 30, 2023 Employee

Mar. 31, 2023 Employee

Dec. 31, 2023 USD ($) $ / shares shares

Dec. 31, 2022 USD ($) $ / shares

Sep. 14, 2023 $ / shares shares

Jun. 14, 2023 shares

Jan. 01, 2023 shares

Jun. 25, 2021 shares

Dec. 31, 2020 $ / shares shares

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Payment, fair value of tax withholding and remitted taxes share-based payment arrangement | $

$ 2,178,000

$ 183,000

Common stock, par value | $ / shares

$ 0.0001

$ 0.0001

Vesting percentage exercisable of the first four anniversaries

25%

Consecutive trading days

30 days

Intrinsic value of options exercised | $

$ 0

$ 800,000

Number of warrants issued

79,612

Warrants or rights exercise price per share | $ / shares

$ 126

Warrants vesting percentage on grant date

25%

Warrants vesting percentage after one year from grant date

25%

Warrants and rights outstanding, term

7 years

10 years

Unrecognized equity-based compensation expense | $

$ 33,100,000

Unvested

318,440

Weighted-average remaining period

2 years 4 months 28 days

Number of employees terminated | Employee

25

100

General and Administrative Expense [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Reduction to equity-based compensation expense | $

$ 1,000,000

Employee Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based compensation number of shares available for grant

137,976

Common stock at a price equal

85%

Maximum percentage of annual increase in shares available for issuance of awards

1%

Common stock issued

47,257

Average price per share | $ / shares

$ 13.78

RSUs [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based compensation arrangement by share-based payment award, award vesting period

4 years

Fair value of RSU, vested | $

$ 7,900,000

$ 2,200,000

RSUs [Member] | Board of Directors [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based compensation arrangement by share-based payment award, award vesting period

1 year

Performance Vesting Options [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Option vest based on performance

318,440

Weighted average exercise price per option | $ / shares

$ 22.02

Number of options exercisable

0

Performance Vesting Options [Member] | Vesting Tranche One [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Number of options vested

79,610

Share Price | $ / shares

$ 50

Performance Vesting Options [Member] | Vesting Tranche Two [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Number of options vested

79,610

Share Price | $ / shares

$ 75

Performance Vesting Options [Member] | Vesting Tranche Three [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Number of options vested

79,610

Share Price | $ / shares

$ 100

Performance Vesting Options [Member] | Vesting Tranche Four [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Number of options vested

79,610

Share Price | $ / shares

$ 125

Amended Underwater Options [member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Number of options vested

255,174

Equity instruments other than options issued minimum threshold exercise price to consider repricing | $ / shares

$ 50

Amended Underwater Options outstanding

531,515

Exercise price | $ / shares

$ 17.35

Employee Benefits and Share-Based Compensation | $

$ 1,600,000

Unrecognized equity-based compensation expense | $

$ 1,500,000

Unvested

276,341

Weighted-average remaining period

1 year 7 months 6 days

Time Vesting Options [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Option vest based on continued service

159,221

Common Class A [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Common stock, par value | $ / shares

$ 0.0001

$ 0.0001

$ 0.0001

Number of warrants issued

543,590

Warrants or rights exercise price per share | $ / shares

$ 11.24

Warrant [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Number of warrants exercisable

79,612

Warrants will be recognized over the requisite service period

4 years 3 months

2021 Plan [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based compensation number of shares available for grant

254,995

254,995

Payment, fair value of tax withholding and remitted taxes share-based payment arrangement | $

$ 2,200,000

$ 200,000

Maximum percentage of annual increase in shares available for issuance of awards

5%

Fair value of awards vested | $

$ 9,600,000

$ 14,400,000

Inducement Plan [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based compensation number of shares available for grant

477,661

Inducement Plan [Member] | Common Class A [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based compensation number of shares available for grant

477,661

Minimum [Member] | Performance Vesting Options [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based compensation arrangement by share-based payment award, award vesting period

4 years

Minimum [Member] | Time Vesting Options [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based compensation arrangement by share-based payment award, award vesting period

4 years

Minimum [Member] | 2020 Plan [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based compensation arrangement by share-based payment award, award vesting period

3 years

Maximum [Member] | Performance Vesting Options [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based compensation arrangement by share-based payment award, award vesting period

5 years

Maximum [Member] | Amended Underwater Options [member] | Board of Directors, CEO and Executive Chairman [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock options threshold exercise price to excluded from repricing | $ / shares

$ 50

Maximum [Member] | Time Vesting Options [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based compensation arrangement by share-based payment award, award vesting period

5 years

Maximum [Member] | 2021 Plan [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based compensation number of shares available for grant

312,162

608,851

Maximum [Member] | 2020 Plan [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based compensation arrangement by share-based payment award, award vesting period

5 years

Equity-Based Compensation - Sum

Equity-Based Compensation - Summary of the Option Activity under the Equity Compensation Plans (Details) - $ / shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Time Vested Options Outstanding [Member]
Schedule of Share Based Compensation Activity [Line Items]
Number of Options, Granted	261,288
Performance Vested Options Outstanding [Member]
Schedule of Share Based Compensation Activity [Line Items]
Number of Options, Granted	318,440
2021 Plan [Member] | Time Vested Options Outstanding [Member]
Schedule of Share Based Compensation Activity [Line Items]
Number of Options, Outstanding Beginning	968,293
Number of Options, Granted	261,288
Number of Options, Expired	(196,216)
Number of Options, Forfeited	(193,886)
Number of Options, Outstanding Ending	839,479	968,293
Number of Options, Exercisable	325,767
Weighted- Average Exercise Price (per option), Outstanding Beginning	$ 132.5
Weighted- Average Exercise Price (per option), Granted	23.58
Weighted- Average Exercise Price (per option), Forfeited	130.82
Weighted- Average Exercise Price (per option), Expired	108.69
Weighted- Average Exercise Price (per option), Outstanding Ending	32.53	$ 132.5
Weighted- Average Exercise Price (per option), Exercisable	$ 36.96
Weighted- Average Remaining Contractual Term (in years), Outstanding	7 years 3 months	6 years 4 months 6 days
Weighted- Average Remaining Contractual Term (in years), Exercisable	5 years 1 month 20 days
2021 Plan [Member] | Performance Vested Options Outstanding [Member]
Schedule of Share Based Compensation Activity [Line Items]
Number of Options, Granted	318,440
Number of Options, Outstanding Ending	318,440
Weighted- Average Exercise Price (per option), Granted	$ 22.02
Weighted- Average Exercise Price (per option), Outstanding Ending	$ 22.02
Weighted- Average Remaining Contractual Term (in years), Outstanding	9 years 5 months 12 days

Equity-Based Compensation - S_2

Equity-Based Compensation - Summary of the Unvested Option Activity (Details)	12 Months Ended
	Dec. 31, 2023 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested, Number of Shares, Ending Balance | shares	318,440
Number of Time Vested Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested, Number of Shares, Beginning Balance | shares	533,173
Number of Options, Granted | shares	261,288
Number of options, Vested | shares	(170,507)
Number of Options, Forfeited | shares	(110,242)
Unvested, Number of Shares, Ending Balance | shares	513,712
Weighted-Average Grant Date Fair Value (per option), Unvested, Beginning | $ / shares	$ 69
Weighted-Average Grant Date Fair Value (per option), Granted | $ / shares	13.23
Weighted-Average Grant Date Fair Value (per option), Vested | $ / shares	56.5
Weighted-Average Grant Date Fair Value (per option), Forfeited | $ / shares	60.63
Weighted-Average Grant Date Fair Value (per option), Unvested, Ending | $ / shares	$ 33.49
Number of Performance Vested Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Options, Granted | shares	318,440
Weighted-Average Grant Date Fair Value (per option), Granted | $ / shares	$ 12.77
Weighted-Average Grant Date Fair Value (per option), Unvested, Ending | $ / shares	$ 12.77

Equity-Based Compensation - S_3

Equity-Based Compensation - Summary of RSU Activity (Details) - Restricted Stock Units (RSUs) [Member]	12 Months Ended
	Dec. 31, 2023 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of RSUs, Outstanding beginning | shares	63,184
Number of RSUs, Granted | shares	496,176
Number of RSUs, Vested | shares	(230,340)
Number of RSUs, Forfeited | shares	(27,139)
Number of RSUs, Outstanding Ending | shares	301,881
Weighted Average Fair Value (per RSU), Outstanding Beginning | $ / shares	$ 72.5
Weighted Average Fair Value (per RSU), Granted | $ / shares	28.37
Weighted-Average Fair Value (per RSU), Vested | $ / shares	34.11
Weighted Average Fair Value (per RSU), Forfeited | $ / shares	34.58
Weighted Average Fair Value (per RSU), Outstanding Ending | $ / shares	$ 31.97

Equity-Based Compensation - S_4

Equity-Based Compensation - Summary of Assumptions Used to Determine the Fair Value of Option Grants (Details) - $ / shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Performance Vesting Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free rate	3.70%
Volatility	53.70%
Expected term (in years)	10 years
Weighted-average grant date fair value	$ 13
Time Vesting Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free rate	3.90%	3%
Volatility	62.20%	52.90%
Expected term (in years)	5 years 2 months 4 days	6 years 1 month 28 days
Weighted-average grant date fair value	$ 13.65	$ 31.5
Employee Stock Purchase Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free rate	4.70%
Volatility	54.40%
Expected term (in years)	6 months
Weighted-average grant date fair value	$ 5.32

Equity-Based Compensation - S_5

Equity-Based Compensation - Summary of Equity-Based Compensation Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Schedule of Compensation Cost for Share Based Payment Arrangements Allocation of Share Based Compensation Costs by Plan [Line Items]
Equity-based compensation	$ 23,891	$ 17,620
Cost of Revenue [Member]
Schedule of Compensation Cost for Share Based Payment Arrangements Allocation of Share Based Compensation Costs by Plan [Line Items]
Equity-based compensation	2,992	1,416
Selling and Marketing [Member]
Schedule of Compensation Cost for Share Based Payment Arrangements Allocation of Share Based Compensation Costs by Plan [Line Items]
Equity-based compensation	9,852	7,015
Enterprise Technology and Development [Member]
Schedule of Compensation Cost for Share Based Payment Arrangements Allocation of Share Based Compensation Costs by Plan [Line Items]
Equity-based compensation	1,330	1,403
General and Administrative [Member]
Schedule of Compensation Cost for Share Based Payment Arrangements Allocation of Share Based Compensation Costs by Plan [Line Items]
Equity-based compensation	$ 9,717	$ 7,786

Derivative Financial Instrume_3

Derivative Financial Instruments - Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Derivative Instruments, Gain (Loss) [Line Items]
Derivative asset, notional amount		$ 462
Derivative liability, notional amount	$ 0	0
Derivative Instruments, gain (loss) Reclassification from accumulated OCI to income, estimated net amount to be transferred	$ 100
Derivative instruments, gain (loss) reclassification from accumulated OCI to income, estimate of time to transfer	12 months
Foreign Exchange Option [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative asset, notional amount	$ 4,400	17,600
Foreign Exchange Forward [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative asset, notional amount	$ 0	$ 0

Derivative Financial Instrume_4

Derivative Financial Instruments - Summary of Derivative Instrument (Details) $ in Thousands	Dec. 31, 2022 USD ($)
Derivative [Line Items]
Derivative assets	$ 462
Designated as Hedging Instrument [Member]
Derivative [Line Items]
Derivative assets	343
Not Designated as Hedging Instrument [Member]
Derivative [Line Items]
Derivative assets	$ 119

Derivative Financial Instrume_5

Derivative Financial Instruments - Summary of Pre-Tax Effects of the Company's Derivative Instruments on its Unaudited Condensed Consolidated Statements of Operations (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Gains (losses) recognized on derivatives not designated as hedging instruments	$ (256)	$ (81)
Total amounts reclassified	(222)	(108)
Foreign Currency Hedges [Member]
Total amounts reclassified	(222)	(108)
Foreign Currency Hedges [Member] | Cost of Revenue [Member]
Gains (losses) recognized on derivatives not designated as hedging instruments	(98)	13
Total amounts reclassified	(101)	(45)
Foreign Currency Hedges [Member] | General and Administrative [Member]
Total amounts reclassified	(121)	(63)
Other comprehensive income (loss) [Member] | Foreign Currency Hedges [Member]
Gains (losses) recognized on derivatives not designated as hedging instruments	$ (334)	$ 24

Income Taxes - Components of Lo

Income Taxes - Components of Loss Before Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
U.S.	$ (154,571)	$ (198,245)
Foreign	1,967	1,000
Loss before income taxes	$ (152,604)	$ (197,245)

Income Taxes - Components of In

Income Taxes - Components of Income Tax Benefit (Provision) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Current:
Federal		$ 31
State and local	$ (113)	202
Foreign	(115)	(141)
Current income tax provision (benefit)	(228)	92
Deferred:
Federal	(23)	1,963
State and local	71	870
Foreign	143	128
Deferred income tax (provision) benefit	191	2,961
Income tax (provision) benefit , net	$ (37)	$ 3,053

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2017
Operating Loss Carryforwards [Line Items]
Research tax credits	$ 3,886	$ 3,886
Deferred tax liabilities	10	$ 181
U.S.
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards	$ 339,900		$ 2,300
Accumulated operating loss carryforward period	20 years
Accumulated operating loss carryforward indefinitely	$ 337,600
Operating loss carryforwards limitation on use description	80% taxable income limitation
Operating loss carryforward expiration year	2037
Research tax credits	$ 3,500
Income tax credit research expiration year	2039
State
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards	$ 384,700
Operating loss carryforward expiration year	2025
Research tax credits	$ 1,700

Income Taxes - Actual Tax Rate

Income Taxes - Actual Tax Rate on Loss Before Income Taxes Reconciles (Details)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Federal statutory rate	21%	21%
State income taxes, net of federal benefit	2.50%	3.60%
Valuation allowance on deferred tax assets	(17.20%)	(24.20%)
Goodwill Impairment	(5.50%)
Equity-based compensation	(1.10%)	(1.10%)
Adjustments to prior year provision	0.70%	1.40%
Note revaluation	(0.60%)
Common stock warrant liability	0.40%	0.90%
Other	(0.20%)	(0.10%)
Effective tax rate	0%	1.50%

Income Taxes - Schedule of Comp

Income Taxes - Schedule of Components of Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Deferred tax assets:
Net operating losses	$ 91,585	$ 74,038
Equity-based compensation	13,358	10,652
Inventory	12,339	18,525
Tax basis step-up	11,570	13,240
Capitalized research expense	9,592	6,057
Intangible assets	6,552	4,915
R & D credit carryover	3,886	3,886
Accrued expenses	1,064	1,438
Lease obligations	837	1,663
Accrued employee compensation and benefits	546	4,246
Other	4,517	2,164
Total deferred tax assets	155,846	140,824
Deferred tax liabilities:
Property and equipment	(5,853)	(13,377)
Content assets	(4,448)	(7,408)
Prepaid expenses	(1,969)	(2,425)
Right-of-use assets	(750)	(1,231)
Total deferred tax liabilities	(13,020)	(24,441)
Net deferred tax assets before valuation allowance	142,826	116,383
Valuation allowance	(142,836)	(116,564)
Net deferred tax liabilities	$ (10)	$ (181)

Income Taxes - Summary of Activ

Income Taxes - Summary of Activity Related to Gross Unrecognized Tax Benefits (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Unrecognized tax benefits, beginning of year	$ 1,044	$ 568
Additions for current year tax positions	0	476
Unrecognized tax benefits (excluding interest and penalties), end of year	1,044	1,044
Interest and penalties associated with unrecognized tax benefits	0	0
Unrecognized tax benefits including interest and penalties, end of year	$ 1,044	$ 1,044

Employee Benefit Plan - Additio

Employee Benefit Plan - Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Employee Benefit Plans [Abstract]
Defined contribution plan employer matching contribution percent of match	50%
Defined contribution plan employer matching contribution percent	6%
Defined contribution plan maximum annual contributions per employee percent	75%
Defined contribution plan cost recognized	$ 1.9	$ 2.9

Earnings (Loss) Per Share - Sum

Earnings (Loss) Per Share - Summary of the Computation of Loss Per Share of Class A and Class X Common Stock (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Numerator:
Net loss	$ (152,641)	$ (194,192)
Denominator:
Weighted-average common shares outstanding, basic	6,238,777	6,149,784
Weighted-average common shares outstanding, diluted	6,238,777	6,149,784
Net loss per common share, basic	$ (24.47)	$ (31.58)
Net loss per common share, diluted	$ (24.47)	$ (31.58)

Earnings (Loss) per Share - Add

Earnings (Loss) per Share - Additional Information (Details) - $ / shares	Dec. 13, 2023	Jun. 15, 2023	Dec. 22, 2021
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Shares issued in the equity offering	420,769
Vesting Tranche One [Member]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Share price			$ 600
Vesting Tranche Two [Member]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Share price			650
Vesting Tranche Three [Member]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Share price			700
Vesting Tranche Four [Member]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Share price			750
Vesting Tranche Five [Member]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Share price			$ 800
Founder Share [Member] | Forest Road
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Earn-out shares threshold trading days			20 days
Earn-out shares threshold consecutive trading days			30 days
Earn-out shares term of vesting			10 years
Founder Share [Member] | Forest Road | Vesting Tranche One [Member]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Earn-out shares vesting percentage			10%
Founder Share [Member] | Forest Road | Vesting Tranche Two [Member]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Earn-out shares vesting percentage			10%
Founder Share [Member] | Forest Road | Vesting Tranche Three [Member]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Earn-out shares vesting percentage			10%
Founder Share [Member] | Forest Road | Vesting Tranche Four [Member]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Earn-out shares vesting percentage			10%
Founder Share [Member] | Forest Road | Vesting Tranche Five [Member]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Earn-out shares vesting percentage			10%
Maximum [Member] | Class A Common Stock [Member]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Pre-funded warrants to purchase	122,821
The Forfeiture Agreement [Member]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Number of shares, forfeited		160,000
The Forfeiture Agreement [Member] | Class A Common Stock [Member]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Number of shares, forfeited		63,999

Earnings (Loss) Per Share - S_2

Earnings (Loss) Per Share - Summary of Common Shares That Are Excluded From the Computation of Diluted Net Loss Per Common Share (Details) - shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	2,562,151	1,587,091
Time Vested Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	839,479	968,293
Performance Vested Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	318,440
RSUs [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	301,881	63,184
Compensation Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	79,612	79,612
Public and Private Placement Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	306,667	306,667
Term Loan Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	97,482	94,335
Common Stock Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	543,590
Forest Road Earn-out Shares [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	75,000	75,000

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Royalty Agreements [Member]
Related Party Transaction [Line Items]
Payments to the related party	$ 400,000	$ 500,000
Amount due to the related party	200,000	200,000
Legal Services [Member]
Related Party Transaction [Line Items]
Payments to the related party	500,000	1,300,000
Amount due to the related party	100,000	$ 0
Financial Advisory Services [Member]
Related Party Transaction [Line Items]
Payments to the related party	1,000,000
Amount due to the related party	$ 0

Segment Information - Additiona

Segment Information - Additional Information (Details)	12 Months Ended
	Dec. 31, 2023 Segment
Segment Reporting [Abstract]
Number of operating segments	2
Number of reportable segments	1

Parent Only Financial Stateme_3

Parent Only Financial Statements - Condensed Balance Sheet (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 33,409	$ 80,091
Prepaid expenses	10,715	13,055
Total current assets	119,273	186,454
Total assets	276,839	443,395
Current liabilities:
Accrued expenses	42,147	64,430
Total current liabilities	165,203	184,640
Total liabilities	194,079	231,853
Stockholders' equity:
Additional paid-in capital	654,657	630,738
Accumulated deficit	(571,876)	(419,235)
Accumulated other comprehensive loss	(23)	37
Total stockholders’ equity	82,760	211,542	$ 385,385
Total liabilities and stockholders' equity	276,839	443,395
Class A Common Stock [Member]
Stockholders' equity:
Common stock value	1	1
Class X Common Stock [Member]
Stockholders' equity:
Common stock value	1	$ 1
The Beachbody Company, Inc.
Current assets:
Cash and cash equivalents	25
Prepaid expenses	12
Investment in subsidiaries	463,955
Total current assets	463,992
Total assets	463,992
Current liabilities:
Accrued expenses	7
Due to subsidiaries	378,100
Total current liabilities	378,107
Warrant liabilities	3,125
Total liabilities	381,232
Stockholders' equity:
Additional paid-in capital	654,657
Accumulated deficit	(571,899)
Total stockholders’ equity	82,760
Total liabilities and stockholders' equity	463,992
The Beachbody Company, Inc. | Class A Common Stock [Member]
Stockholders' equity:
Common stock value	1
The Beachbody Company, Inc. | Class X Common Stock [Member]
Stockholders' equity:
Common stock value	$ 1

Parent Only Financial Stateme_4

Parent Only Financial Statements - Condensed Balance Sheet (Parenthetical) (Details) - shares	Dec. 31, 2023	Dec. 31, 2022
Class A Common Stock [Member]
Common stock, shares issued	3,978,356	3,418,237
Common stock, shares outstanding	3,978,356	3,418,237
Class X Common Stock [Member]
Common stock, shares issued	2,729,003	2,825,006
Common stock, shares outstanding	2,729,003	2,825,006
Parent Company [Member] | Class A Common Stock [Member]
Common stock, shares issued	3,978,356
Common stock, shares outstanding	3,978,356
Parent Company [Member] | Class X Common Stock [Member]
Common stock, shares issued	2,729,003
Common stock, shares outstanding	2,729,003

Parent Only Financial Stateme_5

Parent Only Financial Statements - Condensed Statement of Operations and Comprehensive Loss (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Change in fair value of warrant liabilities	$ 2,679	$ 8,322
Other income	1,747	958
Total comprehensive loss	(152,701)	$ (194,134)
The Beachbody Company, Inc.
Change in fair value of warrant liabilities	2,679
Other income	127
Equity in net loss of subsidiaries	(155,507)
Total comprehensive loss	$ (152,701)

Parent Only Financial Stateme_6

Parent Only Financial Statements - Condensed Statement of Cash Flows (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net loss	$ (152,641)	$ (194,192)
Adjustments to reconcile net loss to net cash provided by operating activities:
Change in fair value of warrant liabilities	(2,679)	(8,322)
Changes in operating assets and liabilities:
Prepaid expenses	2,340	2,806
Accrued expenses	(20,293)	(8,673)
Net cash used in operating activities	(22,537)	(47,173)
Cash flows from investing activities:
Net cash used in investing activities	(10,826)	(26,493)
Cash flows from financing activities:
Proceeds from issuance of common shares in the Employee Stock Purchase Plan	4,908
Net cash (used in) provided by financing activities	(13,717)	47,561
Effect of exchange rates on cash	398	(858)
Net decrease in cash, cash equivalents and restricted cash	(46,682)	(26,963)
Cash, cash equivalents and restricted cash, beginning of year	80,091	107,054
Cash, cash equivalents and restricted cash, end of year	33,409	80,091
Supplemental disclosure of noncash investing activities:
Change in fair value of term loan warrants due to amended exercise price	802
The Beachbody Company, Inc.
Cash flows from operating activities:
Net loss	(152,701)
Adjustments to reconcile net loss to net cash provided by operating activities:
Change in fair value of warrant liabilities	(2,679)
Equity in net loss of subsidiaries	155,507
Changes in operating assets and liabilities:
Prepaid expenses	8
Accrued expenses	9
Net cash used in operating activities	144
Cash flows from investing activities:
Net cash used in investing activities	0
Cash flows from financing activities:
Decrease in due to subsidiaries	(8,299)
Proceeds from issuance of common shares in the Employee Stock Purchase Plan	553
Tax withholdings payments for vesting of restricted stock	(2,178)
Proceeds from issuance of Equity Offering, net of issuance costs	4,908
Net cash (used in) provided by financing activities	(5,016)
Net decrease in cash, cash equivalents and restricted cash	(4,872)
Cash, cash equivalents and restricted cash, beginning of year	4,897
Cash, cash equivalents and restricted cash, end of year	$ 25	$ 4,897

Subsequent Events - Additional

Subsequent Events - Additional Information (Details) $ in Thousands				3 Months Ended	12 Months Ended
	Feb. 29, 2024 USD ($) Option	Jan. 09, 2024 USD ($)	Jul. 24, 2023 USD ($)	Mar. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Subsequent Event [Line Items]
Borrowings outstanding					$ 35,095
Property and equipment, net					45,055	$ 74,147
Annual lease base rate					2,459	2,991
Investment in equity securities of privately-held company					1,000	$ 5,000
Van Nuys Production Facility [Member]
Subsequent Event [Line Items]
Property and equipment, net					4,800
Term Loan [Member]
Subsequent Event [Line Items]
Partial prepayment on term loan			$ 15,000
Percentage of repayment of debt instrument			5%
Financial covenants, minimum revenue required, thereafter till maturity		$ 24,000
Financial covenants, minimum revenue required till consent effective date through and including March 31, 2024		19,000
Borrowings outstanding					$ 35,500
Subsequent Event [Member] | Van Nuys Production Facility [Member]
Subsequent Event [Line Items]
Proceed from sale of plant and equipment	$ 6,200
Number of lease options | Option	2
Annual lease base rate	$ 300
Lease term	5 years
Lease extend period	3 years
Subsequent Event [Member] | Term Loan [Member]
Subsequent Event [Line Items]
Partial prepayment on term loan		$ 1,000
Percentage of repayment of debt instrument		3%
Financial covenants, minimum revenue required, thereafter till maturity	$ 22,000
Financial covenants, minimum revenue required till consent effective date through and including March 31, 2024	17,000
Borrowings outstanding	28,600
Investment in equity securities of privately-held company		$ 1,000
Subsequent Event [Member] | Term Loan [Member] | Van Nuys Production Facility [Member]
Subsequent Event [Line Items]
Partial prepayment on term loan	$ 5,500
Percentage of repayment of debt instrument	3%
Increase in lease cost every year	3%
Scenario Forecast [Member]
Subsequent Event [Line Items]
Termination benefits costs				$ 1,700

Financial Statement Schedule -

Financial Statement Schedule - (Details) - Deferred Tax Asset Valuation Allowance [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2020
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]
Beginning of year	$ 68,109
Additions charged to earnings	47,640	$ 26,272
Other	815
End of year	$ 116,564	$ 142,836